Method for producing cured product, method for producing multilayer body, method for producing semiconductor device, resin composition, cured product, multilayer body and semiconductor device

A method for manufacturing cured products with low outgassing by heating at 180°C or lower and a glass transition temperature of 200°C or higher addresses the outgassing issue, resulting in improved adhesion and reliability for semiconductor devices.

KR1020260161908APending Publication Date: 2026-11-10FUJIFILM CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
KR1020267035178
Authority / Receiving Office
KR · KR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-07-30
Filing Date
2022-06-30
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing methods for manufacturing cured products from cyclized resin compositions result in significant outgassing, which is undesirable for applications such as semiconductor devices.

Method used

A method involving a film-forming process followed by heating at 180°C or lower, with a glass transition temperature of 200°C or higher, and including exposure and development processes to form a cured product with low outgassing, using a resin composition containing a precursor of cyclized resin with specific polymerizable compounds and a high imidization rate.

Benefits of technology

The method achieves a cured product with minimal outgassing, enhancing adhesion and reducing outgas leakage, thereby improving the reliability of semiconductor devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PAT00001
    Figure PAT00001
  • Figure PAT00002
    Figure PAT00002
  • Figure PAT00003
    Figure PAT00003
Patent Text Reader

Abstract

The invention provides a method for manufacturing a cured product having low outgassing generation, a method for manufacturing a laminate using the method for manufacturing the cured product, and a method for manufacturing a semiconductor device; and a resin composition having low outgassing generation from the obtained cured product, and a cured product formed by curing the resin composition, a laminate including the cured product, and a semiconductor device. The method for manufacturing the cured product includes a film forming process in which a resin composition including a precursor of a cyclized resin is applied to a substrate to form a film, and a heating process in which the film is heated at a heating temperature of 180°C or lower, and the glass transition temperature of the obtained cured product is 200°C or higher.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The present invention relates to a method for manufacturing a cured product, a method for manufacturing a laminate, a method for manufacturing a semiconductor device, a resin composition, a cured product, a laminate, and a semiconductor device. Background Technology

[0002] Cyclic resins, such as polyimide, are applied in various uses due to their excellent heat resistance and insulation properties. While these applications are not particularly limited, taking semiconductor devices for mounting as an example, they are used as insulating films, sealing materials, or protective films. They are also utilized as base films or cover layers for flexible substrates.

[0003] For example, in the above-described use, a cyclized resin such as polyimide is used in the form of a resin composition comprising at least one of a cyclized resin such as polyimide and a precursor of a cyclized resin.

[0004] A resin composition of this kind can be applied to a substrate, for example by coating, to form a photosensitive film, and then, if necessary, by performing exposure, development, heating, etc., a cured product can be formed on the substrate.

[0005] The precursor of the above-mentioned cyclized resin, such as a polyimide precursor, is cyclized by, for example, heating, and becomes a cyclized resin such as polyimide in the cured product.

[0006] Since the resin composition can be applied using known coating methods, it can be said to have excellent manufacturing adaptability, such as a high degree of design freedom regarding the shape, size, and application location of the resin composition when applied. In addition to the high performance of cyclized resins such as polyimide, the development of industrial applications of the aforementioned resin composition is increasingly anticipated from the perspective of such excellent manufacturing adaptability.

[0007] For example, Patent Document 1 describes a semiconductor device comprising a semiconductor chip, a sealing material covering the semiconductor chip, and a redistribution layer having an area larger than that of the semiconductor chip in a planar state, wherein the weight loss rate after heating to 700°C at a rate of 10°C / min in an air atmosphere of the interlayer insulating film of the redistribution layer is 5 to 95 weight%. Prior art literature

[0008] Patent Document 1: Japanese Published Patent Application No. 2020-113748 The problem to be solved

[0009] In a method for obtaining a cured product by curing a resin composition containing a precursor of a cyclized resin, there are cases where it is required that the generation of outgassing from the cured product be minimal.

[0010] The present invention aims to provide a method for manufacturing a cured product in which the generation of outgassing is low, a method for manufacturing a laminate using the method for manufacturing the cured product, and a method for manufacturing a semiconductor device.

[0011] In addition, the present invention aims to provide a resin composition having low outgassing from the obtained cured product, a cured product formed by curing the resin composition, a laminate comprising the cured product, and a semiconductor device. means of solving the problem

[0012] Examples of representative embodiments of the present invention are shown below.

[0013] <1> A film forming process in which a resin composition comprising a precursor of a cyclized resin is applied to a substrate to form a film, and,

[0014] A method for manufacturing a cured product comprising a heating process of heating the above film at a heating temperature of 180°C or lower,

[0015] A method for manufacturing a cured product having a glass transition temperature of 200°C or higher.

[0016] <2> The above heating temperature is 170℃ or lower, <1> Method for manufacturing a cured product as described in

[0017] <3> The film after the above heating process is a polyimide film, and the imidization rate of the film is 90% or higher, <1> or <2> Method for manufacturing a cured product as described in

[0018] <4> Between the above film formation process and the above heating process, further comprising an exposure process for selectively exposing the film, <1> inside <3> A method for manufacturing a cured product as described in any one of the following.

[0019] <5> Between the above exposure process and the above heating process, further comprising a developing process that forms a pattern by developing the film after exposure using a developing solution. <4> Method for manufacturing a cured product as described in

[0020] <6> The above developer includes an organic solvent, <5> Method for manufacturing a cured product as described in

[0021] <7> The above-mentioned phenomenon process is a process for forming a negative type pattern, <5> or <6> Method for manufacturing a cured product as described in

[0022] <8> The above developer contains a base, <5> inside <7> A method for manufacturing a cured product as described in any one of the following.

[0023] <9> Between the above-mentioned development process and the above-mentioned heating process, a treatment process comprising contacting a treatment solution containing a base with the above-mentioned pattern, <5> inside <8> A method for manufacturing a cured product as described in any one of the following.

[0024] <10> The above resin composition comprises a photosensitive agent, <1> inside <9> A method for manufacturing a cured product as described in any one of the following.

[0025] <11> The above resin composition comprises a solvent, and the content of the precursor of the cyclized resin is 70 mass% or more with respect to the total solid content of the resin composition, <1> inside <10> A method for manufacturing a cured product as described in any one of the following.

[0026] <12> The above resin composition comprises a polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere, <1> inside <11> A method for manufacturing a cured product as described in any one of the following.

[0027] <13> A polymerizable compound having a boiling point of 200°C or higher at the above 1 atmosphere is a compound having three or more (meth)acrylate groups, <12> Method for manufacturing a cured product as described in

[0028] <14> The above resin composition comprises a polymerizable compound having an aliphatic ring structure, <1> inside <13> A method for manufacturing a cured product as described in any one of the following.

[0029] <15> The precursor of the above-mentioned cyclization resin is a resin having at least one of the repeating unit represented by the following formula (2) and the repeating unit represented by the formula (PAI-2). <1> inside <14> A method for manufacturing a cured product as described in any one of the following.

[0030] [Chemical Formula 1]

[0031]

[0032] Among equation (2), A 1 and A 2 are, respectively, oxygen atoms or -NR z - indicates, R 111 Silver represents a divalent organic group, and R 115 represents a tetravalent organic group, and R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group.

[0033] In equation (PAI-2), R 117 represents a trivalent organic group, and R 111 represents a divalent organic group, and A 2 is an oxygen atom or -NR z - indicates, R 113represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group.

[0034] <16> R in the above equation (2) 115 a is a group represented by any one of the following formulas (X1-1) to (X1-3), or a group comprising one or more aliphatic ring structures, wherein R in the above formula (PAI-2) 117 A group represented by any one of the following formulas (X2-1) to (X2-3), or a group comprising one or more aliphatic ring structures, <15> Method for manufacturing a cured product as described in

[0035] [Chemical Formula 2]

[0036]

[0037] In formula (X1-1), R represents a substituent, n1 represents an integer from 0 to 2, and * represents a binding site with another structure.

[0038] In equation (X1-2), R represents a substituent independently, m1 represents an integer from 0 to 3 independently, and * represents a binding site with another structure.

[0039] In equation (X1-3), R independently represents a substituent, m1 independently represents an integer from 0 to 2, and L 1 -CR C Represents 2- or -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0040] In formula (X2-1), R represents a substituent, n2 represents an integer from 0 to 2, and * represents a binding site with another structure.

[0041] In formula (X2-2), R represents a substituent independently, m2 represents an integer from 0 to 3, m3 represents an integer from 0 to 4, and * represents a binding site with another structure.

[0042] In equation (X2-3), R represents a substituent independently, m2 represents an integer from 0 to 2, m3 represents an integer from 0 to 3, and L 2 is -CR C Represents 2-, -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0043] <17> R in the above equation (2) 111 A group represented by any one of the following formulas (W1-1) to (W1-5), or a group comprising one or more aliphatic ring structures, wherein R in the above formula (PAI-2) 111 A group represented by any one of the following formulas (W1-1) to (W1-3), or a group comprising one or more aliphatic ring structures, <15> or <16> Method for manufacturing a cured product as described in

[0044] [Chemical Formula 3]

[0045]

[0046] In formula (W1-1), R represents a substituent, n1 represents an integer from 0 to 4, and * represents a binding site with another structure.

[0047] In formula (W1-2), R independently represents a substituent, m4 independently represents an integer from 0 to 4, and * each represents a binding site with another structure.

[0048] In equation (W1-3), R independently represents a substituent, m4 independently represents an integer from 0 to 3, and L 3 -CR CRepresents 2- or -S(=O)2-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0049] In formula (W1-4), R represents a substituent independently, n3 represents an integer from 0 to 6, and * represents a binding site with another structure.

[0050] In equation (W1-5), R independently represents a substituent, n4 independently represents an integer from 0 to 3, and X 1 and X 2 Each independently is an oxygen atom, -S(=O)2 or -CR C Represents 2-, and R C Each represents independently a hydrogen atom or a monovalent organic group, and * represents a bonding site with another structure.

[0051] <18> Satisfying at least one of the following Condition 1 and Condition 2, <15> inside <17> A method for manufacturing a cured product as described in any one of the following.

[0052] Condition 1: The precursor of the above-mentioned cyclization resin is -A in the above-mentioned formula (2). 2 -R 113 and -A 1 -R 114 At least one of them includes a repeating unit that is represented by the following formula (3-1).

[0053] Condition 2: The precursor of the above-mentioned cyclizing resin is -A in the above-mentioned formula (PAI-2). 2 -R 113 This includes the repeating unit represented by the following equation (3-1).

[0054] [Chemical Formula 4]

[0055]

[0056] In Equation (3-1), Z 1 and Z 2 Each represents an organic group independently, and Z1 and Z 2 It may combine to form a ring structure, and * indicates a site of connection with another structure.

[0057] <19> <1> inside <18> A method for manufacturing a laminate comprising repeating the method for manufacturing a cured product described in any one of the above multiple times.

[0058] <20> <1> inside <18> A method for manufacturing a cured product as described in any one of the following, or, <19> A method for manufacturing a semiconductor device comprising a method for manufacturing a laminate as described in

[0059] <21> A resin composition comprising a precursor of a cyclized resin,

[0060] A resin composition having at least one glass transition temperature of 200°C or higher among three films of different thicknesses when the glass transition temperature is measured under measurement condition 1 below;

[0061] Measurement Condition 1:

[0062] The above resin composition is applied to a silicon substrate to a thickness of 5 μm, 10 μm, or 20 μm, respectively, dried at 100°C for 5 minutes, and then a cured product is obtained by heating at 180°C for 2 hours, and the glass transition temperature of the cured product, returned to 25°C, is measured using a differential scanning calorimeter.

[0063] <22> <21> A cured product formed by curing the resin composition described in

[0064] <23> It comprises two or more layers of a cured product formed by curing a resin composition containing a precursor of a cyclized resin, and

[0065] At least one layer among the layers consisting of the above-mentioned cured material <22> A layer consisting of the hardened material described in

[0066] Laminated structure.

[0067] <24> <22> The hardened material or listed in <23> A semiconductor device comprising a laminate as described in Effects of the invention

[0068] According to the present invention, a method for manufacturing a cured product having low out-gas generation is provided, and a method for manufacturing a laminate using the method for manufacturing the cured product and a method for manufacturing a semiconductor device are provided.

[0069] In addition, according to the present invention, a resin composition having low out-gas generation from the obtained cured product, a cured product formed by curing the resin composition, a laminate comprising the cured product, and a semiconductor device are provided. Specific details for implementing the invention

[0070] The main embodiments of the present invention will be described below. However, the present invention is not limited to the embodiments specified.

[0071] In this specification, a numerical range indicated by the symbol "~" means a range that includes the values ​​listed before and after "~" as a lower limit and an upper limit, respectively.

[0072] In this specification, the term "process" includes not only independent processes but also processes that are not clearly distinguishable from other processes insofar as they can achieve the intended function of the process.

[0073] In the notation of groups (atomic groups) in this specification, notations that do not specify substitution or non-substitution include groups (atomic groups) that have substituents along with groups (atomic groups) that do not have substituents. For example, "alkyl group" includes not only alkyl groups that do not have substituents (non-substituted alkyl groups) but also alkyl groups that have substituents (substituted alkyl groups).

[0074] In this specification, the term "exposure" includes not only exposure using light, but also exposure using particle beams such as electron beams and ion beams, unless specifically explained otherwise. In addition, light used for exposure may include active light or radiation such as the emission spectrum of mercury lamps, far ultraviolet light represented by excimer lasers, extreme ultraviolet light (EUV light), X-rays, and electron beams.

[0075] In this specification, "(meth)acrylate" means either "acrylate" or "methacrylate," "(meth)acryl" means either "acryl" or "methacryl," and "(meth)acryloyl" means either "acryloyl" or "methacryloyl."

[0076] In the present specification, Me represents a methyl group, Et represents an ethyl group, Bu represents a butyl group, and Ph represents a phenyl group in the structural formula.

[0077] In this specification, "total solid content" refers to the total mass of the components excluding the solvent from the total components of the composition. Also in this specification, "solid content concentration" refers to the mass percentage of the components excluding the solvent relative to the total mass of the composition.

[0078] In this specification, the weight-average molecular weight (Mw) and number-average molecular weight (Mn) are values ​​measured using gel permeation chromatography (GPC) unless specifically stated otherwise, and are defined as polystyrene equivalent values. In this specification, the weight-average molecular weight (Mw) and number-average molecular weight (Mn) can be obtained, for example, by using HLC-8220GPC (manufactured by Dosho Co., Ltd.) and connecting in series guard columns HZ-L, TSKgel Super HZM-M, TSKgel Super HZ4000, TSKgel Super HZ3000, and TSKgel Super HZ2000 (all manufactured by Dosho Co., Ltd.) as columns. Unless specifically stated otherwise, their molecular weights are to be measured using THF (tetrahydrofuran) as the eluent. However, if THF is not suitable as the eluent, such as in cases of low solubility, NMP (N-methyl-2-pyrrolidone) may be used. In addition, unless otherwise specified, detection in GPC measurement is assumed to use a detector with a wavelength of 254 nm of UV rays (ultraviolet rays).

[0079] In this specification, when the positional relationship of each layer constituting a laminate is described as "up" or "down," it is sufficient that there is another layer above or below the reference layer among the multiple layers being considered. That is, a third layer or element may be additionally interposed between the reference layer and the other layer, and the reference layer and the other layer do not need to be in contact. Furthermore, unless specifically explained otherwise, the direction in which layers are stacked relative to the substrate is referred to as "up," or, if there is a resin composition layer, the direction from the substrate toward the resin composition layer is referred to as "up," and the opposite direction is referred to as "down." Additionally, such setting of up and down directions is for convenience within this specification, and in actual embodiment, the "up" direction in this specification may differ from the vertical upward direction.

[0080] In this specification, unless otherwise specified, a composition may include two or more compounds corresponding to each component included in the composition. Also, unless otherwise specified, the content of each component in the composition refers to the total content of all compounds corresponding to that component.

[0081] In this specification, unless specifically described otherwise, the temperature is 23℃, the pressure is 101,325 Pa (1 atm), and the relative humidity is 50%RH.

[0082] In this specification, a combination of preferred embodiments is a more preferred embodiment.

[0083] (Method for manufacturing a hardened material)

[0084] The method for manufacturing a cured product according to the present invention comprises a film forming process in which a resin composition comprising a precursor of a cyclized resin is applied to a substrate to form a film, and a heating process in which the film is heated at a heating temperature of 180°C or lower, and the glass transition temperature of the obtained cured product is 200°C or higher.

[0085] According to the method for manufacturing a cured product of the present invention, a cured product with low outgassing is obtained.

[0086] The mechanism by which the above effect is obtained is unknown, but it is speculated as follows.

[0087] Conventionally, a cured product has been obtained using a resin composition containing a precursor of a cyclized resin.

[0088] In the method for manufacturing a cured product of the present invention, the heating temperature in the heating process is 180°C or lower, and the glass transition temperature of the film after the heating process is 200°C or higher.

[0089] Here, it is presumed that when the glass transition temperature is 200°C or higher, the cyclization rate of the cyclization resin in the film is high.

[0090] It is believed that the high cyclization rate when cured at 180°C or lower suppresses the generation of outgases caused by cyclization within the film again after curing.

[0091] Due to these actions, it is presumed that according to the method for manufacturing a cured product of the present invention, even if the cured product is obtained by heating at a low temperature of 180°C or lower, the amount of outgassing is suppressed when the glass transition temperature is 200°C or higher.

[0092] In addition, when the resin composition contains a polymerizable compound, the glass transition temperature is thought to be correlated with the rigidity of the structure of the polymerizable compound and the reaction rate. That is, when the glass transition temperature is 200°C or higher, the structure formed by the polymerization of the polymerizable compound is relatively rigid, and the amount of unreacted polymerizable compound in the film is small.

[0093] It is believed that out-gas leakage is more easily suppressed because the structure formed by the polymerization of polymerizable compounds is a rigid structure.

[0094] In addition, it is thought that because the amount of unreacted polymerizable compound is small, the crosslinking becomes denser, making it easier to suppress outgassing, and also making it easier to suppress outgassing caused by the volatilization of the polymerizable compound itself.

[0095] In addition, it is believed that when the oxidization rate is high, the migration of metal ions from the metal layer, which uses the unoxidized portion as a penetration path, to the hardened material is also suppressed.

[0096] Therefore, it is presumed that if the glass transition temperature is 200°C or higher, the adhesion to the metal is also improved.

[0097] Hereinafter, each process included in the method for manufacturing a cured product of the present invention and the physical properties of the cured product will be described in detail.

[0098] Film formation process

[0099] The method for manufacturing a cured product of the present invention includes a film-forming process in which a resin composition comprising a precursor of a cyclized resin is applied to a substrate to form a film.

[0100] Details of the above resin composition will be described later.

[0101] 〔write〕

[0102] The type of substrate can be appropriately determined according to the application, but may include semiconductor manufacturing substrates such as silicon, silicon nitride, polysilicon, silicon oxide, and amorphous silicon; quartz, glass, optical film, ceramic material, deposition film, magnetic film, reflective film, metal substrates such as Ni, Cu, Cr, and Fe (e.g., any of a substrate formed of metal and a substrate in which a metal layer is formed, for example, by plating or deposition); paper, SOG (Spin On Glass), TFT (Thin Film Transistor) array substrate, mold substrate, electrode plate of a plasma display panel (PDP), etc., and is not particularly limited. In the present invention, a semiconductor manufacturing substrate is particularly preferred, and a silicon substrate, a Cu substrate, and a mold substrate are more preferred.

[0103] In addition, the substrate may have a layer such as an adhesion layer or an oxide layer formed by hexamethyldisilase (HMDS), etc., provided on its surface.

[0104] In addition, the shape of the material is not particularly limited and may be circular or rectangular.

[0105] As for the size of the substrate, if it is circular, for example, the diameter is 100 to 450 mm, preferably 200 to 450 mm. If it is rectangular, for example, the length of the short side is 100 to 1000 mm, preferably 200 to 700 mm.

[0106] In addition, as a substrate, for example, a plate-shaped substrate (substrate) is used, preferably a panel-shaped substrate.

[0107] In addition, when a film is formed by applying a resin composition to the surface of a resin layer (for example, a layer made of a cured material) or a metal layer, the resin layer or the metal layer serves as the substrate.

[0108] As a means of applying the resin composition onto a substrate, coating is preferred.

[0109] Examples of means of application include, specifically, dip coating, air knife coating, curtain coating, wire bar coating, gravure coating, extrusion coating, spray coating, spin coating, slit coating, and inkjet methods. In terms of the uniformity of film thickness, spin coating, slit coating, spray coating, or inkjet methods are more preferably used, and spin coating and slit coating methods are preferred in terms of film thickness uniformity and productivity. Depending on the method, a film of a desired thickness can be obtained by adjusting the solid content concentration of the resin composition or the application conditions.

[0110] In addition, the coating method can be appropriately selected depending on the shape of the substrate. For circular substrates such as wafers, spin coating, spray coating, or inkjet methods are preferred, and for rectangular substrates, slit coating, spray coating, or inkjet methods are preferred. In the case of spin coating, for example, it can be applied for about 10 seconds to 3 minutes at a rotation speed of 500 to 3,500 rpm.

[0111] In addition, a method of transferring a coating film formed by applying it to a support in advance using the above-mentioned method onto a substrate may also be applied.

[0112] Regarding the transfer method, the manufacturing method described in paragraphs 0023, 0036 to 0051 of Japanese Patent Publication No. 2006-023696 or paragraphs 0096 to 0108 of Japanese Patent Publication No. 2006-047592 can also be suitably used in the present invention.

[0113] In addition, a process for removing excess film at the end portion of the substrate may be performed. Examples of such a process include edge bead rinse (EBR) and back rinse.

[0114] In addition, a pre-wet process may be adopted in which various solvents are applied to the substrate before applying the resin composition to improve the wettability of the substrate, and then the resin composition is applied.

[0115] Drying Process

[0116] The above film may be provided to a drying process (drying process) for drying the formed film (layer) to remove the solvent after a film forming process (layer forming process).

[0117] That is, the method for manufacturing a cured product of the present invention may include a drying process for drying a film formed by a film forming process.

[0118] In addition, it is preferable that the above drying process be performed after the film formation process and before the photolithography process.

[0119] In the drying process, the drying temperature of the film is preferably 50 to 150°C, more preferably 70°C to 130°C, and more preferably 90°C to 110°C. Additionally, drying may be performed under reduced pressure. As for the drying time, 30 seconds to 20 minutes is exemplified, 1 minute to 10 minutes is preferable, and 2 minutes to 7 minutes is more preferable.

[0120] Heating Process

[0121] The method for manufacturing a cured product of the present invention includes a heating process of heating the film at a heating temperature of 180°C or lower.

[0122] Here, the film in the heating process may be a film (pattern) after development that has undergone the exposure and development processes described later, or a film that has undergone the exposure process described later but has not undergone the development process, or a film formed by the film formation process described above (and, if necessary, the drying process described above) and has not undergone any other processes.

[0123] In addition, in the method for manufacturing a cured product of the present invention, it is preferable that the temperature of the film be 180°C or lower in the entire process including the heating process. According to the above embodiment, damage caused by heat to materials such as a substrate can be suppressed.

[0124] In addition, in the method for manufacturing a cured product of the present invention, it is preferable that the temperature of the film be 180°C or lower in the entire process including the heating process. According to the above embodiment, damage caused by heat to materials such as a substrate can be suppressed.

[0125] In the heating process, the resin, such as the polyimide precursor, is cyclized to become the polyimide resin.

[0126] In addition, during the heating process, the crosslinking of unreacted crosslinkable groups in the specific resin or crosslinking agent other than the specific resin described later is also carried out.

[0127] As for the heating temperature (maximum heating temperature) in the heating process, 20 to 180°C is preferred, 150 to 180°C is more preferred, and 160 to 180°C is more preferred.

[0128] Here, it is preferable that the film after the heating process is a polyimide film. Specifically, it is preferable that the resin included in the film after the heating process is a resin having an imide ring structure in its repeating units.

[0129] The heating process is preferably a process that promotes the cyclization reaction of the precursor of the cyclizing resin within the membrane by heating, and is more preferably a process that promotes the cyclization reaction of the precursor of the cyclizing resin within the membrane by the action of a specific resin described later, or a base generated from a base generating agent, a base penetrating from a developer, a base penetrating from a rinse solution, etc.

[0130] That is, it is desirable that the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin in the film after the heating process increases before and after the heating process.

[0131] Specifically, when the cyclization rate (%) of the precursor of the cyclization resin in the film before the heating process is cyclization rate A, and the cyclization rate (%) of the cyclization resin obtained from the precursor of the cyclization resin in the film after the heating process is cyclization rate B, it is preferable that the difference in cyclization rates shown by the following formula is 70% or more, more preferable that it is 80% or more, and even more preferable that it is 90% or more. The upper limit of the above cyclization rate is not particularly limited and may be 100%.

[0132] Difference in exchange rates = Exchange rate B - Exchange rate A

[0133] The method for measuring the membrane's oxidization rate will be described later.

[0134] In the heating process, it is preferable to perform heating at a heating rate of 0.1 to 30°C / min from the temperature at the start of heating to the maximum heating temperature. The heating rate is more preferably 0.5 to 20°C / min, and more preferably 2 to 10°C / min. By increasing the heating rate to 1°C / min or higher, productivity can be ensured while preventing excessive volatilization of the acid or solvent, and by increasing the heating rate to 12°C / min or lower, residual stress in the cured product can be relieved.

[0135] In addition, for a rapid heating oven, it is preferable to heat at a rate of 1 to 30°C / second from the temperature at the start of heating to the maximum heating temperature, more preferable at 2 to 20°C / second, and more preferable at 3 to 10°C / second.

[0136] The temperature at which heating is initiated is preferably 20°C to 150°C, more preferably 20°C to 130°C, and even more preferably 25°C to 120°C. The temperature at which heating is initiated refers to the temperature at which the process of heating to the maximum heating temperature is initiated. For example, when a resin composition is applied to a substrate and then dried, it is the temperature of the film (layer) after drying, and it is preferable to increase the temperature from a temperature 30°C to 200°C lower than the boiling point of the solvent included in the resin composition.

[0137] The heating time (heating time at the maximum heating temperature) is preferably 30 minutes to 5 hours, and more preferably 1 hour to 3 hours.

[0138] In addition, the temperature deviation range when maintaining the maximum heating temperature (the difference between the maximum and minimum temperature values ​​during the heating time at the maximum temperature) is preferably 0.1℃ to 20℃, more preferably 0.1℃ to 10℃, and more preferably 0.1℃ to 3℃.

[0139] In particular, when forming a multilayer laminate, from the perspective of interlayer adhesion, the heating temperature is preferably 30°C or higher, more preferably 80°C or higher, more preferably 100°C or higher, particularly preferably 120°C or higher, and most preferably exceeds 150°C.

[0140] The upper limit of the above heating temperature is 180℃ or lower, and preferably 170℃ or lower.

[0141] The method for manufacturing a cured product may include a process of heating at a heating temperature of 180°C or higher, or may not include a process of heating at a heating temperature of 180°C or higher.

[0142] Heating may be performed in stages. For example, a process such as increasing the temperature from 25°C to 120°C at a rate of 3°C / min, maintaining it at 120°C for 60 minutes, increasing the temperature from 120°C to 180°C at a rate of 2°C / min, and maintaining it at 180°C for 120 minutes may be performed. In addition, it is also desirable to treat while irradiating with ultraviolet light as described in U.S. Patent Publication No. 9159547. It is possible to improve the characteristics of the film through such a pretreatment process. The pretreatment process may be performed for a short period of about 10 seconds to 2 hours, and 15 seconds to 30 minutes is more preferable. The pretreatment may be performed in two or more steps; for example, a first pretreatment process may be performed in the range of 100 to 150°C, and then a second pretreatment process may be performed in the range of 150 to 180°C.

[0143] In addition, it may be cooled after heating, and in this case, the cooling rate is preferably 1 to 5°C / min.

[0144] It is preferable to perform the heating process in an atmosphere of low oxygen concentration by flowing inert gases such as nitrogen, helium, or argon, or by performing it under reduced pressure, in order to prevent the decomposition of the specific resin. The oxygen concentration is preferably 50 ppm (volume ratio) or less, and more preferably 20 ppm (volume ratio) or less.

[0145] In the heating process, heating may be performed under atmospheric pressure or under reduced pressure. When heating is performed under reduced pressure, the reduction may be completed before the start of heating, during the temperature rise from the start of heating, or after reaching the maximum heating temperature; the timing of the completion of the reduction is not particularly limited. Completion of the reduction refers to the pressure becoming 20 mmHg (volume ratio) or lower. The above pressure can be measured by a differential pressure gauge. Here, it is also a preferred embodiment for the film to be under reduced pressure for the entire time the maximum heating temperature is maintained.

[0146] As for the heating means in the heating process, there are no particular limitations, but examples include a hot plate, an infrared furnace, an electric oven, a hot air oven, an infrared oven, etc.

[0147] Photolithography Process

[0148] After the above film formation process, the film prior to the above heating process may be provided to an exposure process for selectively exposing the film.

[0149] That is, the method for manufacturing a cured product of the present invention may include an exposure process for selectively exposing the film formed by the film formation process between the film formation process and the heating process.

[0150] Selective exposure means exposing a portion of the film. Furthermore, through selective exposure, an exposed area (exposed region) and an unexposed area (unexposed region) are formed in the film.

[0151] The exposure dose is not specifically determined as long as it can cure the resin composition, but, for example, 50 to 10,000 mJ / cm² in terms of exposure energy at a wavelength of 365 nm. 2 It is desirable, and 200~8,000 mJ / cm² 2 It is more desirable.

[0152] The exposure wavelength can be appropriately set in the range of 190 to 1,000 nm, and 240 to 550 nm is preferred.

[0153] Exposure wavelengths, in relation to the light source, include (1) semiconductor lasers (wavelengths 830 nm, 532 nm, 488 nm, 405 nm, 375 nm, 355 nm, etc.), (2) metal halide lamps, (3) high-pressure mercury lamps, g-lines (wavelength 436 nm), h-lines (wavelength 405 nm), i-lines (wavelength 365 nm), broad (three wavelengths of g, h, and i lines), (4) excimer lasers, KrF excimer lasers (wavelength 248 nm), ArF excimer lasers (wavelength 193 nm), F2 excimer lasers (wavelength 157 nm), (5) extreme ultraviolet light; EUV (wavelength 13.6 nm), (6) electron beams, and (7) the second harmonic of a YAG laser at 532 nm and the third harmonic at 355 nm. For the resin composition, exposure by a high-pressure mercury lamp is particularly preferred, and among them, exposure by i-rays is preferred. By doing so, particularly high exposure sensitivity can be obtained.

[0154] In addition, the method of exposure is not particularly limited and any method in which at least a portion of a film made of a resin composition is exposed is sufficient, but examples include exposure using a photomask and exposure by laser direct imaging.

[0155] Post-exposure heating process

[0156] The above film may be provided in a heating process after exposure (heating process after exposure).

[0157] That is, the method for manufacturing a cured product of the present invention may include a post-exposure heating process for heating a film exposed by a photolithography process.

[0158] It is also desirable that the cyclization rate of the film after the heating process (i.e., the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin) does not substantially increase before and after the heating process following photolithography.

[0159] Specifically, it is desirable that the difference in the exchange rate described above be 30% or less, more desirable that it be 20% or less, and even more desirable that it be 10% or less. The upper limit of the exchange rate is not specifically limited and may be 0%.

[0160] In particular, when the above membrane does not contain the photobase generator described below, it is preferable that the difference in the above-described oxidization rate be 30% or less, more preferable that it be 20% or less, and more preferable that it be 10% or less. The upper limit of the above-described oxidization rate is not specifically limited and may be 0%.

[0161] The post-exposure heating process can be performed after the exposure process and before the development process.

[0162] In the heating process after exposure, the heating temperature is preferably 50℃ to 140℃, and more preferably 60℃ to 120℃.

[0163] The heating time in the heating process after exposure is preferably 30 seconds to 300 minutes, and more preferably 1 minute to 10 minutes.

[0164] In the heating process after exposure, the heating rate from the starting temperature to the maximum heating temperature is preferably 1 to 12°C / min, more preferably 2 to 10°C / min, and more preferably 3 to 10°C / min.

[0165] In addition, the heating rate may be appropriately changed during heating.

[0166] As a heating means for the heating process after exposure, there are no particular limitations, and known hot plates, ovens, infrared heaters, etc., can be used.

[0167] In addition, it is also desirable to perform the process in an atmosphere of low oxygen concentration by flowing inert gases such as nitrogen, helium, or argon during heating.

[0168] <Development Process>

[0169] The above film after exposure may be provided to a development process that forms a pattern by developing it using a developer solution.

[0170] That is, the method for manufacturing a cured product of the present invention may include a developing process in which a film exposed by a photolithography process is developed using a developer to form a pattern. By performing development, one of the exposed portion and the unexposed portion of the film is removed, and a pattern is formed.

[0171] Here, the phenomenon in which the non-exposed portion of the film is removed by the development process is called negative-type development, and the resulting pattern is called a negative-type pattern. Furthermore, the phenomenon in which the exposed portion of the film is removed by the development process is called positive-type development, and the resulting pattern is called a positive-type pattern.

[0172] In the present invention, the developing process is preferably a process for forming a negative type pattern.

[0173] 〔developer〕

[0174] Examples of developers used in the development process include an alkaline aqueous solution or a developer containing an organic solvent, and it is preferable that the developer be one containing an organic solvent.

[0175] When the developer is an alkaline aqueous solution, basic compounds that may be included in the alkaline aqueous solution include inorganic alkalis, primary amines, secondary amines, tertiary amines, and quaternary ammonium salts, and TMAH (tetramethylammonium hydroxide), potassium hydroxide, sodium carbonate, sodium hydroxide, sodium silicate, sodium metasilicate, ammonia, ethylamine, n-propylamine, diethylamine, di-n-butylamine, triethylamine, methyldiethylamine, dimethylethanolamine, triethanolamine, tetraethylammonium hydroxide, tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, tetrapentylammonium hydroxide, tetrahexylammonium hydroxide, tetraoctylammonium hydroxide, ethyltrimethylammonium hydroxide, butyltrimethylammonium hydroxide, Methyltriamylammonium hydroxide, dibutyldipentylammonium hydroxide, dimethylbis(2-hydroxyethyl)ammonium hydroxide, trimethylphenylammonium hydroxide, trimethylbenzylammonium hydroxide, triethylbenzylammonium hydroxide, pyrrole, and piperidine are preferred, and more preferably TMAH. The content of the basic compound in the developer is, for example, 0.01 to 10 mass% of the total mass of the developer when TMAH is used, 0.1 to 5 mass% is more preferred, and 0.3 to 3 mass% is even more preferred.

[0176] Where the developer contains an organic solvent, the organic solvent is an ester, for example, ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyl butyl butyl, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkyloxyacetates (e.g., methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), alkyl 3-alkyloxypropionate esters (e.g., methyl 3-alkyloxypropionate, 3-ethyl alkyloxypropionate, etc. (e.g., 3-methyl methoxypropionate, 3-ethyl methoxypropionate, 3-methyl ethoxypropionate, 3-ethyl ethoxypropionate, etc.)), 2-alkyloxypropionate alkyl esters (e.g., 2-methyl alkyloxypropionate, 2-ethyl alkyloxypropionate, 2-propyl alkyloxypropionate, etc. (e.g., 2-methyl methoxypropionate, 2-ethyl methoxypropionate, 2-propyl methoxypropionate, 2-methyl ethoxypropionate, 2-ethyl ethoxypropionate)), 2-methyl alkyloxy-2-methylpropionate and 2-alkyloxy-2-ethyl methylpropionate (e.g., 2-methyl methoxy-2-methylpropionate, 2-ethoxy-2-methylpropionate ethyl, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, 2-methyl oxobutanate, 2-ethyl oxobutanate, etc., and, as ethers, for example, diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate,Suitable examples include propylene glycol monopropyl ether acetate, etc., and ketones such as methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone, etc., and cyclic hydrocarbons such as aromatic hydrocarbons such as toluene, xylene, and anisole, cyclic terpenes such as limonene, sulfoxides such as dimethyl sulfoxide, and alcohols such as methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutylcarbinol, triethylene glycol, etc., and amides such as N-methylpyrrolidone, N-ethylpyrrolidone, dimethylformamide, etc.

[0177] When the developer includes an organic solvent, one or more types of organic solvents may be used in combination. In the present invention, a developer is particularly preferred that includes at least one selected from the group consisting of cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methyl-2-pyrrolidone, and cyclohexanone, a developer is more preferred that includes at least one selected from the group consisting of cyclopentanone, γ-butyrolactone, and dimethyl sulfoxide, and a developer containing cyclopentanone is most preferred.

[0178] When the developer solution contains an organic solvent, the content of the organic solvent relative to the total mass of the developer solution is preferably 50 mass% or more, more preferably 70 mass% or more, more preferably 80 mass% or more, and particularly preferably 90 mass% or more. In addition, the content may be 100 mass%.

[0179] In addition, when the developer solution contains an organic solvent, the water content relative to the total mass of the developer solution is preferably 10 mass% or less, more preferably 5 mass% or less, more preferably 1 mass% or less, and particularly preferably 0.1 mass% or less. The water content is not particularly limited and may be 0 mass%.

[0180] An embodiment in which the developer comprises at least one compound selected from the group consisting of bases and base generating agents is also preferred.

[0181] According to the above embodiment, it is believed that in the developing process, a base or a base generating agent in the developing solution penetrates into the film, and in the subsequent heating process, the cyclization of the precursor of the cyclization resin is promoted by the action of the base generated from the base or the base generating agent.

[0182] As a result, the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin in the film after the heating process is increased, and even when heated at a low temperature of 180°C or lower, the glass transition temperature is increased, and it is thought that the generation of outgas is reduced.

[0183] In the above embodiment, from the perspective of suppressing the amount of outgassing, it is preferable that the developer solution contains a base.

[0184] In addition, in the above embodiment, it is preferable that the developer is a developer containing an organic solvent.

[0185] -base-

[0186] As for the preferred base, an organic base is preferred from the perspective of reliability when remaining in the cured product (adhesion to the substrate when the cured product is further heated).

[0187] In addition, as a base, a base having an amino group is preferred, and primary amines, secondary amines, tertiary amines, ammonium salts, tertiary amides, etc. are preferred, but to promote the imidization reaction, primary amines, secondary amines, and tertiary amines are preferred, secondary amines or tertiary amines are more preferred, and tertiary amines are most preferred.

[0188] Regarding the base, from the perspective of the mechanical properties (elongation at break) of the cured product, it is desirable that it is difficult to retain in the resulting cured product, and from the perspective of promoting cyclization (imidization), it is desirable that the amount remaining before heating is difficult to reduce due to volatilization, vaporization, etc.

[0189] Accordingly, the boiling point of the base is preferably 30°C to 350°C at atmospheric pressure (101,325 Pa), more preferably 80°C to 270°C, and even more preferably 100°C to 230°C.

[0190] In addition, it is preferable that the boiling point of the base be higher than the boiling point of the organic solvent contained in the developer by subtracting 20°C, and more preferable that it be higher than the boiling point of the organic solvent contained in the developer.

[0191] For example, when the boiling point of an organic solvent is 100°C, the base used is preferably 80°C or higher, and more preferably 100°C or higher.

[0192] The pKa of the conjugate acid of the above base in DMSO (dimethyl sulfoxide) is preferably 1 or higher, and more preferably 3 or higher. The upper limit of the pKa is not particularly limited, but it is preferably 20 or lower.

[0193] When the conjugate acid of the above base has multiple pKa values ​​in DMSO, it is preferable that at least one of them is within the above range.

[0194] Here, the above pKa represents the logarithm of the reciprocal of the first dissociation constant of an acid, and the value listed in *Determination of Organic Structures by Physical Methods* (Authors: Brown, HC, McDaniel, DH, Hafliger, O., Nachod, FC; Edited by: Braude, EA, Nachod, FC; Academic Press, New York, 1955) or *Data for Biochemical Research* (Authors: Dawson, RMC et al; Oxford, Clarendon Press, 1959). For compounds not listed in these documents, the value calculated from the structural formula using the software ACD / pKa (ACD / Labs) is used as the pKa.

[0195] Specific examples of bases included in the developer include ethanolamine, diethanolamine, triethanolamine, ethylamine, diethylamine, triethylamine, hexylamine, dodecylamine, cyclohexylamine, cyclohexylmethylamine, dimethylcyclohexylamine, aniline, N-methylaniline, N,N-dimethylaniline, diphenylamine, pyridine, butylamine, isobutylamine, dibutylamine, tributylamine, dicyclohexylamine, DBU (diazabicycloundecene), DABCO (1,4-diazabicyclo[2.2.2]octane), N,N-diisopropylethylamine, tetramethylammonium hydroxide, tetrabutylammonium hydroxide, ethylenediamine, 1,5-diaminopentane, N-methylhexylamine, N-methyldicyclohexylamine, trioctylamine. Examples include N-ethylethylenediamine, N,N-diethylethylenediamine, N,N,N',N'-tetrabutyl-1,6-hexanediamine, spermidine, diaminocyclohexane, bis(2-methoxyethyl)amine, piperidine, methylpiperidine, piperazine, tropane, N-phenylbenzylamine, 1,2-dianilinoethane, 2-aminoethanol, toluidine, aminophenol, hexylaniline, phenylenediamine, phenylethylamine, dibenzylamine, pyrrole, N-methylpyrrole, N,N,N,N-tetramethylethylenediamine, N,N,N,N-tetramethyl-1,3-propanediamine, etc.

[0196] When the developer contains a base, the content of the base relative to the total mass of the developer is preferably 0.1 to 100 mass%, more preferably 0.3 to 30 mass%, and even more preferably 0.5 to 20 mass%.

[0197] In addition, when the base is not liquid at 10 to 30°C, it is preferable that the base content be 0.3 to 30 mass%, and more preferable that it be 0.5 to 20 mass%.

[0198] A base may be used alone or in combination of two or more types. When two or more bases are used in combination in a developer, it is preferable that their total content be within the range described above.

[0199] -Base generator-

[0200] The developer may contain a base-generating agent.

[0201] Examples of base-generating agents include photobase-generating agents or thermal base-generating agents, and thermal base-generating agents are preferred.

[0202] As the above photobase generator or thermobase generator, for example, a base generator described as a component included in the resin composition described below may be used without particular limitation.

[0203] When the developer solution contains a base generating agent, the content of the base generating agent relative to the total mass of the developer solution is preferably 0.005 to 100 mass%, more preferably 0.05 to 20 mass%, and even more preferably 0.08 to 5 mass%.

[0204] A base generating agent may be used alone or in combination of two or more. When two or more base generating agents are used in combination in a developing solution, it is preferable that their total content be within the range described above.

[0205] The developer may contain additional components.

[0206] Other ingredients include, for example, known surfactants or known antifoaming agents.

[0207] [Method of supplying developing solution]

[0208] There are no particular restrictions on the method of supplying the developer as long as a desired pattern can be formed; methods include immersing a substrate with a formed film in the developer, puddle development using a nozzle to supply the developer to the film formed on the substrate, or a method of continuously supplying the developer. There are no particular restrictions on the type of nozzle; examples include straight nozzles, shower nozzles, and spray nozzles.

[0209] From the perspective of developer penetration, removal of non-image areas, and manufacturing efficiency, a method of supplying the developer through a straight nozzle or a method of continuously supplying it through a spray nozzle is preferred, and from the perspective of developer penetration into the image area, the method of supplying it through a spray nozzle is more preferred.

[0210] In addition, a process may be adopted in which the developer is continuously supplied through a straight nozzle, the substrate is spun to remove the developer from the substrate, and after spin drying, the developer is continuously supplied through a straight nozzle again, and the substrate is spun to remove the developer from the substrate, and this process may be repeated multiple times.

[0211] In addition, as a method for supplying the developer solution in the developing process, a process in which the developer solution is continuously supplied to the substrate, a process in which the developer solution is maintained in a roughly stationary state on the substrate, a process in which the developer solution is vibrated on the substrate using ultrasound or the like, and a process combining the same can be adopted.

[0212] The development time is preferably 10 seconds to 10 minutes, and more preferably 20 seconds to 5 minutes. The temperature of the developer solution during development is not specifically determined, but is preferably 10 to 45°C, more preferably 18°C ​​to 30°C.

[0213] Processing Process

[0214] The method for manufacturing a cured product of the present invention preferably includes a treatment process in which a pattern is brought into contact with a treatment solution comprising at least one compound selected from the group consisting of a base and a base generating agent between a developing process and a heating process, and more preferably includes a treatment process in which a treatment solution containing a base is brought into contact with the pattern between a developing process and a heating process.

[0215] According to this embodiment, it is believed that at least one compound selected from the group consisting of bases and base generating agents included in the treatment solution penetrates into the pattern after development.

[0216] As a result, it is believed that the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin in the film after the heating process is increased, and even when heated at a low temperature of 180°C or lower, the glass transition temperature is increased, and a cured product with less outgassing is obtained.

[0217] The above processing step is preferably a rinsing step that cleans the pattern with the above processing solution.

[0218] In addition, it is preferable that the treatment solution be a rinse solution.

[0219] In addition, it is preferable that the above treatment solution is a rinse solution, and that the above treatment process is a rinse process that cleans a pattern with the above rinse solution.

[0220] That is, the above processing process is preferably a rinsing process that cleans the pattern (a pattern obtained by the development process) with a rinsing solution containing at least one compound selected from the group consisting of a base and a base generating agent.

[0221] In addition, the above processing step may be performed after, for example, the "other rinsing process" described later.

[0222] [Treatment Solution]

[0223] The water content relative to the total mass of the treatment solution is preferably 50 mass% or less, preferably 20 mass% or less, more preferably 10 mass% or less, more preferably 5 mass% or less, and particularly preferably 2 mass% or less. The lower limit of the water content is not particularly limited and may be 0 mass%.

[0224] As a treatment solution, for example, a solvent that is different from the solvent included in the developer solution (for example, an organic solvent different from the organic solvent included in the developer solution) and a solvent that includes at least one compound selected from the group consisting of a base and a base generating agent may be used.

[0225] -base-

[0226] A preferred embodiment of the base included in the treatment solution is the same as a preferred embodiment of the base included in the developer solution described above.

[0227] Among them, tertiary amines are preferred as the base included in the treatment solution.

[0228] In addition, regarding the base included in the treatment solution, it is desirable that it is difficult to react with the solvent used in the treatment solution (e.g., cyclopentanone, etc.).

[0229] When the treatment solution contains a base, the content of the base relative to the total mass of the treatment solution is preferably 0.1 to 100 mass%, more preferably 0.3 to 30 mass%, and even more preferably 0.5 to 20 mass%.

[0230] In addition, when the base is not liquid at 10 to 30°C, it is preferable that the base content be 0.3 to 30 mass%, and more preferable that it be 0.5 to 20 mass%.

[0231] A base may be used alone or in combination of two or more types. When two or more bases are used in combination in a treatment solution, it is preferable that their total content be within the range described above.

[0232] -Base generator-

[0233] The treatment solution may contain a base-generating agent.

[0234] Examples of base-generating agents include photobase-generating agents or thermal base-generating agents, and thermal base-generating agents are preferred.

[0235] As the above photobase generator or thermobase generator, for example, the photobase generator or thermobase generator described as a component included in the resin composition described below may be used without particular limitation.

[0236] When the treatment solution contains a base generating agent, the content of the base generating agent relative to the total mass of the treatment solution is preferably 0.005 to 100 mass%, more preferably 0.05 to 20 mass%, and even more preferably 0.08 to 5 mass%.

[0237] A base generating agent may be used alone or in combination of two or more. When two or more base generating agents are used in combination in the treatment solution, it is preferable that their total content be within the range described above.

[0238] As organic solvents included in the treatment solution, esters include, for example, ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkyloxyacetates (e.g., methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkyloxypropionate esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate). et al. (e.g., methyl methoxypropionate, ethyl methoxypropionate, methyl ethoxypropionate, ethyl ethoxypropionate, etc.), alkyl esters of 2-alkyloxypropionates (e.g., methyl 2-alkyloxypropionate, ethyl 2-alkyloxypropionate, propyl 2-alkyloxypropionate, etc. (e.g., methyl methoxypropionate, ethyl methoxypropionate, propyl methoxypropionate, methyl ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkyloxy-2-methylpropionate and ethyl 2-alkyloxy-2-methylpropionate (e.g., methyl methoxy-2-methylpropionate, propyl methoxypropionate, methyl 2-ethoxy-2-methylpropionate)), ethyl, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, 2-methyl oxobutanate, 2-ethyl oxobutanate, etc., and, as ethers, for example, diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and,Suitable examples of ketones include, for instance, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone, etc.; cyclic hydrocarbons include, for instance, aromatic hydrocarbons such as toluene, xylene, and anisole; cyclic terpenes such as limonene; sulfoxides include dimethyl sulfoxide; alcohols include methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutylcarbinol, triethylene glycol, etc.; and amides include N-methylpyrrolidone, N-ethylpyrrolidone, dimethylformamide, etc.

[0239] In addition, if the above-described base (e.g., organic base) is a liquid in the environment where the treatment solution is used, the above-described base can be used as a solvent and a base.

[0240] When the treatment solution contains an organic solvent, one type of organic solvent or a mixture of two or more types may be used. In the present invention, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methylpyrrolidone, cyclohexanone, PGMEA, and PGME are particularly preferred, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, PGMEA, and PGME are more preferred, and cyclohexanone and PGMEA are more preferred.

[0241] When the treatment solution contains an organic solvent, it is preferable that at least 50 mass% of the total mass of the treatment solution is an organic solvent, more preferable that at least 70 mass% is an organic solvent, and more preferable that at least 90 mass% is an organic solvent. In addition, the treatment solution may be 100 mass% organic solvent.

[0242] The treatment solution may contain additional components.

[0243] Other ingredients include, for example, known surfactants or known antifoaming agents.

[0244] [Method of supplying treatment solution]

[0245] As for the method of supplying the treatment solution, there are no particular limitations as long as the treatment solution can be brought into contact with the pattern obtained from the development process; for example, an embodiment in which the treatment solution is supplied onto the pattern obtained from the development process can be cited. There are no particular limitations on the above supply method, and methods include immersing the substrate in the treatment solution, supplying by pudding (liquid filling) on ​​the substrate, supplying the treatment solution to the substrate by showering, or continuously supplying the treatment solution onto the substrate by means such as a straight nozzle.

[0246] From the perspective of the penetration of the treatment solution into the image area and manufacturing efficiency, there are methods of supplying the treatment solution using shower nozzles, straight nozzles, spray nozzles, etc., and a method of continuous supply through nozzles is preferred. From the perspective of the penetration of the treatment solution into the image area, a method in which the treatment solution supplied through nozzles is maintained on the substrate is more preferable.

[0247] The above-mentioned method of supplying the treatment solution (e.g., a combination of supplying by puddle and supplying by shower, or supplying by puddle and supplying by straight nozzle) may be used in combination. For example, puddle supply has the effect of swelling the membrane, making it easier for subsequent treatment solution to penetrate. In addition, the treatment solution may be used in at least one of the combined methods. Here, in the present invention, the treatment solution that does not contain bases and base-generating agents (e.g., the rinse solution in another rinse process described later) may be supplied onto the pattern, and then the treatment process with the treatment solution may be performed (e.g., after supplying the rinse solution onto the pattern and cleaning the pattern in another rinse process described later). A preferred embodiment of the treatment solution that does not contain bases and base-generating agents is the same as a preferred embodiment of the rinse solution in another rinse process described later.

[0248] As a method of supplying a treatment solution that does not contain a base and a base generating agent in the above embodiment onto a pattern, supply by puddles may be cited, although not particularly limited.

[0249] The method of supplying the processing liquid onto the pattern in the above embodiment is not particularly limited, but preferably includes supply by shower, supply by straight nozzle, etc.

[0250] It is believed that by supplying a treatment solution that does not contain bases through a puddle, the pattern swells, making it easier for at least one compound selected from the group consisting of bases and base generators in the treatment solution supplied thereafter to penetrate into the pattern, thereby making it easier to obtain effects such as improved elongation at break. In addition, by supplying the treatment solution through a shower, straight nozzle, etc., the ability to remove developing gases (rinseability) is also excellent.

[0251] In addition, as a method for supplying the treatment liquid in the treatment process, a process in which the treatment liquid is continuously supplied to the substrate, a process in which the treatment liquid is maintained in a roughly stationary state on the substrate, a process in which the treatment liquid is vibrated on the substrate using ultrasound or the like, and a combination of the same can be adopted.

[0252] Among these, it is preferable that the treatment process be a process in which the treatment solution is supplied by showering or continuously supplied to the pattern after development.

[0253] In addition, it is desirable to perform the development in the development process by puddle development, and also to perform at least one supply of the treatment solution in the treatment process by showering or by continuous supply by a straight nozzle, etc. According to the above embodiment, as the pattern swells by puddle development, at least one compound selected from the group consisting of bases and base generating agents in the treatment solution becomes easier to penetrate into the pattern, and it is thought that effects such as improvement of elongation at break become easier to obtain.

[0254] The processing time in the processing process (i.e., the time during which the processing liquid and the pattern are in contact) is preferably 10 seconds to 10 minutes, and more preferably 20 seconds to 5 minutes. The temperature of the processing liquid during the processing process is not specifically determined, but is preferably 10 to 45°C, and more preferably 18°C ​​to 30°C.

[0255] Other rinsing processes

[0256] The method for manufacturing a cured product of the present invention may include a rinsing process (hereinafter also referred to as "another rinsing process") in which the pattern (a pattern obtained by the development process) is cleaned with a rinsing solution that does not contain either a base or a base generating agent.

[0257] The method for manufacturing a cured product of the present invention may include another rinsing process, for example, before the treatment process described above and after the development process described above. In addition, if the method for manufacturing a cured product of the present invention does not include the treatment process described above, it may include the process after the development process described above and before the heating process described above.

[0258] As a rinsing liquid for other rinsing processes, the same liquid as the treatment liquid described above may be used, except that it does not contain a base and a base generating agent, and the preferred embodiment of each component included in the rinsing liquid is the same as the preferred embodiment of each component other than the base and base generating agent included in the treatment liquid described above.

[0259] In addition, the rinse solution can be supplied to the pattern by the same method as the treatment solution described above.

[0260] Post-development exposure process

[0261] The pattern obtained by the development process (or the pattern after rinsing in the case of performing a rinsing process) may be provided to a post-development exposure process in which the pattern after the development process is exposed, instead of or in addition to the heating process.

[0262] That is, the method for manufacturing a cured product of the present invention may include a post-development exposure process for exposing a pattern obtained by a development process. The method for manufacturing a cured product of the present invention may include a heating process and a post-development exposure process, or it may include only one of the heating process and the post-development exposure process.

[0263] In the post-development exposure process, for example, reactions such as the cyclization of polyimide precursors by the photosensitive action of a photobase generator, or the detachment of acid-degradable groups by the photosensitive action of a photocatalytic agent, can be promoted.

[0264] In the exposure process after development, at least a portion of the pattern obtained in the development process needs to be exposed, but it is preferable that the entire pattern be exposed.

[0265] The exposure amount in the post-development exposure process is 50–20,000 mJ / cm², converted to exposure energy at the wavelength where the photosensitive compound is sensitive. 2 It is desirable that it be 100~15,000 mJ / cm² 2 It is more desirable to be.

[0266] The exposure process after development can be performed, for example, using a light source in the exposure process described above, and it is preferable to use broadband light.

[0267] Metal layer formation process

[0268] A pattern obtained by a developing process (preferably provided in at least one of a heating process and a post-development exposure process) may be provided to a metal layer forming process for forming a metal layer on the pattern.

[0269] That is, the method for manufacturing a cured product of the present invention preferably includes a metal layer forming process for forming a metal layer on a pattern obtained by a developing process (preferably provided in at least one of a heating process and a post-development exposure process).

[0270] As for the metal layer, existing metal types may be used without particular limitation, and copper, aluminum, nickel, vanadium, titanium, chromium, cobalt, gold, tungsten, tin, silver, and alloys containing these metals are examples, copper and aluminum are more preferred, and copper is more preferred.

[0271] The method for forming the metal layer can be any existing method without particular limitation. For example, methods described in Japanese Patent Publication No. 2007-157879, Japanese Patent Publication No. 2001-521288, Japanese Patent Publication No. 2004-214501, Japanese Patent Publication No. 2004-101850, U.S. Patent Publication No. 7888181B2, and U.S. Patent Publication No. 9177926B2 may be used. Examples include photolithography, PVD (physical vapor deposition), CVD (chemical vapor deposition), lift-off, electroplating, electroless plating, etching, printing, and methods combining the same. More specifically, sputtering, a patterning method combining photolithography and etching, and a patterning method combining photolithography and electroplating may be cited. A preferred embodiment of plating is electroplating using a copper sulfate or copper cyanide plating solution.

[0272] As for the thickness of the metal layer, in the thickest part, 0.01 to 50 μm is preferred, and 1 to 10 μm is more preferred.

[0273] <Physical properties of hardened material>

[0274] [Glass Transition Temperature]

[0275] In the method for manufacturing a cured product of the present invention, the glass transition temperature of the obtained cured product is 200°C or higher, preferably 220°C or higher, and more preferably 250°C or higher.

[0276] The upper limit of the above glass transition temperature is not particularly limited, but it is preferably 350°C or lower.

[0277] The above glass transition temperature is calculated by the method described in the example.

[0278] [Exchange Rate]

[0279] In the method for manufacturing a cured product of the present invention, the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin in the film after the heating process is preferably 90% or higher, more preferably 95% or higher, more preferably 98% or higher, and particularly preferably 99% or higher.

[0280] In particular, the film after the heating process is a polyimide film, and it is preferable that the imidization rate of the polyimide is 90% or higher, more preferable that it is 95% or higher, more preferable that it is 98% or higher, and particularly preferable that it is 99% or higher.

[0281] The upper limit of the above exchange rate is not specifically limited and may be 100%.

[0282] The above exchange rate is calculated by the following method.

[0283] When the precursor of the cyclization resin is a polyimide precursor or a polyamideimide precursor, the infrared absorption spectrum of the film after the heating process is measured, and the absorption peak originating from the imide structure, at 1377 cm⁻¹, is... -1 The peak intensity P1 in the vicinity is determined. Next, after heat-treating the film following the heating process at 350°C for 1 hour, the infrared absorption spectrum is measured again at 1377 cm⁻¹.-1 The peak intensity P2 in the vicinity is calculated. Using the obtained peak intensities P1 and P2, the conversion rate (imidization rate) can be calculated based on the following formula.

[0284] Imidization Rate (%) = (Peak Intensity P1 / Peak Intensity P2) × 100

[0285] When the precursor of the cyclization resin is a polybenzoxazole precursor, the 1650 cm⁻¹ absorption peak originating from the amide structure of the film after the heating process. -1 Calculate the peak intensity Q1 in the vicinity. Next, 1490 cm -1 It is standardized by the absorption intensity of the aroma ring visible nearby. Next, after heat-treating the film following the above heating process at 350°C for 1 hour, the infrared absorption spectrum is measured again at 1650 cm⁻¹. -1 Calculate the peak intensity Q2 near 1490cm -1 It is normalized by the absorption intensity of the aromatic ring visible nearby. Using the standard values ​​of the obtained peak intensities Q1 and Q2, the cyclization rate (oxazolization rate) can be calculated based on the following formula.

[0286] Oxazolization rate (%) = (Specification value of peak intensity Q1 / Specification value of peak intensity Q2) × 100

[0287] In addition, in measuring the above cyclization rate (imidization rate, oxazoleization rate), 1377 cm in the composition -1 Or 1377cm -1 , or, 1490cm -1 Or 1650cm -1 In the case of including a compound having absorption at the wavelength (e.g., phthalimide, etc.), the peak intensity derived from this compound can be excluded as background.

[0288] [Form, etc.]

[0289] The form of the cured product of the resin composition is not particularly limited and can be selected according to the application, such as in the form of a film, rod, sphere, or pellet. In the present invention, it is preferable that the cured product be in the form of a film. Additionally, by pattern processing of the resin composition, the shape of the cured product may be selected according to the application, such as forming a protective film on a wall surface, forming via holes for conductivity, adjusting impedance, capacitance, or internal stress, or providing a heat dissipation function. It is preferable that the film thickness of the cured product (the film formed from the cured product) be 0.5 μm or more and 150 μm or less.

[0290] In addition, the shrinkage rate of the film before and after the heating process is preferably 50% or less, more preferably 45% or less, and more preferably 40% or less. Here, the shrinkage rate refers to the percentage of volume change before and after the heating process and can be calculated from the following formula.

[0291] Shrinkage rate [%] = 100 - (Volume after heating process ÷ Volume before heating process) × 100

[0292] The elongation at break of the hardened material is preferably 30% or more, more preferably 40% or more, and more preferably 50% or more. The upper limit of the above elongation at break is not specifically limited, but, for example, it should be 200% or less. The elongation at break can be measured in accordance with JIS (Japanese Industrial Standards) K 6251:2017.

[0293] In addition, the coefficient of thermal expansion (CTE) of the cured product is preferably 70 ppm / K or less, preferably 60 ppm / K or less, and more preferably 50 ppm / K or less. The lower limit of the above CTE is not particularly limited and may be 0 ppm / K.

[0294] <Uses>

[0295] Examples of applications for the method of manufacturing the cured product of the present invention, or for the cured product of the present invention, include insulating films for electronic devices, interlayer insulating films for redistribution layers, stress buffer films, etc. Other applications include sealing films, substrate materials (base films or cover layers of flexible printed circuit boards, interlayer insulating films), or forming patterns by etching on insulating films for mounting purposes as described above. For these applications, for example, one may refer to Science & Technology Co., Ltd., “High-performance and Application Technology of Polyimide,” April 2008, supervised by Masaaki Kakimoto, CMC Technical Library; “Fundamentals and Development of Polyimide Materials,” published November 2011; and the Japan Polyimide and Aromatic Polymer Research Group, ed., “Fundamentals and Applications of Latest Polyimide,” NTS, August 2010.

[0296] In addition, the method for manufacturing the cured product of the present invention, or the cured product of the present invention, may also be used for manufacturing plates such as offset plates or screen plates, for use in etching molded parts, and for manufacturing protective lacquers and dielectric layers in electronics, particularly in microelectronics.

[0297] (Resin composition)

[0298] Hereinafter, a resin composition used in the method for manufacturing a cured product of the present invention will be described.

[0299] Specific Resin

[0300] The resin composition of the present invention includes a precursor of a cyclized resin (a specific resin).

[0301] It is preferable that the cyclic resin be a resin containing an imide ring structure or an oxazole ring structure in its main chain structure.

[0302] In the present invention, the main chain refers to the relatively longest bonding chain among the resin molecules.

[0303] Examples of cyclic resins include polyimide, polybenzoxazole, and polyamideimide.

[0304] A precursor of a cyclized resin refers to a resin that becomes a cyclized resin by causing a change in its chemical structure due to external stimuli; a resin that becomes a cyclized resin by causing a change in its chemical structure due to heat is preferred, and a resin that becomes a cyclized resin by causing a ring-closing reaction due to heat to form a ring structure is more preferred.

[0305] Examples of precursors for cyclized resins include polyimide precursors, polybenzoxazole precursors, and polyamideimide precursors.

[0306] That is, the resin composition in the present invention preferably comprises at least one resin (specific resin) selected from the group consisting of a polyimide precursor, a polybenzoxazole precursor, and a polyamideimide precursor as a specific resin.

[0307] In the present invention, the resin composition preferably includes a polyimide precursor as a specific resin.

[0308] In addition, it is desirable for a specific resin to have a polymerizable group, and it is more desirable to include a radical polymerizable group.

[0309] When a specific resin has radical polymerizable groups, the resin composition of the present invention preferably includes a radical polymerization initiator described below, and more preferably includes a radical crosslinking agent described below. If necessary, a sensitizer described below may be further included. From such a resin composition of the present invention, for example, a negative-type photosensitive film is formed.

[0310] In addition, certain resins may have polarity converters such as acid-degradable groups.

[0311] When a specific resin has an acid-degradable group, the resin composition of the present invention preferably includes a photogenerator described below. From such a resin composition of the present invention, for example, a chemically amplified positive photosensitive film or a negative photosensitive film is formed.

[0312] Here, the precursor of the cyclization resin is preferably a resin having at least one of the repeating unit represented by Formula (2) described later and the repeating unit represented by Formula (PAI-2).

[0313] In the above embodiment, from the perspective of suppressing out-gas generation from the cured material, R in Equation (2) described later 115 A group represented by any one of the formulas (X1-1) to (X1-3) described below, or a group comprising one or more aliphatic ring structures, wherein R in the formula (PAI-2) described below 117 It is preferable that the group be formed by any one of the formulas (X2-1) to (X2-3) described below, or by including one or more aliphatic ring structures. Hereinafter, such an embodiment is referred to as Embodiment A.

[0314] Also, in the above embodiment A, from the perspective of suppressing out-gas generation from the cured material, R in Equation (2) described later 111 A group represented by any one of the formulas (W1-1) to (W1-5) described below, or a group comprising one or more aliphatic ring structures, wherein R in the formula (PAI-2) described below 111 It is preferable that the group be one that appears as any one of the formulas (W1-1) to (W1-5) described below, or a group that includes one or more aliphatic ring structures.

[0315] In addition, in the above embodiment A, from the perspective of suppressing outgassing from the cured material, it is desirable to satisfy at least one of the following conditions 1 and 2.

[0316] Condition 1: The precursor of the above-mentioned cyclization resin is -A in the above-mentioned formula (2). 2 -R 113 and -A 1 -R 114 At least one of them includes a repeating unit that is represented by the following formula (3-1).

[0317] Condition 2: The precursor of the above-mentioned cyclizing resin is -A in the above-mentioned formula (PAI-2). 2 -R 113 This includes the repeating unit represented by the following equation (3-1).

[0318] If the precursor of the cyclizing resin does not include a repeating unit represented by formula (PAI-2), condition 1 is satisfied; if the precursor of the cyclizing resin does not include a repeating unit represented by formula (2), condition 2 is satisfied; and if the precursor of the cyclizing resin includes a repeating unit represented by formula (2) and a repeating unit represented by formula (PAI-2), it is more preferable to satisfy at least one of condition 1 and condition 2.

[0319] [Polyimide Precursor]

[0320] The polyimide precursor used in the present invention is not specifically defined in terms of type, but it is preferable to include a repeating unit represented by the following formula (2).

[0321] [Chemical Formula 5]

[0322]

[0323] Among equation (2), A 1 and A 2 are, respectively, oxygen atoms or -NR z - indicates, R 111 Silver represents a divalent organic group, and R 115 represents a tetravalent organic group, and R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, and R zrepresents a hydrogen atom or a monovalent organic group.

[0324] A in Equation (2) 1 and A 2 are, respectively, oxygen atoms or -NR z - indicates, and oxygen atoms are desirable.

[0325] R z represents a hydrogen atom or a monovalent organic group, and a hydrogen atom is preferred. R z If represents a monovalent organic group, R Z A preferred embodiment is Z in the formula (3-1) described below. 1 It is identical to the desirable mode of.

[0326] R in Equation (2) 111 Examples of divalent organic groups include straight-chain or branched aliphatic groups, cyclic aliphatic groups, and aromatic groups. A straight-chain or branched aliphatic group having 2 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 3 to 20 carbon atoms, or a combination thereof is preferred, and a group including an aromatic group having 6 to 20 carbon atoms is more preferred. The straight-chain or branched aliphatic group may be substituted with a hydrocarbon group containing a heteroatom, and the cyclic aliphatic group and aromatic group may be substituted with a reducing hydrocarbon group containing a heteroatom. As a preferred embodiment of the present invention, a group represented as -Ar- and -Ar-L-Ar- is exemplified, and particularly preferably, a group represented as -Ar-L-Ar-. However, Ar is an aromatic group independently, and L is an aliphatic hydrocarbon group having 1 to 10 carbon atoms that may be substituted with a single bond or a fluorine atom, -O-, -CO-, -S-, -SO2-, or -NHCO-, or a combination of two or more of the above. The preferred ranges thereof are as described above.

[0327] R111 It is preferable that the diamine be derived from a diamine. Examples of diamines used in the preparation of polyimide precursors include straight-chain or branched aliphatic, cyclic aliphatic, or aromatic diamines. Only one type of diamine may be used, or two or more types may be used.

[0328] Specifically, it is preferable that the diamine comprises a straight or branched aliphatic group having 2 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 3 to 20 carbon atoms, or a combination thereof, and it is more preferable that the diamine comprises an aromatic group having 6 to 20 carbon atoms. The straight or branched aliphatic group may be substituted with a hydrocarbon group containing a heteroatom in the chain, and the cyclic aliphatic group and the aromatic group may be substituted with a reducing hydrocarbon group containing a heteroatom. Examples of groups comprising an aromatic group include the following.

[0329] [Chemical Formula 6]

[0330]

[0331] In the formula, A represents a single bond or a divalent linker, and is preferably a group selected from a single bond, or an aliphatic hydrocarbon group having 1 to 10 carbon atoms that may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, -SO2-, -NHCO-, or a combination thereof, more preferably a group selected from a single bond, or an alkylene group having 1 to 3 carbon atoms that may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, or -SO2-, and more preferably -CH2-, -O-, -S-, -SO2-, -C(CF3)2-, or -C(CH3)2-.

[0332] In the formula, * indicates a binding site with another structure.

[0333] As diamines, specifically, 1,2-diaminoethane, 1,2-diaminopropane, 1,3-diaminopropane, 1,4-diaminobutane and 1,6-diaminohexane; 1,2- or 1,3-diaminocyclopentane, 1,2-, 1,3- or 1,4-diaminocyclohexane, 1,2-, 1,3- or 1,4-bis(aminomethyl)cyclohexane, bis-(4-aminocyclohexyl)methane, bis-(3-aminocyclohexyl)methane, 4,4'-diamino-3,3'-dimethylcyclohexylmethane and isophoronediamine; m- or p-phenylenediamine, diaminotoluene, 4,4'- or 3,3'-diaminobiphenyl, 4,4'-diaminodiphenyl ether, 3,3-diaminodiphenyl ether, 4,4'- and 3,3'-diaminodiphenylmethane, 4,4'- and 3,3'-diaminodiphenylsulfone, 4,4'- and 3,3'-diaminodiphenylsulfide, 4,4'- or 3,3'-diaminobenzophenone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2-bis(4-aminophenyl)propane, 2,2-Bis(4-aminophenyl)hexafluoropropane, 2,2-Bis(3-hydroxy-4-aminophenyl)propane, 2,2-Bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-Bis(3-amino-4-hydroxyphenyl)propane, 2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane, Bis(3-amino-4-hydroxyphenyl)sulfone, Bis(4-amino-3-hydroxyphenyl)sulfone, 4,4'-Diaminoparaterphenyl, 4,4'-Bis(4-aminophenoxy)biphenyl, Bis[4-(4-aminophenoxy)phenyl]sulfone, Bis[4-(3-aminophenoxy)phenyl]sulfone, Bis[4-(2-aminophenoxy)phenyl]sulfone, 1,4-Bis(4-aminophenoxy)benzene, 9,10-Bis(4-aminophenyl)anthracene, 3,3'-Dimethyl-4,4'-Diaminodiphenylsulfone, 1,3-Bis(4-aminophenoxy)benzene, 1,3-Bis(3-aminophenoxy)benzene, 1,3-Bis(4-aminophenyl)benzene, 3,3'-Diethyl-4,4'-Diaminodiphenylmethane, 3,3'-Dimethyl-4,4'-Diaminodiphenylmethane, 4,4'-Diaminooctafluorobiphenyl, 2,2-Bis[4-(4-aminophenoxy)phenyl]propane, 2,2-Bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 9,9-Bis(4-aminophenyl)-10-hydroanthracene, 3,3',4,4'-Tetraaminobiphenyl, 3,3',4,4'-Tetraaminodiphenyl ether, 1,4-Diaminoanthraquinone, 1,5-Diaminoanthraquinone, 3,3-Dihydroxy-4,4'-Diaminobiphenyl, 9,9'-Bis(4-aminophenyl)fluorene, 4,4'-Dimethyl-3,3'-Diaminodiphenylsulfone, 3,3',5,5'-Tetramethyl-4,4'-Diaminodiphenylmethane, 2,4- and 2,5-Diaminocumene, 2,5-Dimethyl-p-phenylenediamine, Acetoguanamin, 2,3,5,6-Tetramethyl-p-phenylenediamine, 2,4,6-Trimethyl-m-phenylenediamine, Bis(3-aminopropyl)Tetramethyldisiloxane, Bis(p-aminophenyl)Octamethylpentasiloxane, 2,7-Diaminofluorene, 2,5-Diaminopyridine, 1,2-Bis(4-aminophenyl)ethane, Diaminobenzanilide, Ester of Diaminobenzoic acid, 1,5-Diaminonaphthalene, Diaminobenzotrifluoride, 1,3-Bis(4-aminophenyl)hexafluoropropane, 1,4-Bis(4-aminophenyl)octafluorobutane, 1,5-Bis(4-aminophenyl)decafluoropentane, 1,7-Bis(4-aminophenyl)tetradecafluoroheptane, 2,2-Bis[4-(3-aminophenoxy)phenyl]hexafluoropropane, 2,2-Bis[4-(2-aminophenoxy)phenyl]hexafluoropropane, 2,2-Bis[4-(4-aminophenoxy)-3,5-dimethylphenyl]hexafluoropropane, 2,2-Bis[4-(4-aminophenoxy)-3,5-bis(trifluoromethyl)phenyl]hexafluoropropane, p-Bis(4-amino-2-trifluoromethylphenoxy)benzene, 4,4'-Bis(4-amino-2-trifluoromethylphenoxy)biphenyl, 4,4'-Bis(4-amino-3-trifluoromethylphenoxy)biphenyl, 4,Examples include at least one diamine selected from 4'-bis(4-amino-2-trifluoromethylphenoxy)diphenylsulfone, 4,4'-bis(3-amino-5-trifluoromethylphenoxy)diphenylsulfone, 2,2-bis[4-(4-amino-3-trifluoromethylphenoxy)phenyl]hexafluoropropane, 3,3',5,5'-tetramethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,2',5,5',6,6'-hexafluorotolidine, and 4,4'-diaminoquaternphenyl.

[0334] In addition, diamines (DA-1) to (DA-18) described in paragraphs 0030 to 0031 of International Publication No. 2017 / 038598 are also preferred.

[0335] In addition, a diamine having two or more alkylene glycol units in its main chain as described in paragraphs 0032 to 0034 of International Publication No. 2017 / 038598 is also preferably used.

[0336] R 111 In terms of the flexibility of the resulting organic film, it is preferable for it to be represented as -Ar-L-Ar-. provided that Ar is independently an aromatic group, and L is an aliphatic hydrocarbon group having 1 to 10 carbon atoms that may be substituted with a fluorine atom, -O-, -CO-, -S-, -SO2-, or -NHCO-, or a combination of two or more of the above. Ar is preferably a phenylene group, and L is preferably an aliphatic hydrocarbon having 1 or 2 carbon atoms that may be substituted with a fluorine atom, -O-, -CO-, -S-, or -SO2-. Here, the aliphatic hydrocarbon group is preferably an alkylene group.

[0337] Also, R 111 In terms of i-line transmittance, it is preferable that the material be a divalent organic group represented by the following formula (51) or formula (61). In particular, in terms of i-line transmittance and availability, it is more preferable that the material be a divalent organic group represented by formula (61).

[0338] Equation (51)

[0339] [Chemical Formula 7]

[0340]

[0341] In equation (51), R 50 ~R 57 Each is independently a hydrogen atom, a fluorine atom, or a monovalent organic group, and R 50 ~R 57 At least one of them is a fluorine atom, a methyl group, or a trifluoromethyl group, and * each independently represents a bonding site with a nitrogen atom in Formula (2).

[0342] R 50 ~R 57 Examples of monovalent organic groups include unsubstituted alkyl groups having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms), fluorinated alkyl groups having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms), etc.

[0343] [Chemical Formula 8]

[0344]

[0345] In equation (61), R 58 and R 59 Each is independently a fluorine atom, a methyl group, or a trifluoromethyl group, and * each independently represents a bonding site with a nitrogen atom in formula (2).

[0346] Examples of diamines that impart the structure of formula (51) or (61) include 2,2'-dimethylbenzidine, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(fluoro)-4,4'-diaminobiphenyl, 4,4'-diaminooctafluorobiphenyl, etc. These may be used as one type or in combination of two or more types.

[0347] In addition, from the perspective of suppressing the generation of outgas from the hardened material, R 111It is also preferable that the group is formed by any one of the following formulas (W1-1) to (W1-5), or by including one or more aliphatic ring structures.

[0348] R 111 It is believed that by including such a structure, the glass transition temperature of the cured product is raised, thereby suppressing the generation of outgas from the cured product.

[0349] [Chemical Formula 9]

[0350]

[0351] In formula (W1-1), R represents a substituent, n1 represents an integer from 0 to 4, and * represents a binding site with another structure.

[0352] In formula (W1-2), R independently represents a substituent, m4 independently represents an integer from 0 to 4, and * each represents a binding site with another structure.

[0353] In equation (W1-3), R independently represents a substituent, m4 independently represents an integer from 0 to 3, and L 3 -CR C Represents 2- or -S(=O)2-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0354] In formula (W1-4), R represents a substituent independently, n3 represents an integer from 0 to 6, and * represents a binding site with another structure.

[0355] In equation (W1-5), R independently represents a substituent, n4 independently represents an integer from 0 to 3, and X 1 and X 2 Each independently consists of an oxygen atom, -S(=O)2- or -CR C Represents 2-, and R CEach represents independently a hydrogen atom or a monovalent organic group, and * represents a bonding site with another structure.

[0356] In addition, in this specification, when a bond is described to extend beyond the edge of a ring structure in a chemical formula, it indicates that the bond may be bonded to any reduction of the ring structure.

[0357] In addition, if a bond is described in the chemical formula that extends across the edges of multiple ring structures, it indicates that the bond may be bonded to any of the reductions of the multiple ring structures.

[0358] In formula (W1-1), the substituent represented by R is not particularly limited, but may include aliphatic hydrocarbon groups, aryl groups, alkoxy groups, alkyl carbonyl groups, alkoxycarbonyl groups, alkyl carbonyloxy groups, aryloxy groups, aryl carbonyl groups, aryl oxycarbonyl groups, aryl carbonyloxy groups, halogen atoms, etc.

[0359] As for the above aliphatic hydrocarbon group, an alkyl group is preferred, an alkyl group having 1 to 10 carbon atoms is more preferred, and an alkyl group having 1 to 4 carbon atoms is more preferred.

[0360] As for the above aryl group, an aromatic hydrocarbon group is preferred, and a phenyl group is more preferred.

[0361] Among the above alkoxy groups, alkyl carbonyl groups, alkoxycarbonyl groups, and alkyl carbonyloxy groups, the alkyl group is preferably an alkyl group having 1 to 10 carbon atoms, and more preferably an alkyl group having 1 to 4 carbon atoms.

[0362] The above alkyl group may be further substituted with a halogen atom, etc. Examples of such embodiments include a trifluoromethyl group, a pentafluoroethyl group, etc.

[0363] Among the above aryloxy group, aryl carbonyl group, aryloxycarbonyl group, and arylcarbonyloxy group, the aryl group is preferably an aromatic hydrocarbon group, and more preferably a phenyl group.

[0364] In formula (W1-1), n1 is preferably an integer from 0 to 3, and more preferably 0 or 1.

[0365] In Equation (W1-2), the preferred embodiments of R and m4 are each identical to the preferred embodiments of R and n1 in Equation (W1-1).

[0366] In Equation (W1-3), the preferred mode of R is the same as the preferred mode of R in Equation (W1-1).

[0367] In formula (W1-3), m4 is preferably an integer from 0 to 2, and more preferably 0 or 1.

[0368] In formula (W1-3), L 3 -CR C It represents 2- or -S(=O)2-, and -S(=O)2- is preferred.

[0369] In equation (W1-3), R C The preferred mode of is the same as the preferred mode of R in formula (W1-1).

[0370] In Equation (W1-4), the preferred mode of R is the same as the preferred mode of R in Equation (W1-1).

[0371] In equation (W1-4), n3 is preferably an integer from 0 to 4, and more preferably an integer from 0 to 2.

[0372] In Equation (W1-5), the preferred mode of R is the same as the preferred mode of R in Equation (W1-1).

[0373] In formula (W1-5), n4 is preferably an integer from 0 to 2, and more preferably 0 or 1.

[0374] In equation (W1-5), X 1 and X 2 One side is an oxygen atom or -S(=O)2-, and the other side is -CR C It is desirable to have 2.

[0375] In equation (W1-5), R CA hydrogen atom or a hydrocarbon group is preferred, and a hydrogen atom is more preferred.

[0376] Examples of groups comprising one or more aliphatic ring structures include groups comprising one aliphatic ring structure, or groups comprising two or more aliphatic ring structures joined by a single bond, -O-, or -C(=O)-.

[0377] The aliphatic ring structure in the group comprising one or more aliphatic ring structures may be a saturated aliphatic ring structure or an unsaturated aliphatic ring structure.

[0378] In addition, the aliphatic ring structure may be a heterocyclic structure, but it is preferable that it be an aliphatic hydrocarbon ring structure.

[0379] In addition, the aliphatic ring structure in the group comprising one or more aliphatic ring structures may be a single ring, or a compound ring such as a condensed ring, a cross-linked condensed ring, or a spiro ring.

[0380] Examples of aliphatic ring structures in a group comprising one or more aliphatic ring structures include cyclohexane structures, cyclohexene structures, and bicyclo[2.2.2]octo-5-ene structures.

[0381] Specific examples of a group represented by any one of formulas (W1-1) to (W1-5), or a group comprising one or more aliphatic ring structures, include, but are not limited to, the following structures. Among the following structures, * indicates a binding site with another structure.

[0382] [Chemical Formula 10]

[0383]

[0384] R in Equation (2) 115 represents a tetravalent organic group. As for the tetravalent organic group, a tetravalent organic group including an aromatic ring is preferred, and a group represented by the following formula (5) or formula (6) is more preferred.

[0385] In Equation (5) or Equation (6), * represents a site of connection with another structure, each independently.

[0386] [Chemical Formula 11]

[0387]

[0388] In Equation (5), R 112 The linker is a single bond or a divalent linker, and is preferably a linker selected from a single bond, an aliphatic hydrocarbon group having 1 to 10 carbon atoms that may be substituted with a fluorine atom, -O-, -CO-, -S-, -SO2-, and -NHCO-, and combinations thereof; more preferably a linker selected from a single bond, an alkylene group having 1 to 3 carbon atoms that may be substituted with a fluorine atom, -O-, -CO-, -S-, and -SO2-; and more preferably a divalent linker selected from the group consisting of -CH2-, -C(CF3)2-, -C(CH3)2-, -O-, -CO-, -S-, and -SO2-.

[0389] In addition, from the perspective of suppressing the generation of outgas from the hardened material, R 115 It is also preferable that the group is represented by any one of the following formulas (X1-1) to (X1-3), or is composed of one or more aliphatic ring structures.

[0390] [Chemical Formula 12]

[0391]

[0392] In formula (X1-1), R represents a substituent, n1 represents an integer from 0 to 2, and * represents a binding site with another structure.

[0393] In equation (X1-2), R represents a substituent independently, m1 represents an integer from 0 to 3 independently, and * represents a binding site with another structure.

[0394] In equation (X1-3), R independently represents a substituent, m1 independently represents an integer from 0 to 3, and L 1 -CR C Represents 2-, -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0395] In Equation (X1-1), the preferred embodiment of R is the same as the preferred embodiment of R in Equation (W1-1) described above.

[0396] In equation (X1-1), n1 is preferably 0 or 1.

[0397] In Equation (X1-2), the preferred embodiment of R is the same as the preferred embodiment of R in Equation (W1-1) described above.

[0398] In equation (X1-2), it is preferable that m1 be 0 or 1.

[0399] In Equation (X1-3), the preferred mode of R is the same as the preferred mode of R in Equation (W1-1).

[0400] In equation (X1-3), it is preferable that m1 be 0 or 1.

[0401] In formula (W1-3), L 1 -CR C It represents 2-, -S(=O)2- or -O-, and -S(=O)2- is preferred.

[0402] In equation (X1-3), R C The preferred mode of is the same as the preferred mode of R in formula (W1-1).

[0403] A preferred embodiment of the aliphatic ring structure in a device comprising one or more aliphatic ring structures is the above-described R 111 It is identical to a preferred mode of an aliphatic ring structure in a group comprising one or more aliphatic ring structures.

[0404] Specific examples of a group represented by any one of formulas (X1-1) to (X1-3), or a group comprising one or more aliphatic ring structures, include, but are not limited to, the following structures. Among the following structures, * indicates a binding site with another structure.

[0405] [Chemical Formula 13]

[0406]

[0407] R 115 Specifically, examples include tetracarboxylic acid residues remaining after the removal of an anhydride group from a tetracarboxylic acid dianhydride. The polyimide precursor is R 115 As a structure corresponding to, it may include only one tetracarboxylic acid dianhydride residue or two or more.

[0408] It is preferable that the tetracarboxylic acid dianhydride be represented by the following formula (O).

[0409] [Chemical Formula 14]

[0410]

[0411] In formula (O), R 115 represents a tetravalent organic group. R 115 The desirable range of is R in Equation (2). 115 It has the same meaning as, and the desirable range is also the same.

[0412] Specific examples of tetracarboxylic acid dianhydrides include pyromellitic acid dianhydride (PMDA), 3,3',4,4'-biphenyltetracarboxylic acid dianhydride, 3,3',4,4'-diphenylsulfidetetracarboxylic acid dianhydride, 3,3',4,4'-diphenylsulfonetetracarboxylic acid dianhydride, 3,3',4,4'-benzophenonetetracarboxylic acid dianhydride, 3,3',4,4'-diphenylmethanetetracarboxylic acid dianhydride, 2,2',3,3'-diphenylmethanetetracarboxylic acid dianhydride, 2,3,3',4'-biphenyltetracarboxylic acid dianhydride, 2,3,3',4'-benzophenonetetracarboxylic acid dianhydride, and 4,4'-oxydiphthalic acid. Anhydride, 2,3,6,7-naphthalenetetracarboxylic acid dianhydride, 1,4,5,7-naphthalenetetracarboxylic acid dianhydride, 2,2-bis(3,4-dicarboxyphenyl)propane dianhydride, 2,2-bis(2,3-dicarboxyphenyl)propane dianhydride, 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride, 1,3-diphenylhexafluoropropane-3,3,4,4-tetracarboxylic acid dianhydride, 1,4,5,6-naphthalenetetracarboxylic acid dianhydride, 2,2',3,3'-diphenyltetracarboxylic acid dianhydride, 3,4,9,10-perylenetetracarboxylic acid dianhydride, Examples include 1,2,4,5-naphthalene tetracarboxylic acid dianhydride, 1,4,5,8-naphthalene tetracarboxylic acid dianhydride, 1,8,9,10-phenanthrene tetracarboxylic acid dianhydride, 1,1-bis(2,3-dicarboxyphenyl)ethane dianhydride, 1,1-bis(3,4-dicarboxyphenyl)ethane dianhydride, 1,2,3,4-benzene tetracarboxylic acid dianhydride, and their alkyl and alkoxy derivatives having 1 to 6 carbon atoms.

[0413] In addition, tetracarboxylic acid dianhydrides (DAA-1) to (DAA-5) described in paragraph 0038 of International Publication No. 2017 / 038598 can also be cited as preferred examples.

[0414] In Equation (2), R 111 and R 115 It is also possible for at least one of them to have an OH group. More specifically, R111 As such, a residue of a bisaminophenol derivative can be cited.

[0415] R in Equation (2) 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group. As the monovalent organic group, it is preferable to include a straight-chain or branched alkyl group, a cyclic alkyl group, an aromatic group, or a polyalkyleneoxy group. In addition, R 113 and R 114 It is preferable that at least one of them includes a polymerizable group, and it is more preferable that both include a polymerizable group. R 113 and R 114 It is also desirable that at least one of the groups comprises two or more polymerizable groups. As a polymerizable group, it is a group capable of undergoing a cross-linking reaction by the action of heat, radicals, etc., and a radical polymerizable group is preferred. Specific examples of polymerizable groups include a group having an ethylenically unsaturated bond, an alkoxymethyl group, a hydroxymethyl group, an acyloxymethyl group, an epoxy group, an oxetanyl group, a benzoxazoleyl group, a block isocyanate group, and an amino group. As a radical polymerizable group having a polyimide precursor, a group having an ethylenically unsaturated bond is preferred.

[0416] Groups having ethylenically unsaturated bonds include vinyl groups, allyl groups, isoallyl groups, 2-methylallyl groups, groups having an aromatic ring directly bonded to a vinyl group (e.g., vinylphenyl groups, etc.), (meth)acrylamide groups, (meth)acryloyloxy groups, and groups represented by the following formula (III), and the group represented by the following formula (III) is preferred.

[0417] [Chemical Formula 15]

[0418]

[0419] In Equation (III), R 200 It represents a hydrogen atom, a methyl group, an ethyl group, or a methylol group, and a hydrogen atom or a methyl group is preferred.

[0420] In formula (III), * indicates a binding site with another structure.

[0421] In Equation (III), R 201 It represents an alkylene group having 2 to 12 carbon atoms, -CH2CH(OH)CH2-, a cycloalkylene group, or a polyalkyleneoxy group.

[0422] Suitable R 201 Examples include alkylene groups such as ethylene groups, propylene groups, trimethylene groups, tetramethylene groups, pentamethylene groups, hexamethylene groups, octamethylene groups, and dodecamethylene groups, 1,2-butanediyl groups, 1,3-butanediyl groups, -CH2CH(OH)CH2-, and polyalkyleneoxy groups; alkylene groups such as ethylene groups and propylene groups, -CH2CH(OH)CH2-, cyclohexyl groups, and polyalkyleneoxy groups are more preferred, and alkylene groups such as ethylene groups and propylene groups, or polyalkyleneoxy groups are more preferred.

[0423] In the present invention, a polyalkyleneoxy group refers to a group to which two or more alkyleneoxy groups are directly bonded. The alkylene groups in the plurality of alkyleneoxy groups included in the polyalkyleneoxy group may each be the same or different.

[0424] When a polyalkyleneoxy group comprises multiple types of alkyleneoxy groups with different alkylene groups, the arrangement of the alkyleneoxy groups in the polyalkyleneoxy group may be a random arrangement, a block arrangement, or an arrangement having a pattern such as alternation.

[0425] The number of carbon atoms of the above alkylene group (including the number of carbon atoms of the substituent when the alkylene group has a substituent) is preferably 2 or more, more preferably 2 to 10, more preferably 2 to 6, more preferably 2 to 5, even more preferably 2 to 4, particularly preferably 2 or 3, and most preferably 2.

[0426] In addition, the above alkylene group may have a substituent. Preferred substituents include alkyl groups, aryl groups, halogen atoms, etc.

[0427] In addition, the number of alkylene oxygen groups included in the polyalkylene oxygen group (number of repetitions of polyalkylene oxygen groups) is preferably 2 to 20, more preferably 2 to 10, and more preferably 2 to 6.

[0428] As for the polyalkylene oxygen group, from the perspective of solvent solubility and solvent resistance, a polyethylene oxygen group, a polypropylene oxygen group, a polytrimethylene oxygen group, a polytetramethylene oxygen group, or a group in which a plurality of ethylene oxygen groups and a plurality of propylene oxygen groups are combined is preferred, a polyethylene oxygen group or a polypropylene oxygen group is more preferred, and a polyethylene oxygen group is even more preferred. In the group in which a plurality of ethylene oxygen groups and a plurality of propylene oxygen groups are combined, the ethylene oxygen groups and propylene oxygen groups may be arranged randomly, arranged to form blocks, or arranged in a pattern such as alternation. Preferred embodiments of the number of repetitions of ethylene oxygen groups, etc. in these groups are as described above.

[0429] In Equation (2), R 113 In the case of this hydrogen atom, or, R 114 When the atom is a hydrogen atom, the polyimide precursor may form a countersalt with a tertiary amine compound having an ethylenically unsaturated bond. An example of such a tertiary amine compound having an ethylenically unsaturated bond is N,N-dimethylaminopropyl methacrylate.

[0430] In Equation (2), R 113 and R 114At least one of them may be a polarity converter such as an acid-degradable group. As for the acid-degradable group, it is not particularly limited as long as it decomposes under the action of acid to generate an alkali-soluble group such as a phenolic hydroxyl group or a carboxyl group, but acetal groups, ketal groups, silyl groups, silyl ether groups, tertiary alkyl ester groups, etc. are preferred, and from the perspective of exposure sensitivity, acetal groups or ketal groups are more preferred.

[0431] Specific examples of acid-degradable groups include tert-butoxycarbonyl groups, isopropoxycarbonyl groups, tetrahydropyranyl groups, tetrahydrofuranyl groups, ethoxyethyl groups, methoxyethyl groups, ethoxymethyl groups, trimethylsilyl groups, tert-butoxycarbonylmethyl groups, trimethylsilyl ether groups, etc. From the perspective of exposure sensitivity, ethoxyethyl groups or tetrahydrofuranyl groups are preferred.

[0432] Also, from the perspective of suppressing outgassing from the cured material, -A 2 -R 113 and -A 1 -R 114 It is also desirable that at least one of them includes a repeating unit that is represented by the following formula (3-1).

[0433] [Chemical Formula 16]

[0434]

[0435] In Equation (3-1), Z 1 and Z 2 Each represents an organic group independently, and Z 1 and Z 2 It may combine to form a ring structure, and * indicates a site of connection with another structure.

[0436] According to this embodiment, when a specific resin is closed, a base is generated from the structure shown in Equation (3-1), and since the closure is further promoted, it is believed that even if the cured product is obtained by heating at a low temperature of 180°C or lower, the glass transition temperature is increased and a cured product with less out-gas generation is obtained.

[0437] In addition, for example, when a base generator described later is used, residues remaining after the base of the base generator is generated may remain in the cured product, and volatilization of these residues may cause outgassing. However, if the resin has a group represented by Equation (3-1), the residue is the resin after ring closure. Therefore, it is thought that the residue of low-molecular-weight compounds remaining in the film after the heating process is eliminated, and the amount of outgassing is reduced.

[0438] When a specific resin has a group represented by formula (3-1), it is desirable that the specific resin generates a base at a temperature between 120 and 180°C.

[0439] In addition, it is desirable that a specific resin generates a base during heating in the above heating process.

[0440] Whether a specific resin generates a base at a predetermined temperature X℃ is determined by the following method.

[0441] After heating 1 mole of a specific resin in a sealed container under 1 atmosphere at X°C for 3 hours, the amount of decomposition can be quantified by a method such as HPLC (High-speed Liquid Chromatography) to determine whether or not a base is generated. It is preferable that the amount of the base generated be 0.1 mole or more, and more preferable that it be 0.5 mole or more. The upper limit of the amount of the base generated is not particularly limited, but, for example, it can be 1000 moles or less.

[0442] The molecular weight of the base generated from a specific resin is preferably 40 to 1,000, more preferably 40 to 500, and even more preferably 50 to 400.

[0443] The boiling point of the base having the above pyridine structure at 1 atm is preferably 50 to 600°C, more preferably 50 to 500°C, and more preferably 50 to 450°C.

[0444] The resulting base is preferably a base with a pKa of 0 or higher, more preferably a base with a pKa of 3 or higher, and more preferably a base with a pKa of 6 or higher. The upper limit of the pKa of the conjugate acid is not particularly limited, but it is preferably 30 or lower.

[0445] pKa is a term representing the equilibrium constant Ka in the dissociation reaction in which hydrogen ions are released from an acid, expressed as the negative common logarithm of pKa. In this specification, pKa is a value calculated by ACD / ChemSketch (registered trademark) unless specifically stated otherwise.

[0446] When there are multiple pKa values ​​of the conjugated acids, it is preferable that at least one is within the above range.

[0447] In Equation (3-1), Z 1 and Z 2 Each independently represents an organic group, a hydrocarbon group, or a hydrocarbon group and -O-, -C(=O)-, -S-, -S(=O)2- and -NR N A group appearing by a combination of at least one group selected from the group consisting of - is preferred, and a hydrocarbon group, or a group appearing by a combination of a hydrocarbon group and -O- is preferred. R N It is as described above.

[0448] As for the above hydrocarbon group, it may be either an aliphatic hydrocarbon group or an aromatic hydrocarbon group, but an aliphatic hydrocarbon group is preferred, and a saturated aliphatic hydrocarbon group is more preferred.

[0449] The number of carbon atoms in the above aliphatic hydrocarbon group is preferably 1 to 20, more preferably 1 to 10, and more preferably 1 to 8.

[0450] In addition, the above-mentioned aliphatic hydrocarbon group may be a straight-chain, branched-chain, or cyclic structure, or a structure formed by a combination thereof.

[0451] The number of carbon atoms in the above aromatic hydrocarbon group is preferably 6 to 20, more preferably 6 to 10, and more preferably 6.

[0452] The above hydrocarbon group may have known substituents within the range in which the effects of the present invention are obtained.

[0453] Also, Z 1 and Z 2 An embodiment in which at least one of the elements has a polymerizable group is also one of the preferred embodiments of the present invention.

[0454] Examples of polymerizable groups include radical polymerizable groups, epoxy groups, oxetanyl groups, methylol groups, alkoxymethyl groups, etc., and radical polymerizable groups are preferred.

[0455] As a radical polymerization group, a group having an ethylenically unsaturated group is preferred, and examples include a (meth)acryloxy group, a (meth)acrylamide group, a vinylphenyl group, a maleimide group, a styryl group, a vinyl group, a (meth)allyl group, etc.

[0456] Among these, (meth)acryloxy groups are preferred from the perspective of reactivity.

[0457] These polymerizable groups may be directly bonded to the nitrogen atom in Formula (3-1), or may be bonded through a linker such as a hydrocarbon group (e.g., an alkylene group).

[0458] Also, in Equation (3-1), Z 1 and Z 2 It may be combined to form a ring structure.

[0459] The ring structure formed may be an aromatic ring structure or an aliphatic ring structure, but an aliphatic ring structure is preferred, and a saturated aliphatic ring structure is more preferred.

[0460] As for the above ring structure, a cyclic amine having 2 to 10 carbon atoms is preferred, and examples include a pyrrolidine ring, a piperidine ring, a morpholine ring, an octahydroindole ring, an octahydroisoindole ring, a pyrrole ring, a pyridine ring, etc., and a pyrrolidine ring, a piperidine ring, or a morpholine ring is preferred.

[0461] In addition, the above ring structure may have substituents within the range in which the effects of the present invention are obtained. Examples of substituents include hydrocarbon groups, halogen atoms, etc. Examples of ring structures substituted by substituents include dimethylpiperidine rings.

[0462] The organism represented by Equation (3-1) is preferably the organism represented by Equation (3-1-1) or Equation (3-1-2) below.

[0463] [Chemical Formula 17]

[0464]

[0465] In formula (3-1-1), Cy represents an aliphatic ring structure or an aromatic ring structure, and * represents a binding site with another structure.

[0466] In Equation (3-1-2), Z 3 and Z 4 Each represents an alkyl group independently, and * represents a bonding site with another structure.

[0467] In formula (3-1-1), the ring structure represented by Cy is preferably an aliphatic ring structure, and more preferably a saturated aliphatic ring structure.

[0468] Examples of ring structures represented by the above Cy include pyrrolidine ring, piperidine ring, morpholine ring, octahydroindole ring, octahydroisoindole ring, pyrrole ring, pyridine ring, etc., and pyrrolidine ring, piperidine ring, or morpholine ring are preferred.

[0469] In addition, the ring structure represented by Cy above may have substituents within the range in which the effects of the present invention are obtained. Examples of substituents include hydrocarbon groups, halogen atoms, etc. Examples of ring structures substituted by substituents include dimethylpiperidine rings, etc.

[0470] In Equation (3-1-2), Z 3 and Z 4 Each independently represents an alkyl group, wherein an alkyl group having 1 to 20 carbon atoms is preferred, an alkyl group having 1 to 10 carbon atoms is more preferred, and an alkyl group having 1 to 8 carbon atoms is more preferred.

[0471] The above alkyl group may be a straight chain, a branched chain, or a cyclic structure, or a structure that appears through a combination thereof.

[0472] Specific examples of the material represented by Equation (3-1) include the following, but are not limited thereto.

[0473] [Chemical Formula 18]

[0474]

[0475] -A in formula (2) included in a specific resin 2 -R 113 and -A 1 -R 114 and -A in the formula (PAI-2) described below 2 -R 113 The ratio of the total molar amount of group represented by Equation (3-1) to the total molar amount of is preferably 0.1 mol% or more, more preferably 5 mol% or more, and more preferably 10 mol% or more.

[0476] -A in the above equation (2) 2 -R 113 and -A 1 -R 114 and -A in the formula (PAI-2) described below 2 -R 113The total molar amount of, and the total molar amount of, represented by Equation (3-1), can be calculated, for example, by NMR (nuclear magnetic resonance device).

[0477] Also, for the reason of improving chemical resistance and pattern formation, -A in Equation (2) 2 -R 113 and -A 1 -R 114 and -A in the formula (PAI-2) described below 2 -R 113 The ratio of the total molar amount of group represented by Equation (3-1) to the total molar amount of is preferably 99.9 mol% or less, more preferably 95 mol% or less, more preferably 90 mol% or less, and particularly preferably 80 mol% or less.

[0478] In addition, -A in formula (2) included in a specific resin promotes the cyclization of the polyimide precursor resin and the polyamideimide precursor resin, and lowers the heating temperature in the heating process to improve the elongation at break. 2 -R 113 and -A 1 -R 114 and -A in the formula (PAI-2) described below 2 -R 113 The ratio of the molar amount of the group represented by Equation (3-1) to the total molar amount of is preferably 80 mol% or more, more preferably 90 mol% or more, more preferably 95 mol% or more, and particularly preferably 98 mol% or more. -A in Equation (2). 2 -R 113 and -A 1 -R 114 and -A in the formula (PAI-2) described below 2 -R 113 One of the preferred embodiments of the present invention is an embodiment in which the ratio of the molar amount of the group represented by Equation (3-1) to the total molar amount of is 100 mol%.

[0479] In addition, the molar amount of the group represented by formula (3-1) contained in the specific resin relative to the total mass of the specific resin is preferably 0.001 to 10 mmol / g, more preferably 0.01 to 5 mmol / g, and even more preferably 0.1 to 3 mmol / g.

[0480] In addition, the mass of the group represented by formula (3-1) contained in the specific resin relative to the total mass of the specific resin is preferably 0.1 to 70%, more preferably 0.5 to 40%, and even more preferably 1 to 20%.

[0481] In addition, it is preferable that the polyimide precursor has fluorine atoms in its structure. The fluorine atom content in the polyimide precursor is preferably 10 mass% or more, and preferably 20 mass% or less.

[0482] In addition, for the purpose of improving adhesion to the substrate, the polyimide precursor may be copolymerized with an aliphatic group having a siloxane structure. Specifically, examples include using bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, etc. as the diamine.

[0483] The repeating unit represented by Equation (2) is preferably the repeating unit represented by Equation (2-A). That is, it is preferable that at least one of the polyimide precursors used in the present invention is a precursor having the repeating unit represented by Equation (2-A). By including the repeating unit represented by Equation (2-A) in the polyimide precursor, it becomes possible to further widen the exposure latitude.

[0484] Equation (2-A)

[0485] [Chemical Formula 19]

[0486]

[0487] In Equation (2-A), A 1 and A 2 represents an oxygen atom, and R 111and R 112 Each independently represents a divalent organic group, and R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, and R 113 and R 114 At least one of them is a group containing a polymerizable group, and it is preferable that both are groups containing a polymerizable group.

[0488] A 1 , A 2 , R 111 , R 113 and R 114 A in Equation (2), independently of each 1 , A 2 , R 111 , R 113 and R 114 It has the same meaning as, and the desirable range is also the same.

[0489] R 112 is R in Equation (5) 112 It has the same meaning as, and the desirable range is also the same.

[0490] The polyimide precursor may include one type of repeating unit represented by Formula (2), but may include two or more types. It may also include a structural isomer of the repeating unit represented by Formula (2). It goes without saying that the polyimide precursor may include other types of repeating units in addition to the repeating unit of Formula (2).

[0491] As one embodiment of the polyimide precursor in the present invention, an embodiment in which the content of the repeating unit represented by Formula (2) is 50 mol% or more of the total repeating unit may be provided. The total content is more preferably 70 mol% or more, more preferably 90 mol% or more, and particularly preferably exceeding 90 mol%. The upper limit of the total content is not particularly limited, and all repeating units in the polyimide precursor, excluding the ends, may be repeating units represented by Formula (2).

[0492] The weight average molecular weight (Mw) of the polyimide precursor is preferably 5,000 to 100,000, more preferably 10,000 to 50,000, and even more preferably 15,000 to 40,000. Also, the number average molecular weight (Mn) is preferably 2,000 to 40,000, more preferably 3,000 to 30,000, and even more preferably 4,000 to 20,000.

[0493] The degree of dispersion of the molecular weight of the polyimide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and more preferably 2.0 or higher. Although the upper limit of the degree of dispersion of the molecular weight of the polyimide precursor is not specifically determined, for example, it is preferably 7.0 or lower, more preferably 6.5 or lower, and more preferably 6.0 or lower.

[0494] In this specification, the degree of dispersion of molecular weight is a value calculated by weight-average molecular weight / number-average molecular weight.

[0495] In addition, when the resin composition includes multiple types of polyimide precursors as a specific resin, it is preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion of at least one type of polyimide precursor are within the above range. In addition, it is also preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion calculated by combining the multiple types of polyimide precursors as a single resin are each within the above range.

[0496] [Polybenzoxazole Precursor]

[0497] The polybenzoxazole precursor used in the present invention is not specifically defined in terms of its structure, but preferably includes a repeating unit represented by the following formula (3).

[0498] [Chemical Formula 20]

[0499]

[0500] In Equation (3), R 121 Silver represents a divalent organic group, and R 122 represents a tetravalent organic group, and R 123 and R 124 Each represents, independently, a hydrogen atom or a monovalent organic group.

[0501] In Equation (3), R 123 and R 124 are, respectively, R in Equation (2). 113 It has the same meaning as and the desirable range is also the same. That is, it is desirable that at least one of them be a polymerizable group.

[0502] In Equation (3), R 121 Silver represents a divalent organic group. As the divalent organic group, a group comprising at least one of an aliphatic group and an aromatic group is preferred. As the aliphatic group, a straight-chain aliphatic group is preferred. R 121 A dicarboxylic acid residue is preferred. Only one type of dicarboxylic acid residue may be used, or two or more types may be used.

[0503] As for the dicarboxylic acid residue, a dicarboxylic acid containing an aliphatic group and a dicarboxylic acid residue containing an aromatic group are preferred, and a dicarboxylic acid residue containing an aromatic group is more preferred.

[0504] As for the dicarboxylic acid containing an aliphatic group, a dicarboxylic acid containing a straight or branched (preferably straight) aliphatic group is preferred, and a dicarboxylic acid consisting of a straight or branched (preferably straight) aliphatic group and two -COOH groups is more preferred. The number of carbon atoms in the straight or branched (preferably straight) aliphatic group is preferably 2 to 30, more preferably 2 to 25, even more preferably 3 to 20, further preferably 4 to 15, and particularly preferably 5 to 10. The straight aliphatic group is preferably an alkylene group.

[0505] As dicarboxylic acids containing straight-chain aliphatic groups, malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, 2,2,6,6-tetramethylpimelic acid, souveric acid, dodecafluorosuberic acid, azelaic acid, sebacic acid, hexadecafluorosebacic acid, 1,9-nonaneinic acid, Examples include dodecane diacid, tridecane diacid, tetradecane diacid, pentadecaine diacid, hexadecane diacid, heptadecaine diacid, octadecaine diacid, nonadecaine diacid, eicocane diacid, hen-eicocane diacid, docosane diacid, tricosane diacid, tetracosane diacid, pentadecaine diacid, hexacosane diacid, heptadecaine diacid, octadecaine diacid, nonadecaine diacid, triacontein diacid, hen-triacontein diacid, do-triacontein diacid, diglycolic acid, and also dicarboxylic acids represented by the following formula.

[0506] [Chemical Formula 21]

[0507]

[0508] (In the formula, Z is a hydrocarbon group having 1 to 6 carbon atoms, and n is an integer from 1 to 6.)

[0509] As for the dicarboxylic acid containing an aromatic group, a dicarboxylic acid having the following aromatic group is preferred, and a dicarboxylic acid consisting only of the following aromatic group and two -COOH groups is more preferred.

[0510] [Chemical Formula 22]

[0511]

[0512] In the formula, A represents a divalent group selected from the group consisting of -CH2-, -O-, -S-, -SO2-, -CO-, -NHCO-, -C(CF3)2-, and -C(CH3)2-, and * represents a binding site with another structure, each independently.

[0513] Specific examples of dicarboxylic acids containing aromatic groups include 4,4'-carbonyl dibenzoic acid, 4,4'-dicarboxydiphenyl ether, and terephthalic acid.

[0514] In Equation (3), R 122 represents a tetravalent organic group. As a tetravalent organic group, R in the above formula (2) 115 It has the same meaning as, and the desirable range is also the same.

[0515] R 122It is also preferable that the group is derived from a bisaminophenol derivative, and as a group derived from a bisaminophenol derivative, for example, 3,3'-diamino-4,4'-dihydroxybiphenyl, 4,4'-diamino-3,3'-dihydroxybiphenyl, 3,3'-diamino-4,4'-dihydroxydiphenylsulfone, 4,4'-diamino-3,3'-dihydroxydiphenylsulfone, bis-(3-amino-4-hydroxyphenyl)methane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis-(3-amino-4-hydroxyphenyl)hexafluoropropane, 2,2-bis-(4-amino-3-hydroxyphenyl)hexafluoropropane, bis-(4-amino-3-hydroxyphenyl)methane, Examples include 2,2-bis-(4-amino-3-hydroxyphenyl)propane, 4,4'-diamino-3,3'-dihydroxybenzophenone, 3,3'-diamino-4,4'-dihydroxybenzophenone, 4,4'-diamino-3,3'-dihydroxydiphenyl ether, 3,3'-diamino-4,4'-dihydroxydiphenyl ether, 1,4-diamino-2,5-dihydroxybenzene, 1,3-diamino-2,4-dihydroxybenzene, 1,3-diamino-4,6-dihydroxybenzene, etc. These bisaminophenols may be used alone or in combination.

[0516] Among bisaminophenol derivatives, a bisaminophenol derivative having the following aromatic group is preferred.

[0517] [Chemical Formula 23]

[0518]

[0519] In the formula, X1 represents -O-, -S-, -C(CF3)2-, -CH2-, -SO2-, or -NHCO-, and * and # each represent a bonding site with another structure. R represents a hydrogen atom or a monovalent substituent, preferably a hydrogen atom or a hydrocarbon group, and more preferably a hydrogen atom or an alkyl group. Also, R 122 It is also desirable that it is a structure represented by the above formula. R122 a. In the case of a structure represented by the above formula, any two of the total four * and # are R in formula (3). 122 It is a bonding site with a nitrogen atom to which it is bonded, and also, the other two are R in Equation (3). 122 It is preferable that the bonding site with the oxygen atom to which it is bonded is the R in Equation (3), and the two * are R in Equation (3). 122 It is a bonding site with an oxygen atom to which it is bonded, and also, the two #s are R in equation (3). 122 It is a bonding site with a nitrogen atom to which it is bonded, or, two * are R in Equation (3). 122 It is a bonding site with a nitrogen atom to which it is bonded, and also, the two #s are R in equation (3). 122 It is more preferable that the bonding site with the oxygen atom to which it is bonded is the R in Equation (3), and the two * are R in Equation (3). 122 It is a bonding site with an oxygen atom to which it is bonded, and also, the two #s are R in equation (3). 122 It is more desirable that it be a bonding site with a nitrogen atom to which it is bonded.

[0520] It is also preferable that the bisaminophenol derivative be a compound represented by the formula (As).

[0521] [Chemical Formula 24]

[0522]

[0523] In formula (As), R1 is a hydrogen atom, an alkylene, a substituted alkylene, -O-, -S-, -SO2-, -CO-, -NHCO-, a single bond, or an organic group selected from the group of the following formula (A-sc). R2 is any one of a hydrogen atom, an alkyl group, an alkoxy group, an acyloxy group, or a cyclic alkyl group, and may be the same or different. R3 is any one of a hydrogen atom, a straight or branched alkyl group, an alkoxy group, an acyloxy group, or a cyclic alkyl group, and may be the same or different.

[0524] [Chemical Formula 25]

[0525]

[0526] (In formula (A-sc), * indicates bonding to the aromatic ring of the aminophenol group of the bisaminophenol derivative represented by the above formula (As).)

[0527] In the above formula (As), having a substituent on the ortho position of the phenolic hydroxyl group, i.e., R3, is thought to bring the distance between the carbonyl carbon of the amide bond and the hydroxyl group closer, and is particularly desirable in that it increases the effect of achieving a high oxidization rate when cured at low temperatures.

[0528] In addition, among the above formula (As), it is preferable that R2 is an alkyl group and R3 is an alkyl group, as this can maintain the effects of high transparency to i-line and high rediation rate when cured at low temperature.

[0529] In addition, among the above formula (As), it is more preferable that R1 is an alkylene or a substituted alkylene. Specific examples of alkylenes and substituted alkylenes regarding R1 include straight-chain or branched-chain alkyl groups having 1 to 8 carbon atoms, but among them, -CH2-, -CH(CH3)-, and -C(CH3)2- are more preferable in that they allow for obtaining a polybenzoxazole precursor with excellent balance that has sufficient solubility in solvents while maintaining the effects of high transparency to i-lines and high oxidization rate when cured at low temperatures.

[0530] As a method for preparing a bisaminophenol derivative represented by the above formula (As), reference may be made to paragraphs 0085 to 0094 and Example 1 (paragraphs 0189 to 0190) of Japanese Patent Publication No. 2013-256506, and the contents thereof are incorporated herein by reference.

[0531] Specific examples of the structure of the bisaminophenol derivative represented by the above formula (As) include those described in paragraphs 0070 to 0080 of Japanese Patent Publication No. 2013-256506, and these contents are incorporated herein by reference. It goes without saying that they are not limited to these.

[0532] The polybenzoxazole precursor may include other types of repeating units in addition to the repeating unit of the above formula (3).

[0533] In order to suppress the occurrence of bending due to ring closure, it is preferable for the polybenzoxazole precursor to include a diamine residue represented by the following formula (SL) as a different type of repeating unit.

[0534] [Chemical Formula 26]

[0535]

[0536] In formula (SL), Z has structures a and b, and R 1s is a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, and R 2s is a hydrocarbon group having 1 to 10 carbon atoms, and R 3s , R 4s , R 5s , R 6s At least one of them is an aromatic group, and the remainder is a hydrogen atom or an organic group having 1 to 30 carbon atoms, and each may be the same or different. The polymerization of structure a and structure b may be block polymerization or random polymerization. The molar percentage of the Z portion is 5 to 95 mol% for structure a, 95 to 5 mol% for structure b, and 100 mol% for a+b.

[0537] In formula (SL), the preferred Z is R in the b structure 5s and R 6sExamples include a phenyl group. In addition, the molecular weight of the structure represented by formula (SL) is preferably 400 to 4,000, and more preferably 500 to 3,000. By setting the molecular weight to the above range, it is possible to more effectively achieve both the effect of suppressing bending by lowering the elastic modulus after dehydration and ring closure of the polybenzoxazole precursor and the effect of improving solvent solubility.

[0538] In the case of including a diamine residue represented by formula (SL) as another type of repeating unit, it is also desirable to further include a tetracarboxylic acid residue remaining after the removal of the anhydride group from the tetracarboxylic acid dianhydride as a repeating unit. An example of such a tetracarboxylic acid residue is R in formula (2). 115 Examples of this can be given.

[0539] The weight average molecular weight (Mw) of the polybenzoxazole precursor is, for example, preferably 18,000 to 30,000, more preferably 20,000 to 29,000, and even more preferably 22,000 to 28,000. Also, the number average molecular weight (Mn) is preferably 7,200 to 14,000, more preferably 8,000 to 12,000, and even more preferably 9,200 to 11,200.

[0540] The degree of dispersion of the molecular weight of the polybenzoxazole precursor is preferably 1.4 or higher, more preferably 1.5 or higher, and even more preferably 1.6 or higher. Although the upper limit of the degree of dispersion of the molecular weight of the polybenzoxazole precursor is not specifically determined, for example, it is preferably 2.6 or lower, more preferably 2.5 or lower, more preferably 2.4 or lower, even more preferably 2.3 or lower, and even more preferably 2.2 or lower.

[0541] In addition, when the resin composition includes multiple types of polybenzoxazole precursors as specific resins, it is preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion of at least one type of polybenzoxazole precursor are within the above ranges. In addition, it is also preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion calculated by combining the multiple types of polybenzoxazole precursors as a single resin are each within the above ranges.

[0542] [Polyamideimide Precursor]

[0543] The polyamideimide precursor preferably comprises a repeating unit represented by the following formula (PAI-2).

[0544] [Chemical Formula 27]

[0545]

[0546] In equation (PAI-2), R 117 represents a trivalent organic group, and R 111 represents a divalent organic group, and A 2 is an oxygen atom or -NR z - indicates, R 113 represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group.

[0547] In equation (PAI-2), R 117 Examples include straight or branched aliphatic groups, cyclic aliphatic groups, aromatic groups, complex aromatic groups, or groups formed by connecting two or more of these by single bonds or linkers, and a straight aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more of these by single bonds or linkers is preferred, and an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more aromatic groups having 6 to 20 carbon atoms by single bonds or linkers is more preferred.

[0548] As the above linker, -O-, -S-, -C(=O)-, -S(=O)2-, alkylene group, alkylene halide group, arylene group, or a linker formed by combining two or more of these is preferred, and -O-, -S-, alkylene group, alkylene halide group, arylene group, or a linker formed by combining two or more of these is more preferred.

[0549] As for the above alkylene group, an alkylene group having 1 to 20 carbon atoms is preferred, an alkylene group having 1 to 10 carbon atoms is more preferred, and an alkylene group having 1 to 4 carbon atoms is more preferred.

[0550] As for the above alkylene halogen group, an alkylene halogen group having 1 to 20 carbon atoms is preferred, an alkylene halogen group having 1 to 10 carbon atoms is more preferred, and an alkylene halogen group having 1 to 4 carbon atoms is more preferred. In addition, as for the halogen atoms in the above alkylene halogen group, fluorine atoms, chlorine atoms, bromine atoms, iodine atoms, etc., may be examples, and fluorine atoms are preferred. The above alkylene halogen group may have hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but it is preferred that all hydrogen atoms are substituted with halogen atoms. Examples of preferred alkylene halogen groups include (ditrifluoromethyl)methylene groups, etc.

[0551] As for the above arylene group, a phenylene group or a naphthylene group is preferred, a phenylene group is more preferred, and a 1,3-phenylene group or a 1,4-phenylene group is more preferred.

[0552] In addition, from the perspective of suppressing the generation of outgas from the hardened material, R 117 It is also preferable that the group is represented by any one of the following formulas (X2-1) to (X2-3), or is composed of one or more aliphatic ring structures.

[0553] [Chemical Formula 28]

[0554]

[0555] In formula (X2-1), R represents a substituent, n2 represents an integer from 0 to 2, and * represents a binding site with another structure.

[0556] In formula (X2-2), R represents a substituent independently, m2 represents an integer from 0 to 3, m3 represents an integer from 0 to 4, and * represents a binding site with another structure.

[0557] In equation (X2-3), R represents a substituent independently, m2 represents an integer from 0 to 2, m3 represents an integer from 0 to 3, and L 2 is -CR C Represents 2-, -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively.

[0558] In Equation (X2-1), the preferred embodiment of R is the same as the preferred embodiment of R in Equation (W1-1) described above.

[0559] In equation (X2-1), n2 is preferably 0 or 1.

[0560] In Equation (X2-2), the preferred embodiment of R is the same as the preferred embodiment of R in Equation (W1-1) described above.

[0561] In equation (X2-2), it is preferable that m2 be 0 or 1.

[0562] In equation (X2-2), it is preferable that m3 be 0 or 1.

[0563] In Equation (X2-3), the preferred mode of R is the same as the preferred mode of R in Equation (W1-1).

[0564] In equation (X2-3), it is preferable that m2 be 0 or 1.

[0565] In equation (X2-3), it is preferable that m3 be 0 or 1.

[0566] In equation (X2-3), L 2 is -CR C It represents 2-, -S(=O)2- or -O-, and -S(=O)2- is preferred.

[0567] In equation (X2-3), R C The preferred mode of is the same as the preferred mode of R in formula (W1-1).

[0568] Specific examples of a group represented by any one of formulas (X2-1) to (X2-3), or a group comprising one or more aliphatic ring structures, include, but are not limited to, the following structures. Among the following structures, * indicates a binding site with another structure.

[0569] [Chemical Formula 29]

[0570]

[0571] In addition, when a specific resin includes a group represented by any one of formulas (X2-1) to (X2-3), it is preferable that the specific resin include, for example, the following structure.

[0572] [Chemical Formula 30]

[0573]

[0574] A preferred embodiment of the aliphatic ring structure in a device comprising one or more aliphatic ring structures is the above-described R 111 It is identical to a preferred mode of an aliphatic ring structure in a group comprising one or more aliphatic ring structures.

[0575] Also, R 117 It is preferable that it be derived from a tricarboxylic acid compound in which at least one carboxyl group may be halogenated. As for the halogenation, chlorination is preferred.

[0576] In the present invention, a compound having three carboxyl groups is called a tricarboxylic acid compound.

[0577] Two of the three carboxyl groups of the above tricarboxylic acid compound may be acid anhydrides.

[0578] Examples of tricarboxylic acid compounds that may be halogenated and used in the manufacture of polyamideimide precursors include branched aliphatic, cyclic aliphatic, or aromatic tricarboxylic acid compounds.

[0579] These tricarboxylic acid compounds may be used as a single type or as two or more types.

[0580] Specifically, as a tricarboxylic acid compound, it is preferable to have a tricarboxylic acid compound comprising a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more of these by a single bond or a linker, and it is more preferable to have a tricarboxylic acid compound comprising an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more aromatic groups having 6 to 20 carbon atoms by a single bond or a linker.

[0581] In addition, specific examples of tricarboxylic acid compounds include 1,2,3-propanetricarboxylic acid, 1,3,5-pentanetricarboxylic acid, citric acid, trimellitic acid, 2,3,6-naphthalenetricarboxylic acid, compounds in which phthalic acid (or phthalic anhydride) and benzoic acid are connected by a single bond, -O-, -CH2-, -C(CH3)2-, -C(CF3)2-, -SO2- or phenylene group, etc.

[0582] These compounds may be compounds in which two carboxyl groups are anhydridated (e.g., trimellitic anhydride) or compounds in which at least one carboxyl group is halogenated (e.g., trimellitic anhydride chloride).

[0583] In equation (PAI-2), R 111 , A 2 , R 113 , R zEach is R in the above-described equation (2). 111 , A 2 , R 113 , R z It has the same meaning as, and the desirable mode is also the same.

[0584] Polyamideimide precursors may include additional repeating units.

[0585] Other repetition units include the repetition unit represented by the above-mentioned equation (2) and the repetition unit represented by the following equation (PAI-1).

[0586] [Chemical Formula 31]

[0587]

[0588] In equation (PAI-1), R 116 represents a divalent organic group, and R 111 It represents a divalent organic group.

[0589] In equation (PAI-1), R 116 Examples include straight or branched aliphatic groups, cyclic aliphatic groups, aromatic groups, complex aromatic groups, or groups formed by connecting two or more of these by single bonds or linkers, and a straight aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more of these by single bonds or linkers is preferred, and an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more aromatic groups having 6 to 20 carbon atoms by single bonds or linkers is more preferred.

[0590] As the above linker, -O-, -S-, -C(=O)-, -S(=O)2-, alkylene group, alkylene halide group, arylene group, or a linker formed by combining two or more of these is preferred, and -O-, -S-, alkylene group, alkylene halide group, arylene group, or a linker formed by combining two or more of these is more preferred.

[0591] As for the above alkylene group, an alkylene group having 1 to 20 carbon atoms is preferred, an alkylene group having 1 to 10 carbon atoms is more preferred, and an alkylene group having 1 to 4 carbon atoms is more preferred.

[0592] As for the above alkylene halogen group, an alkylene halogen group having 1 to 20 carbon atoms is preferred, an alkylene halogen group having 1 to 10 carbon atoms is more preferred, and an alkylene halogen group having 1 to 4 carbon atoms is more preferred. In addition, as for the halogen atoms in the above alkylene halogen group, fluorine atoms, chlorine atoms, bromine atoms, iodine atoms, etc., may be examples, and fluorine atoms are preferred. The above alkylene halogen group may have hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but it is preferred that all hydrogen atoms are substituted with halogen atoms. Examples of preferred alkylene halogen groups include (ditrifluoromethyl)methylene groups, etc.

[0593] As for the above arylene group, a phenylene group or a naphthylene group is preferred, a phenylene group is more preferred, and a 1,3-phenylene group or a 1,4-phenylene group is more preferred.

[0594] Also, R 116 It is preferable that it be derived from a dicarboxylic acid compound or a dicarboxylic acid dihalide compound.

[0595] In the present invention, a compound having two carboxyl groups is called a dicarboxylic acid compound, and a compound having two halogenated carboxyl groups is called a dicarboxylic acid dihalide compound.

[0596] The carboxyl group in the dicarboxylic acid dihalide compound may be halogenated, but, for example, it is preferable that it be chlorinated. That is, the dicarboxylic acid dihalide compound is preferably a dicarboxylic acid dichloride compound.

[0597] Examples of dicarboxylic acid compounds or dicarboxylic acid dihalide compounds that may be halogenated and used in the preparation of polyamideimide precursors include linear or branched aliphatic, cyclic aliphatic, or aromatic dicarboxylic acid compounds or dicarboxylic acid dihalide compounds.

[0598] These dicarboxylic acid compounds or dicarboxylic acid dihalide compounds may be used in isolation, or in two or more.

[0599] Specifically, as a dicarboxylic acid compound or a dicarboxylic acid dihalide compound, it is preferable to have a dicarboxylic acid compound or a dicarboxylic acid dihalide compound comprising a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more of these by a single bond or a linker, and it is more preferable to have a dicarboxylic acid compound or a dicarboxylic acid dihalide compound comprising an aromatic group having 6 to 20 carbon atoms, or a group formed by combining two or more aromatic groups having 6 to 20 carbon atoms by a single bond or a linker.

[0600] In addition, specific examples of dicarboxylic acid compounds include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, 2,2,6,6-tetramethylpimelic acid, souveric acid, dodecafluorosuberic acid, azelaic acid, sebacic acid, hexadecafluorosebacic acid, 1,9-nonaneinic acid, Dodecane diacid, tridecane diacid, tetradecane diacid, pentadecaine diacid, hexadecane diacid, heptadecaine diacid, octadecaine diacid, nonadecaine diacid, eicosane diacid, hen-eicosane diacid, docosane diacid, tricosane diacid, tetracosane diacid, pentacosane diacid, hexacosane diacid, heptacosane diacid, octacosane diacid, nonacosane diacid, triacontein diacid, hen-triacontein diacid, do-triacontein diacid, diglycolic acid, phthalic acid, isophthalic acid, terephthalic acid, 4,4'-biphenylcarboxylic acid, 4,4'-biphenylcarboxylic acid, 4,4'-dicarboxydiphenyl ether, Examples include benzophenone-4,4'-dicarboxylic acid.

[0601] Specific examples of dicarboxylic acid dihalide compounds include compounds having a structure in which two carboxyl groups in the specific examples of the dicarboxylic acid compounds are halogenated.

[0602] In equation (PAI-1), R 111 is R in the above-described formula (2). 111 It has the same meaning as, and the desirable mode is also the same.

[0603] In addition, it is preferable that the polyamideimide precursor has fluorine atoms in its structure. The fluorine atom content in the polyamideimide precursor is preferably 10 mass% or more, and also preferably 20 mass% or less.

[0604] In addition, for the purpose of improving adhesion to the substrate, the polyamideimide precursor may be copolymerized with an aliphatic group having a siloxane structure. Specifically, examples include using bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, etc. as the diamine component.

[0605] As one embodiment of the polyamideimide precursor in the present invention, an embodiment may be provided in which the total content of the repeating unit represented by Formula (PAI-2), the repeating unit represented by Formula (PAI-1), and the repeating unit represented by Formula (2) is 50 mol% or more of the total repeating unit. The total content is more preferably 70 mol% or more, more preferably 90 mol% or more, and particularly preferably exceeds 90 mol%. The upper limit of the total content is not particularly limited, and all repeating units in the polyamideimide precursor excluding the ends may be any one of the repeating unit represented by Formula (PAI-2), the repeating unit represented by Formula (PAI-1), and the repeating unit represented by Formula (2).

[0606] In addition, as another embodiment of the polyamideimide precursor in the present invention, an embodiment in which the total content of the repeating unit represented by Formula (PAI-2) and the repeating unit represented by Formula (PAI-1) is 50 mol% or more of the total repeating unit may be provided. The total content is more preferably 70 mol% or more, more preferably 90 mol% or more, and particularly preferably exceeds 90 mol%. The upper limit of the total content is not particularly limited, and all repeating units in the polyamideimide precursor excluding the terminals may be either the repeating unit represented by Formula (PAI-2) or the repeating unit represented by Formula (PAI-1).

[0607] The weight average molecular weight (Mw) of the polyamideimide precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and even more preferably 10,000 to 50,000. Also, the number average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and even more preferably 4,000 to 25,000.

[0608] The degree of dispersion of the molecular weight of the polyamideimide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and more preferably 2.0 or higher. Although the upper limit of the degree of dispersion of the molecular weight of the polyamideimide precursor is not specifically determined, for example, it is preferably 7.0 or lower, more preferably 6.5 or lower, and more preferably 6.0 or lower.

[0609] In addition, when the resin composition includes multiple types of polyamideimide precursors as specific resins, it is preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion of at least one type of polyamideimide precursor are within the above ranges. In addition, it is also preferable that the weight average molecular weight, number average molecular weight, and degree of dispersion calculated by combining the multiple types of polyamideimide precursors as a single resin are each within the above ranges.

[0610] [Method for manufacturing polyimide precursors, etc.]

[0611] Polyimide precursors, etc., can be obtained by methods such as, for example, reacting a tetracarboxylic acid dianhydride with a diamine at low temperature; reacting a tetracarboxylic acid dianhydride with a diamine at low temperature to obtain a polyamic acid and then esterifying it using a condensing agent or an alkylating agent; obtaining a diester by a tetracarboxylic acid dianhydride with an alcohol and then reacting it with a diamine in the presence of a condensing agent; or obtaining a diester by a tetracarboxylic acid dianhydride with an alcohol and then acid-halogenating the remaining dicarboxylic acid using a halogenating agent and reacting it with a diamine. Among the above manufacturing methods, the method of obtaining a diester by a tetracarboxylic acid dianhydride with an alcohol and then acid-halogenating the remaining dicarboxylic acid using a halogenating agent and reacting it with a diamine is more preferable.

[0612] Examples of the above condensation agents include dicyclohexylcarbodiimide, diisopropylcarbodiimide, 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, 1,1-carbonyldioxy-di-1,2,3-benzotriazole, N,N'-diosuccinimidylcarbonate, trifluoroacetic anhydride, etc.

[0613] Examples of the above alkylating agents include N,N-dimethylformamide dimethylacetal, N,N-dimethylformamide diethylacetal, N,N-dialkylformamide dialkylacetal, trimethyl orthoformate, triethyl orthoformate, etc.

[0614] Examples of the above-mentioned halogenating agents include thionyl chloride, oxaryl chloride, oxyphosphorus chloride, etc.

[0615] In the method for manufacturing polyimide precursors, etc., it is preferable to use an organic solvent during the reaction. The organic solvent may be one type or two or more types.

[0616] As for organic solvents, they can be appropriately determined depending on the raw material, but examples include pyridine, diethylene glycol dimethyl ether (diglaim), N-methylpyrrolidone, N-ethylpyrrolidone, ethyl propionate, dimethylacetamide, dimethylformamide, tetrahydrofuran, γ-butyrolactone, etc.

[0617] In a method for manufacturing polyimide precursors, etc., it is preferable to add a basic compound during the reaction. The basic compound may be one type or two or more types.

[0618] Basic compounds can be appropriately determined depending on the raw material, but examples include triethylamine, diisopropylethylamine, pyridine, 1,8-diazabicyclo[5.4.0]undes-7-ene, N,N-dimethyl-4-aminopyridine.

[0619] -Terminal Sealant-

[0620] In a method for manufacturing polyimide precursors, etc., it is desirable to seal carboxylic acid anhydrides, acid anhydride derivatives, or amino groups remaining at the resin ends of polyimide precursors, etc., in order to further improve storage stability. When sealing carboxylic acid anhydrides and acid anhydride derivatives remaining at the resin ends, examples of end sealants include monoalcohols, phenols, thiols, thiophenols, monoamines, etc., and it is more desirable to use monoalcohols, phenols, or monoamines due to reactivity and membrane stability. Preferred monoalcohol compounds include primary alcohols such as methanol, ethanol, propanol, butanol, hexanol, octanol, dodecinol, benzyl alcohol, 2-phenylethanol, 2-methoxyethanol, 2-chloromethanol, and furfuryl alcohol; secondary alcohols such as isopropanol, 2-butanol, cyclohexyl alcohol, cyclopentanol, and 1-methoxy-2-propanol; and tertiary alcohols such as t-butyl alcohol and adamantane alcohol. Preferred phenolic compounds include phenols such as phenol, methoxyphenol, methylphenol, naphthalene-1-ol, naphthalene-2-ol, and hydroxystyrene.In addition, as preferred compounds of monoamine, aniline, 2-ethyleneilaniline, 3-ethyleneilaniline, 4-ethyleneilaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxy-7-aminonaphthalene, 1-carboxy-6-aminonaphthalene, 1-carboxy-5-aminonaphthalene, 2-carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-6-aminonaphthalene. Examples include 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminothiophenol, 3-aminothiophenol, 4-aminothiophenol, etc. Two or more of these may be used, and multiple different end groups may be introduced by reacting multiple end sealants.

[0621] In addition, when sealing the amino group at the end of the resin, it is possible to seal it with a compound having a functional group capable of reacting with the amino group. Preferred sealants for the amino group include carboxylic acid anhydride, carboxylic acid chloride, carboxylic acid bromide, sulfonic acid chloride, sulfonic acid anhydride, sulfonic acid carboxylic acid anhydride, etc., and carboxylic acid anhydride and carboxylic acid chloride are more preferred. Preferred compounds of carboxylic acid anhydride include acetic anhydride, propionic anhydride, oxalic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, benzoic anhydride, 5-norbornene-2,3-dicarboxylic acid anhydride, etc. In addition, preferred compounds of carboxylic acid chlorides include acetyl chloride, acrylic acid chloride, propionyl chloride, methacrylic acid chloride, pivaloyl chloride, cyclohexane carbonyl chloride, 2-ethylhexane oil chloride, cinnamoyl chloride, 1-adamanthene carbonyl chloride, heptafluorobutyryl chloride, stearic acid chloride, benzoyl chloride, etc.

[0622] In addition, a compound represented by formula (T-1) may be used as a terminal sealant. By sealing the terminals with such a compound, a structure in which a base is likely to form at the terminals can be introduced, and it is believed that the cyclization rate of the cyclization resin obtained from the precursor of the cyclization resin is likely to increase even when cured at low temperatures.

[0623] [Chemical Formula 32]

[0624]

[0625] In equation (T-1), L T represents a divalent organic group, and Z 1 and Z 2 Each independently represents an organic group, and Z 1 and Z 2 It may be combined to form a ring structure.

[0626] In equation (T-1), L TIt is preferable that it be a hydrocarbon group, and it may be either an aromatic hydrocarbon group or an aliphatic hydrocarbon group, but it is preferable that it be one of an aromatic hydrocarbon group, an unsaturated aliphatic hydrocarbon group, or a cyclic aliphatic hydrocarbon group.

[0627] L T The length of the connecting chain in (i.e., L T The minimum number of atoms among the number of atoms connecting the two carbonyl groups bonded to it is preferably 2 to 4, and more preferably 2.

[0628] In equation (T-1), Z 1 and Z 2 is Z in Equation (3-1) 1 and Z 2 It has the same meaning as, and the desirable mode is also the same.

[0629] In particular, Z 1 and Z 2 An embodiment in which at least one of the elements has a polymerizable group is also one of the preferred embodiments of the present invention.

[0630] Examples of polymerizable groups include radical polymerizable groups, epoxy groups, oxetanyl groups, methylol groups, alkoxymethyl groups, etc., and radical polymerizable groups are preferred.

[0631] As a radical polymerization group, a group having an ethylenically unsaturated group is preferred, and examples include a (meth)acryloxy group, a (meth)acrylamide group, a vinylphenyl group, a maleimide group, a styryl group, a vinyl group, a (meth)allyl group, etc.

[0632] Among these, (meth)acryloxy groups are preferred from the perspective of reactivity.

[0633] These polymerizable groups may be directly bonded to the nitrogen atom in formula (T-1), or may be bonded through a linker such as a hydrocarbon group (e.g., an alkylene group).

[0634] Specific examples of the compound represented by formula (T-1) include the following compounds, but are not limited thereto.

[0635] [Chemical Formula 33]

[0636]

[0637] -Solid Precipitation-

[0638] The manufacturing of polyimide precursors, etc. may include a process for precipitating a solid. Specifically, the absorption byproduct of the dehydration condensation agent coexisting in the reaction solution may be filtered and separated as necessary, and the obtained polymer component may be added to a poor solvent such as water, an aliphatic lower alcohol, or a mixture thereof, and the polymer component may be precipitated as a solid and dried to obtain the polyimide precursor, etc. To improve the degree of purification, operations such as redissolving, redeposition, and drying of the polyimide precursor, etc. may be repeated. Additionally, the process may include a process for removing ionic impurities using an ion exchange resin.

[0639] 〔content〕

[0640] In the resin composition of the present invention, the content of a specific resin is preferably 20 mass% or more with respect to the total solid content of the resin composition, more preferably 30 mass% or more, more preferably 40 mass% or more, even more preferably 50 mass% or more, and particularly preferably 70 mass% or more.

[0641] Here, from the perspective of suppressing the amount of out-gas generation, an embodiment in which the resin composition of the present invention includes a solvent and the content of the precursor of the cyclized resin is 70 mass% or more relative to the total solid content of the resin composition is also one of the preferred embodiments of the present invention.

[0642] In addition, the resin content in the resin composition of the present invention is preferably 99.5 mass% or less with respect to the total solid content of the resin composition, more preferably 99 mass% or less, more preferably 98 mass% or less, even more preferably 97 mass% or less, and even more preferably 95 mass% or less.

[0643] The resin composition of the present invention may include only one type of specific resin or two or more types. When two or more types are included, it is preferable that the total amount be within the above range.

[0644] In addition, the resin composition of the present invention may preferably include at least two types of resins.

[0645] Specifically, the resin composition in the present invention may include a specific resin and two or more other resins described below, and may include two or more specific resins, but it is preferable to include two or more specific resins.

[0646] In the case where the resin composition of the present invention comprises two or more specific resins, for example, as a polyimide precursor, a structure derived from a dianhydride (R referred to in the formula (2) above) 115 It is preferable that ) includes two or more different types of polyimide precursors.

[0647] Another Suzy

[0648] The resin composition in the present invention may include the specific resin described above and another resin different from the specific resin (hereinafter simply referred to as "another resin").

[0649] Other resins include phenolic resin, polyamide, epoxy resin, polysiloxane, resin containing a siloxane structure, (meth)acrylic resin, (meth)acrylamide resin, uretane resin, butyral resin, styryl resin, polyether resin, polyester resin, etc.

[0650] For example, by adding (meth)acrylic resin, a resin composition with excellent coating properties is obtained, and a pattern (cured product) with excellent solvent resistance is obtained.

[0651] For example, instead of the polymerizable compound described below, or in addition to the polymerizable compound described below, a polymerizable group having a weight-average molecular weight of 20,000 or less and a high polymerizable group number (for example, the molar amount of the polymerizable group contained in 1 g of resin is 1 × 10⁻⁶ -3 By adding a (meth)acrylic resin (at a mol / g or higher) to the resin composition, the applicability of the resin composition and the solvent resistance of the pattern (cured product) can be improved.

[0652] In the present invention, when the resin composition includes another resin, the content of the other resin is preferably 0.01 mass% or more with respect to the total solid content of the resin composition, more preferably 0.05 mass% or more, more preferably 1 mass% or more, even more preferably 2 mass% or more, even more preferably 5 mass% or more, and even more preferably 10 mass% or more.

[0653] In addition, the content of another resin in the resin composition of the present invention is preferably 80 mass% or less with respect to the total solid content of the resin composition, more preferably 75 mass% or less, more preferably 70 mass% or less, even more preferably 60 mass% or less, and even more preferably 50 mass% or less.

[0654] In addition, as a preferred embodiment of the resin composition in the present invention, the content of the other resin may be low. In the above embodiment, the content of the other resin is preferably 20 mass% or less with respect to the total solid content of the resin composition, more preferably 15 mass% or less, more preferably 10 mass% or less, even more preferably 5 mass% or less, and even more preferably 1 mass% or less. The lower limit of the content is not particularly limited and may be 0 mass% or more.

[0655] The resin composition in the present invention may include only one type of other resin, or may include two or more types. When two or more types are included, it is preferable that the total amount be within the above range.

[0656] Polymerizable Compounds

[0657] In the present invention, the resin composition preferably includes a polymerizable compound.

[0658] Examples of polymerizable compounds include radical crosslinkers or other crosslinkers.

[0659] In the present invention, the resin composition preferably comprises a polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere.

[0660] The above boiling point is preferably 200°C or higher, and more preferably 250°C or higher. In addition, the upper limit of the above boiling point is not particularly limited and, for example, can be 500°C or lower.

[0661] According to the above embodiment, the amount of outgassing generated can be reduced.

[0662] The polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere is preferably a compound having three or more polymerizable groups, more preferably a compound having four or more polymerizable groups, and even more preferably a compound having five or more polymerizable groups. The upper limit of the number of polymerizable groups is not particularly limited, but it is preferably 20 or fewer.

[0663] In addition, the polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere is preferably a compound having three or more (meth)acrylate groups, more preferably a compound having four or more (meth)acrylate groups, and even more preferably a compound having five or more (meth)acrylate groups. The upper limit of the number of (meth)acrylate groups is not particularly limited, but it is preferably 20 or fewer.

[0664] Specific examples of polymerizable compounds having a boiling point of 200°C or higher at 1 atmosphere include dipentaerythritol hexaacrylate, pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, ditrimethylolpropane tetraacrylate, ethoxylated dipentaerythritol polymethacrylate, etc.

[0665] In addition, these compounds can be used whether they are acrylates or methacrylates if they have a boiling point of 200°C or higher.

[0666] As these compounds, commercially available products may be used, for example, those manufactured by Shin-Nakamura Kagaku High School Co., Ltd. may be used.

[0667] In addition, from the perspective of suppressing the amount of outgassing from the cured product, it is preferable that the resin composition includes a polymerizable compound having an aliphatic ring structure.

[0668] The above polymerizable compound may have only one polymerizable group, but it is preferable to have two or more, more preferable to have 2 to 10, more preferable to have 2 to 6, and particularly preferable to have 4 to 6.

[0669] The above aliphatic ring structure may be a saturated aliphatic ring structure or an unsaturated aliphatic ring structure.

[0670] In addition, the above-mentioned aliphatic ring structure may be a single ring, or a compound ring such as a condensed ring, a cross-linked condensed ring, or a spiro ring.

[0671] Examples of the above aliphatic ring structures include the cyclohexane structure, the cyclohexene structure, and the bicyclo[2.2.2]octo-5-ene structure.

[0672] [Radical Crosslinking Agent]

[0673] In the present invention, the resin composition preferably includes a radical crosslinking agent.

[0674] A radical crosslinking agent is a compound having a radical polymerizable group. As the radical polymerizable group, a group containing an ethylenically unsaturated bond is preferred. Examples of the group containing the ethylenically unsaturated bond include a vinyl group, an allyl group, a vinylphenyl group, a (meth)acryloyl group, a maleimide group, a (meth)acrylamide group, and other groups having an ethylenically unsaturated bond.

[0675] Among these, as the group containing the above-mentioned ethylenically unsaturated bond, (meth)acryloyl group, (meth)acrylamide group, and vinylphenyl group are preferred, and from the perspective of reactivity, (meth)acryloyl group is more preferred.

[0676] The radical crosslinking agent is preferably a compound having one or more ethylenically unsaturated bonds, but is more preferably a compound having two or more. The radical crosslinking agent may have three or more ethylenically unsaturated bonds.

[0677] Among the compounds having two or more ethylenically unsaturated bonds, a compound having 2 to 15 ethylenically unsaturated bonds is preferred, a compound having 2 to 10 ethylenically unsaturated bonds is more preferred, and a compound having 2 to 6 bonds is even more preferred.

[0678] In addition, from the perspective of the film strength of the obtained pattern (cured product), it is also preferable that the resin composition in the present invention comprises a compound having two ethylenically unsaturated bonds and a compound having three or more ethylenically unsaturated bonds.

[0679] The molecular weight of the radical crosslinking agent is preferably 2,000 or less, more preferably 1,500 or less, and more preferably 900 or less. The lower limit of the molecular weight of the radical crosslinking agent is preferably 100 or more.

[0680] Specific examples of radical crosslinking agents include unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, crotonic acid, isocrotonic acid, maleic acid, etc.) or their esters and amides, preferably esters of unsaturated carboxylic acids and polyhydric alcohol compounds, and amides of unsaturated carboxylic acids and polyhydric amine compounds. In addition, unsaturated carboxylic acid esters or amides having nucleogenic substituents such as hydroxyl groups, amino groups, or sulfanyl groups, addition products of monofunctional or polyfunctional isocyanates or epoxys, or dehydration condensation products of monofunctional or polyfunctional carboxylic acids are also suitably used. In addition, addition products of monofunctional or polyfunctional alcohols, amines, and thiols with unsaturated carboxylic acid esters or amides having electrophilic substituents such as isocyanate groups or epoxy groups, and substitution products of monofunctional or polyfunctional alcohols, amines, and thiols with unsaturated carboxylic acid esters or amides having leaching substituents such as halogen groups or tosyloxy groups are also suitable. Furthermore, as another example, it is possible to use a group of compounds substituted with unsaturated phosphonic acid, vinylbenzene derivatives such as styrene, vinyl ether, allyl ether, etc., instead of the above unsaturated carboxylic acid. For specific examples, reference may be made to paragraphs 0113 to 0122 of Japanese Patent Publication No. 2016-027357, the contents of which are incorporated herein by reference.

[0681] In addition, the radical crosslinking agent is also preferably a compound having a boiling point of 100°C or higher under atmospheric pressure. Examples include polyethylene glycol di(meth)acrylate, trimethylol ethane tri(meth)acrylate, neopentyl glycol di(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, hexanediol di(meth)acrylate, trimethylolpropane tri(acryloyloxypropyl)ether, tri(acryloyloxyethyl)isocyanurate, compounds obtained by adding ethylene oxide or propylene oxide to polyfunctional alcohols such as glycerin or trimethylol ethane and then (meth)acrylating them, Japanese Patent Publication No. Sho 48-041708, Japanese Patent Publication Examples include polyfunctional acrylates or methacrylates and mixtures thereof, such as urethan (meth)acrylates as described in Japanese Patent Publication No. 50-006034 and Japanese Patent Publication No. 51-037193, polyester acrylates as described in Japanese Patent Publication No. 48-064183, Japanese Patent Publication No. 49-043191, and Japanese Patent Publication No. 52-030490, and epoxy acrylates which are reaction products of epoxy resin and (meth)acrylic acid. In addition, compounds described in paragraphs 0254 to 0257 of Japanese Patent Publication No. 2008-292970 are also suitable. In addition, polyfunctional (meth)acrylates obtained by reacting a polyfunctional carboxylic acid with a compound having a cyclic ether group, such as glycidyl (meth)acrylate, and an ethylenically unsaturated bond can also be cited.

[0682] In addition, as a preferred radical crosslinking agent other than those described above, it is also possible to use a compound having two or more groups having an ethylene unsaturated bond and having a fluorene ring, as described in Japanese Patent Publication No. 2010-160418, Japanese Patent Publication No. 2010-129825, Japanese Patent Publication No. 4364216, etc., or a Kado resin.

[0683] In addition, other examples include specific unsaturated compounds described in Japanese Patent Publication No. Sho 46-043946, Japanese Patent Publication No. Hei 01-040337, and Japanese Patent Publication No. Hei 01-040336, or vinylphosphonic acid-based compounds described in Japanese Patent Publication No. Hei 02-025493. Additionally, compounds containing perfluoroalkyl groups described in Japanese Patent Publication No. Sho 61-022048 may be used. Furthermore, those introduced as photopolymerizable monomers and oligomers in the Journal of the Japan Adhesion Association Vol. 20, No. 7, pp. 300-308 (1984) may also be used.

[0684] In addition to the above, compounds described in paragraphs 0048 to 0051 of Japanese Patent Publication No. 2015-034964 and compounds described in paragraphs 0087 to 0131 of International Patent Publication No. 2015 / 199219 may also be preferably used, and the contents thereof are incorporated herein by reference.

[0685] In addition, a compound obtained by adding ethylene oxide or propylene oxide to a polyfunctional alcohol and then (meth)acrylating it, as described in Japanese Patent Publication No. Hei 10-062986 with specific examples of formulas (1) and (2), can also be used as a radical crosslinking agent.

[0686] In addition, compounds described in paragraphs 0104 to 0131 of Japanese Patent Publication No. 2015-187211 may also be used as radical crosslinking agents, and the contents thereof are incorporated herein by reference.

[0687] As radical crosslinking agents, a structure in which the (meth)acryloyl groups thereof are bonded via an ethylene glycol residue or a propylene glycol residue is preferred, such as dipentaerythritol triacrylate (commercially available KAYARAD D-330; manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol tetraacrylate (commercially available KAYARAD D-320; manufactured by Nippon Kayaku Co., Ltd., A-TMMT; manufactured by Shin-Nakamura Kagaku Kogyo Co., Ltd.), dipentaerythritol penta(meth)acrylate (commercially available KAYARAD D-310; manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol hexa(meth)acrylate (commercially available KAYARAD DPHA; manufactured by Nippon Kayaku Co., Ltd., A-DPH; manufactured by Shin-Nakamura Kagaku Kogyo Co., Ltd.), and the (meth)acryloyl groups thereof are bonded via an ethylene glycol residue or a propylene glycol residue. Their oligomer types can also be used.

[0688] Commercially available radical crosslinking agents include, for example, SR-494 (manufactured by Satomer Co., Ltd.), a tetrafunctional acrylate having four ethylene oxychains; SR-209, 231, and 239 (manufactured by Satomer Co., Ltd.), difunctional methacrylates having four ethylene oxychains; DPCA-60 (manufactured by Nippon Kagaku Co., Ltd.), a hexafunctional acrylate having six pentylene oxychains; TPA-330 (manufactured by Nippon Kagaku Co., Ltd.), a trifunctional acrylate having three isobutylene oxychains; uretane oligomers UAS-10 and UAB-140 (manufactured by Nippon Seishi Co., Ltd.); NK ester M-40G, NK ester 4G, NK ester M-9300, NK ester A-9300; UA-7200 (manufactured by Shin-Nakamura Kagaku Kogyo Co., Ltd.); and DPHA-40H (Nippon Examples include the Kayaku (Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, AI-600 (Kyoeisha Kagaku Co., Ltd.), and Blemmer PME400 (Nichiyu Co., Ltd.).

[0689] As radical crosslinking agents, uretain acrylates as described in Japanese Patent Publication No. Sho 48-041708, Japanese Patent Publication No. Sho 51-037193, Japanese Patent Publication No. Hei 02-032293, and Japanese Patent Publication No. Hei 02-016765, or uretain compounds having an ethylene oxide-based framework as described in Japanese Patent Publication No. Sho 58-049860, Japanese Patent Publication No. Sho 56-017654, Japanese Patent Publication No. Sho 62-039417, and Japanese Patent Publication No. Sho 62-039418 are also suitable. In addition, as a radical crosslinking agent, compounds having an amino structure or a sulfide structure within the molecule, as described in Japanese Patent Publication No. Sho 63-277653, Japanese Patent Publication No. Sho 63-260909, and Japanese Patent Publication No. Hei 01-105238, may also be used.

[0690] The radical crosslinking agent may be a radical crosslinking agent having acid groups such as carboxyl groups or phosphate groups. The radical crosslinking agent having acid groups is preferably an ester of an aliphatic polyhydroxy compound and an unsaturated carboxylic acid, and a radical crosslinking agent in which acid groups are formed by reacting an unreacted hydroxyl group of an aliphatic polyhydroxy compound with a non-aromatic carboxylic acid anhydride is more preferable. Particularly preferably, in the radical crosslinking agent in which acid groups are formed by reacting an unreacted hydroxyl group of an aliphatic polyhydroxy compound with a non-aromatic carboxylic acid anhydride, the aliphatic polyhydroxy compound is a compound in which pentaerythritol or dipentaerythritol. Examples of commercially available products include polybasic acid modified acrylic oligomers manufactured by Doa Kosei Co., Ltd., such as M-510 and M-520.

[0691] The preferred acid value of a radical crosslinking agent having acid groups is 0.1 to 300 mg KOH / g, and particularly preferably 1 to 100 mg KOH / g. When the acid value of the radical crosslinking agent is within the above range, the handling properties during manufacturing are excellent, and furthermore, the developability is excellent. In addition, the polymerization properties are good. The above acid value is measured in accordance with the description in JIS K 0070:1992.

[0692] For the resin composition, it is preferable to use a difunctional methacrylate or acrylate in terms of pattern resolution and film elasticity.

[0693] Specific compounds include triethylene glycol diacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, PEG (polyethylene glycol) 200 diacrylate, PEG 200 dimethacrylate, PEG 600 diacrylate, PEG 600 dimethacrylate, polytetraethylene glycol diacrylate, polytetraethylene glycol dimethacrylate, neopentyl glycol diacrylate, neopentyl glycol dimethacrylate, 3-methyl-1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, 1,6-hexanediol dimethacrylate, dimethylol-tricyclodecane diacrylate, Dimethylol-tricyclodecaine dimethacrylate, EO (ethylene oxide) adduct diacrylate of bisphenol A, EO adduct dimethacrylate of bisphenol A, PO (propylene oxide) adduct diacrylate of bisphenol A, PO adduct dimethacrylate of bisphenol A, 2-hydroxy-3-acryloyloxypropyl methacrylate, EO-modified diacrylate of isocyanuric acid, isocyanuric acid-modified dimethacrylate, other difunctional acrylates having uretane bonds, and difunctional methacrylates having uretane bonds may be used. If necessary, two or more of these may be mixed and used.

[0694] Also, for example, PEG200 diacrylate is polyethylene glycol diacrylate, and refers to a polyethylene glycol chain with a food content of about 200.

[0695] In the resin composition of the present invention, a monofunctional radical crosslinking agent may preferably be used as a radical crosslinking agent in terms of suppressing bending by controlling the elastic modulus of the pattern (cured product). As monofunctional radical crosslinking agents, (meth)acrylic acid derivatives such as n-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, butoxyethyl (meth)acrylate, carbitol (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, N-methylol (meth)acrylamide, glycidyl (meth)acrylate, polyethylene glycol mono(meth)acrylate, and polypropylene glycol mono(meth)acrylate), N-vinyl compounds such as N-vinylpyrrolidone and N-vinyl caprolactam, and allylglycidyl ether are preferably used. As a monofunctional radical crosslinking agent, a compound having a boiling point of 100°C or higher under atmospheric pressure is also preferred in order to suppress volatilization before exposure.

[0696] In addition, as radical crosslinking agents with two or more functions, allyl compounds such as diallyl phthalate and triallyl trimellitate can be cited.

[0697] When a radical crosslinking agent is included, the content thereof is preferably greater than 0 mass% and less than or equal to 60 mass% with respect to the total solid content of the resin composition in the present invention. The lower limit is more preferably 5 mass% or more. The upper limit is more preferably 50 mass% or less, and more preferably 30 mass% or less.

[0698] Radical crosslinking agents may be used as a single type, or two or more types may be used in combination. When two or more types are used in combination, it is desirable that the total amount be within the above range.

[0699] [Other crosslinking agents]

[0700] In the present invention, the resin composition may also include a different crosslinking agent that is different from the radical crosslinking agent described above.

[0701] In the present invention, "other crosslinking agent" refers to a crosslinking agent other than the radical crosslinking agent described above, and it is preferable that the compound has a plurality of groups within its molecule that promote the reaction of forming a covalent bond with another compound in the composition or the reaction product thereof by photosensitization of the photogenerator or photobase generator described above, and it is preferable that the compound has a plurality of groups within its molecule that promote the reaction of forming a covalent bond with another compound in the composition or the reaction product thereof by the action of an acid or a base.

[0702] The above acid or base is preferably an acid or base generated from a photogenerator or a photobase generator in the photolithography process.

[0703] As other crosslinking agents, a compound having at least one group selected from the group consisting of acyloxymethyl, methylol, and alkoxymethyl groups is preferred, and a compound having a structure in which at least one group selected from the group consisting of acyloxymethyl, methylol, and alkoxymethyl groups is directly bonded to a nitrogen atom is more preferred.

[0704] Other crosslinking agents include, for example, compounds having a structure in which a hydrogen atom of an amino group is substituted with an acyloxymethyl group, a methylol group, or an alkoxymethyl group by reacting an amino group-containing compound such as melamine, glycoluryl, urea, alkylene urea, or benzoguanamine with formaldehyde or an alcohol. The method of preparing these compounds is not particularly limited, and any compound having the same structure as the compound prepared by the above method is sufficient. In addition, it may be an oligomer formed by the self-condensation of the methylol groups of these compounds.

[0705] Among the above amino group-containing compounds, a crosslinking agent using melamine is called a melamine-based crosslinking agent, a crosslinking agent using glycoluryl, urea, or alkylene urea is called a urea-based crosslinking agent, a crosslinking agent using alkylene urea is called an alkylene urea-based crosslinking agent, and a crosslinking agent using benzoguanamine is called a benzoguanamine-based crosslinking agent.

[0706] Among these, the resin composition of the present invention preferably comprises at least one compound selected from the group consisting of urea-based crosslinking agents and melamine-based crosslinking agents, and more preferably comprises at least one compound selected from the group consisting of glycoluryl-based crosslinking agents and melamine-based crosslinking agents described below.

[0707] As a compound containing at least one of an alkoxymethyl group and an acyloxymethyl group in the present invention, an example of a structural example may be a compound in which the alkoxymethyl group or the acyloxymethyl group is substituted directly onto an aromatic group or a nitrogen atom of the following urea structure, or onto a triazine.

[0708] The alkoxymethyl group or acyloxymethyl group of the above compound preferably has 2 to 5 carbon atoms, preferably 2 or 3 carbon atoms, and more preferably 2 carbon atoms.

[0709] The total number of alkoxymethyl groups and acyloxymethyl groups in the above compound is preferably 1 to 10, more preferably 2 to 8, and particularly preferably 3 to 6.

[0710] The molecular weight of the above compound is preferably 1500 or less, and preferably 180 to 1200.

[0711] [Chemical Formula 34]

[0712]

[0713] R 100 It represents an alkyl group or an acyl group.

[0714] R 101 and R 102Each of them independently represents a monovalent organic group and may be combined with each other to form a ring.

[0715] Examples of compounds in which an alkoxymethyl group or an acyloxymethyl group is directly substituted with an aromatic group include compounds of the following general formula.

[0716] [Chemical Formula 35]

[0717]

[0718] In the formula, X represents a single bond or a divalent organic group, and individual R 104 Each independently represents an alkyl group or an acyl group, and R 103 Silver, hydrogen atoms, alkyl groups, alkenyl groups, aryl groups, aralkyl groups, or, groups that decompose by the action of an acid to produce alkali-soluble groups (e.g., groups detached by the action of an acid, -C(R 4 )2COOR 5 The energy appearing as (R 4 Each independently represents a hydrogen atom or a C1- to C4 alkyl group, and R 5 represents the energy that is defused by the action of acid.))

[0719] R 105 Each independently represents an alkyl group or an alkeneyl group, a, b, and c are each independently 1 to 3, d is 0 to 4, e is 0 to 3, f is 0 to 3, a+d is 5 or less, b+e is 4 or less, and c+f is 4 or less.

[0720] A group that decomposes by the action of acid to generate an alkali-soluble group, a group that is detached by the action of acid, -C(R 4 )2COOR 5 R in the group represented as 5 Regarding this, for example, -C(R 36 )(R 37 )(R 38 ), -C(R 36 )(R 37 )(OR39 ), -C(R 01 )(R 02 )(OR 39 Examples include ) etc.

[0721] During the meal, R 36 ~R 39 represents, respectively, an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, or an alkeneyl group. 36 and R 37 Silver may be combined with each other to form a ring.

[0722] As for the above alkyl group, an alkyl group having 1 to 10 carbon atoms is preferred, and an alkyl group having 1 to 5 carbon atoms is more preferred.

[0723] The above alkyl group may be either a straight chain or a branched chain.

[0724] As for the cycloalkyl group, a cycloalkyl group having 3 to 12 carbon atoms is preferred, and a cycloalkyl group having 3 to 8 carbon atoms is more preferred.

[0725] The above cycloalkyl group may have a single-ring structure or a polycyclic structure such as a condensed ring.

[0726] The above aryl group is preferably an aromatic hydrocarbon group having 6 to 30 carbon atoms, and more preferably a phenyl group.

[0727] As for the above aracle group, an aracle group having 7 to 20 carbon atoms is preferred, and an aracle group having 7 to 16 carbon atoms is more preferred.

[0728] The above aryl group is intended to be an aryl group substituted by an alkyl group, and preferred embodiments of these alkyl and aryl groups are the same as the preferred embodiments of the alkyl and aryl groups described above.

[0729] The above alkenyl group is preferably an alkenyl group having 3 to 20 carbon atoms, and more preferably an alkenyl group having 3 to 16 carbon atoms.

[0730] In addition, these groups may further have known substituents within the range in which the effects of the present invention are obtained.

[0731] R 01 and R 02 Each represents, independently, a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, or an alkeneyl group.

[0732] These groups are preferably tertiary alkyl ester groups, acetal ester groups, cumyl ester groups, enol ester groups, etc. More preferably, they are tertiary alkyl ester groups and acetal ester groups.

[0733] Specifically, compounds having an alkoxymethyl group include the following structures. Compounds having an acyloxymethyl group include compounds in which the alkoxymethyl group of the following compounds is changed to an acyloxymethyl group. Compounds having an alkoxymethyl group or an acyloxymethyl group within the molecule include the following compounds, but are not limited thereto.

[0734] [Chemical Formula 36]

[0735]

[0736] [Chemical Formula 37]

[0737]

[0738] A compound containing at least one of an alkoxymethyl group and an acyloxymethyl group may be a commercially available one or a one synthesized by a known method.

[0739] From the perspective of heat resistance, compounds in which an alkoxymethyl group or an acyloxymethyl group is directly substituted on an aromatic ring or a triazine ring are preferred.

[0740] Specific examples of melamine-based crosslinking agents include hexamethoxymethylmelamine, hexaethoxymethylmelamine, hexapropoxymethylmelamine, hexabutoxybutylmelamine, etc.

[0741] Specific examples of urea-based crosslinking agents include, for example, monohydroxymethylated glycolyl, dihydroxymethylated glycolyl, trihydroxymethylated glycolyl, tetrahydroxymethylated glycolyl, monomethoxymethylated glycolyl, dimethoxymethylated glycolyl, trimethoxymethylated glycolyl, tetramethoxymethylated glycolyl, monomethoxymethylated glycolyl, dimethoxymethylated glycolyl, trimethoxymethylated glycolyl, tetraethoxymethylated glycolyl, monopropoxymethylated glycolyl, dipropoxymethylated glycolyl, tripropoxymethylated glycolyl, tetrapropoxymethylated glycolyl, monobutoxymethylated glycolyl, dibutoxymethylated glycolyl, and tributoxymethylated glycolyl. Or, glycoluryl-based crosslinking agents such as tetrabutoxymethylated glycoluryl;

[0742] Urea-based crosslinking agents such as bismethoxymethyl urea, bisethoxymethyl urea, bispropoxymethyl urea, bisbutoxymethyl urea, etc.

[0743] Monohydroxymethylated ethylene urea or dihydroxymethylated ethylene urea, monomethoxymethylated ethylene urea, dimethoxymethylated ethylene urea, monoethoxymethylated ethylene urea, diethoxymethylated ethylene urea, monopropoxymethylated ethylene urea, dipropoxymethylated ethylene urea, monobutoxymethylated ethylene urea, or, ethylene urea-based crosslinking agents such as dibutoxymethylated ethylene urea,

[0744] Monohydroxymethylated propylene urea, dihydroxymethylated propylene urea, monomethoxymethylated propylene urea, dimethoxymethylated propylene urea, monoethoxymethylated propylene urea, diethoxymethylated propylene urea, monopropoxymethylated propylene urea, dipropoxymethylated propylene urea, monobutoxymethylated propylene urea, or, propylene urea-based crosslinking agents such as dibutoxymethylated propylene urea,

[0745] Examples include 1,3-di(methoxymethyl)-4,5-dihydroxy-2-imidazolidinone, 1,3-di(methoxymethyl)-4,5-dimethoxy-2-imidazolidinone, etc.

[0746] Specific examples of benzoguanamine-based crosslinking agents include, for example, monohydroxymethylated benzoguanamine, dihydroxymethylated benzoguanamine, trihydroxymethylated benzoguanamine, tetrahydroxymethylated benzoguanamine, monomethoxymethylated benzoguanamine, dimethoxymethylated benzoguanamine, trimethoxymethylated benzoguanamine, tetramethoxymethylated benzoguanamine, monomethoxymethylated benzoguanamine, dimethoxymethylated benzoguanamine, trimethoxymethylated benzoguanamine, tetraethoxymethylated benzoguanamine, monopropoxymethylated benzoguanamine, dipropoxymethylated benzoguanamine, tripropoxymethylated benzoguanamine, tetrapropoxymethylated benzoguanamine, monobutoxymethylated benzoguanamine. Examples include dibutoxymethylated benzoguanamine, tribubutoxymethylated benzoguanamine, tetrabutoxymethylated benzoguanamine, etc.

[0747] In addition, as a compound having at least one group selected from the group consisting of methylol groups and alkoxymethyl groups, a compound in which at least one group selected from the group consisting of methylol groups and alkoxymethyl groups is directly bonded to an aromatic ring (preferably a benzene ring) is also suitably used.

[0748] Specific examples of such compounds include benzenedimethanol, bis(hydroxymethyl)cresol, bis(hydroxymethyl)dimethoxybenzene, bis(hydroxymethyl)diphenyl ether, bis(hydroxymethyl)benzophenone, hydroxymethylphenyl of hydroxymethylbenzoic acid, bis(hydroxymethyl)biphenyl, dimethylbis(hydroxymethyl)biphenyl, bis(methoxymethyl)benzene, bis(methoxymethyl)cresol, bis(methoxymethyl)dimethoxybenzene, bis(methoxymethyl)diphenyl ether, bis(methoxymethyl)benzophenone, methoxymethylphenyl of methoxymethylbenzoic acid, bis(methoxymethyl)biphenyl, dimethylbis(methoxymethyl)biphenyl, 4,4',4''-ethylidentris[2,6-bis(methoxymethyl)phenol], Examples include 5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[2-hydroxy-1,3-benzenedimethanol], 3,3',5,5'-tetrakis(methoxymethyl)-1,1'-biphenyl-4,4'-diol.

[0749] Commercially available products may be used as other crosslinking agents, and suitable commercially available products include 46DMOC, 46DMOEP (both manufactured by Asahi Yukizai High School), DML-PC, DML-PEP, DML-OC, DML-OEP, DML-34X, DML-PTBP, DML-PCHP, DML-OCHP, DML-PFP, DML-PSBP, DML-POP, DML-MBOC, DML-MBPC, DML-MTrisPC, DML-BisOC-Z, DML-BisOCHP-Z, DML-BPC, DMLBisOC-P, DMOM-PC, DMOM-PTBP, DMOM-MBPC, TriML-P, TriML-35XL, TML-HQ, TML-BP, TML-pp-BPF, TML-BPE, TML-BPA, TML-BPAF, TML-BPAP, TMOM-BP, TMOM-BPE, Examples include TMOM-BPA, TMOM-BPAF, TMOM-BPAP, HML-TPPHBA, HML-TPHAP, HMOM-TPPHBA, HMOM-TPHAP (all manufactured by Honshu Kagaku High School), NikaRac (registered trademark, hereinafter the same), MX-290, NikaRac MX-280, NikaRac MX-270, NikaRac MX-279, NikaRac MW-100LM, NikaRac MX-750LM (all manufactured by Sanwa Chemical Co., Ltd.).

[0750] In addition, the resin composition of the present invention preferably includes at least one compound selected from the group consisting of epoxy compounds, oxetane compounds, and benzoxazine compounds as another crosslinking agent.

[0751] -Epoxy compound (compound having an epoxy group)-

[0752] As for the epoxy compound, it is preferable to have a compound having two or more epoxy groups in one molecule. Since the epoxy groups undergo a crosslinking reaction at 200°C or lower and the dehydration reaction resulting from crosslinking does not occur, film shrinkage is unlikely to occur. For this reason, containing an epoxy compound is effective for low-temperature curing and suppression of warping of the resin composition in the present invention.

[0753] It is preferable that the epoxy compound contains polyethylene oxide groups. This allows for a lower elastic modulus and suppression of bending. The polyethylene oxide groups refer to a repeating unit of ethylene oxide having 2 or more repeating units, and it is preferable that the repeating unit number be 2 to 15.

[0754] Examples of epoxy compounds include, but are not limited to, bisphenol A type epoxy resin; bisphenol F type epoxy resin; alkylene glycol type epoxy resin or polyhydric alcohol hydrocarbon type epoxy resin such as propylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, ethylene glycol diglycidyl ether, butylene glycol diglycidyl ether, hexamethylene glycol diglycidyl ether, and trimethylolpropane triglycidyl ether; polyalkylene glycol type epoxy resin such as polypropylene glycol diglycidyl ether; and epoxy group-containing silicone such as polymethyl(glycidyloxypropyl)siloxane.Specifically, Epiclon (registered trademark) 850-S, Epiclon (registered trademark) HP-4032, Epiclon (registered trademark) HP-7200, Epiclon (registered trademark) HP-820, Epiclon (registered trademark) HP-4700, Epiclon (registered trademark) HP-4770, Epiclon (registered trademark) EXA-830LVP, Epiclon (registered trademark) EXA-8183, Epiclon (registered trademark) EXA-8169, Epiclon (registered trademark) N-660, Epiclon (registered trademark) N-665-EXP-S, Epiclon (registered trademark) N-740 (all product names, manufactured by DIC Co., Ltd.), Ricaresin (registered trademark) BEO-20E, Ricaresin (registered trademark) BEO-60E, Rica Resin (Registered Trademark) HBE-100, Rica Resin (Registered Trademark) DME-100, Rica Resin (Registered Trademark) L-200 (Trade Name, Manufactured by Shin Nippon Rica Co., Ltd.), EP-4003S, EP-4000S, EP-4088S, EP-3950S (Trade Names, Manufactured by ADEKA Co., Ltd.), Celoxide (Registered Trademark) 2021P, Celoxide (Registered Trademark) 2081, Celoxide (Registered Trademark) 2000, EHPE3150, Epolid (Registered Trademark) GT401, Epolid (Registered Trademark) PB4700, Epolid (Registered Trademark) PB3600 (Trade Names, Manufactured by Daicel Co., Ltd.), NC-3000, NC-3000-L, NC-3000-H, NC-3000-FH-75M, Examples include NC-3100, CER-3000-L, NC-2000-L, XD-1000, NC-7000L, NC-7300L, EPPN-501H, EPPN-501HY, EPPN-502H, EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, CER-1020, EPPN-201, BREN-S, BREN-10S (all trade names, manufactured by Nippon Kayaku Co., Ltd.), etc. In addition, the following compounds are also suitably used.

[0755] [Chemical Formula 38]

[0756]

[0757] In the expression, n is an integer from 1 to 5, and m is an integer from 1 to 20.

[0758] Among the above structures, in order to achieve both heat resistance and improved elongation, it is preferable that n be 1 to 2 and m be 3 to 7.

[0759] -Oxetane compounds (compounds having an oxetane group)-

[0760] Examples of oxetane compounds include compounds having two or more oxetane rings in one molecule, 3-ethyl-3-hydroxymethyloxetane, 1,4-bis{[(3-ethyl-3-oxetanyl)methoxy]methyl}benzene, 3-ethyl-3-(2-ethylhexylmethyl)oxetane, 1,4-benzenedicarboxylic acid-bis[(3-ethyl-3-oxetanyl)methyl]ester, etc. As specific examples, the Aaron oxetane series manufactured by Doa Kosei Co., Ltd. (e.g., OXT-121, OXT-221) can be suitably used, and these may be used alone or a mixture of two or more types.

[0761] -Benzoxazine compounds (compounds having a benzoxazole group-

[0762] Benzoxazine compounds are desirable because, due to the cross-linking reaction derived from the ring-opening addition reaction, degassing does not occur during curing, and also, thermal shrinkage is small, thereby suppressing the occurrence of warping.

[0763] Preferred examples of benzoxazine compounds include Pd-type benzoxazine, Fa-type benzoxazine (both trade names, manufactured by Shikoku Kasei Kogyo Co., Ltd.), benzoxazine adducts of polyhydroxystyrene resins, and phenol novolak-type dihydrobenzoxazine compounds. These may be used individually or mixed in combination of two or more types.

[0764] The content of other crosslinking agents is preferably 0.1 to 30 mass% with respect to the total solid content of the resin composition in the present invention, more preferably 0.1 to 20 mass%, more preferably 0.5 to 15 mass%, and particularly preferably 1.0 to 10 mass%. The other crosslinking agents may be contained in only one type or in two or more types. When two or more other crosslinking agents are contained, the total amount thereof is preferably within the above range.

[0765] In the present invention, the resin composition preferably includes a photosensitive agent.

[0766] Examples of photosensitive agents include photopolymerization initiators and photogenerators, and photopolymerization initiators are preferred.

[0767] [Polymerization Initiator]

[0768] In the present invention, the resin composition preferably comprises a polymerization initiator capable of initiating polymerization by light and / or heat. In particular, it is preferable to comprise a photopolymerization initiator.

[0769] The photopolymerization initiator is preferably a photoradical polymerization initiator. There are no particular limitations on the photoradical polymerization initiator, and it can be appropriately selected from known photoradical polymerization initiators. For example, a photoradical polymerization initiator having photosensitivity to light in the ultraviolet to visible range is preferred. In addition, it may be an activator that generates an active radical by interacting with a photo-excited sensitizer.

[0770] The photoradical polymerization initiator is at least about 50 L·mol within a wavelength range of about 240 to 800 nm (preferably 330 to 500 nm). -1· cm -1It is preferable to contain at least one compound having a molar extinction coefficient. The molar extinction coefficient of the compound can be measured using known methods. For example, it is preferable to measure at a concentration of 0.01 g / L using an ultraviolet-visible spectrophotometer (Varian Cary-5 spectrophotometer) with an ethyl acetate solvent.

[0771] As a photoradical polymerization initiator, known compounds may be optionally used. Examples include halogenated hydrocarbon derivatives (e.g., compounds having a triazine backbone, compounds having an oxadiazole backbone, compounds having a trihalomethyl group, etc.), acylphosphine compounds such as acylphosphine oxide, oxime compounds such as hexaarylbiimidazole and oxime derivatives, organic peroxides, thio compounds, ketone compounds, aromatic onium salts, ketoxime ethers, α-aminoketone compounds such as aminoacetophenone, α-hydroxyketone compounds such as hydroxyacetophenone, azo compounds, azide compounds, metallocene compounds, organic boron compounds, iron arene complexes, etc. For details regarding these, reference may be made to paragraphs 0165–0182 of Japanese Patent Publication No. 2016-027357 and paragraphs 0138–0151 of International Patent Publication No. 2015 / 199219, the contents of which are incorporated herein by reference. Additionally, paragraphs 0065–0111 of Japanese Patent Publication No. 2014-130173, the compound described in Japanese Patent Publication No. 6301489, MATERIAL STAGE pp. 37–60, vol. 19, No. Examples include the peroxide-based photopolymerization initiator described in 3, 2019, the photopolymerization initiator described in International Publication No. 2018 / 221177, the photopolymerization initiator described in International Publication No. 2018 / 110179, the photopolymerization initiator described in Japanese Patent Publication No. 2019-043864, the photopolymerization initiator described in Japanese Patent Publication No. 2019-044030, and the peroxide-based initiator described in Japanese Patent Publication No. 2019-167313, and these contents are also incorporated by reference into this specification.

[0772] As for ketone compounds, for example, the compound described in paragraph 0087 of Japanese Patent Publication No. 2015-087611 is exemplified, and this content is incorporated herein by reference. As for commercially available products, Kayacure-DETX-S (manufactured by Nippon Kayaku Co., Ltd.) is also suitably used.

[0773] In one embodiment of the present invention, hydroxyacetophenone compounds, aminoacetophenone compounds, and acylphosphine compounds may be suitably used as photoradical polymerization initiators. More specifically, for example, an aminoacetophenone-based initiator described in Japanese Patent Publication No. Hei 10-291969 and an acylphosphine oxide-based initiator described in Japanese Patent Publication No. 4225898 may be used, and the contents thereof are incorporated herein by reference.

[0774] As α-hydroxyketone initiators, Omnirad 184, Omnirad 1173, Omnirad 2959, Omnirad 127 (all manufactured by IGM Resins BV), IRGACURE 184 (IRGACURE is a registered trademark), DAROCURE 1173, IRGACURE 500, IRGACURE-2959, and IRGACURE 127 (trade names: all manufactured by BASF) may be used.

[0775] As α-aminoketone-based initiators, Omnirad 907, Omnirad 369, Omnirad 369E, Omnirad 379EG (all manufactured by IGM Resins BV), IRGACURE 907, IRGACURE 369, and IRGACURE 379 (trade names: all manufactured by BASF) may be used.

[0776] As an aminoacetophenone-based initiator, a compound described in Japanese Patent Publication No. 2009-191179, in which the wavelength of maximum absorption is matched to a light source of wavelength such as 365 nm or 405 nm, may also be used, and this content is incorporated herein by reference.

[0777] Examples of acylphosphine-based initiators include 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide. Additionally, Omnirad 819, Omnirad TPO (both manufactured by IGM Resins BV), IRGACURE-819, or IRGACURE-TPO (trade names: both manufactured by BASF) may be used.

[0778] Examples of metallocene compounds include IRGACURE-784, IRGACURE-784EG (both manufactured by BASF), and Keycure VIS 813 (manufactured by King Brother Chem).

[0779] As a photoradical polymerization initiator, an oxime compound is more preferably used. By using an oxime compound, it becomes possible to more effectively improve the exposure latitude. Oxime compounds are particularly preferred because they have a wide exposure latitude (exposure margin) and also act as a photocuring promoter.

[0780] Specific examples of oxime compounds include the compound described in Japanese Published Patent Application No. 2001-233842, the compound described in Japanese Published Patent Application No. 2000-080068, the compound described in Japanese Published Patent Application No. 2006-342166, the compound described in JCS Perkin II (1979, pp. 1653-1660), the compound described in JCS Perkin II (1979, pp. 156-162), the compound described in the Journal of Photopolymer Science and Technology (1995, pp. 202-232), the compound described in Japanese Published Patent Application No. 2000-066385, the compound described in Japanese Published Patent Application No. 2004-534797, the compound described in Japanese Published Patent Application No. 2006-342166, and Japanese Published Patent Application Examples include compounds described in Japanese Patent Publication No. 2017-019766, compounds described in Japanese Patent Publication No. 6065596, compounds described in International Publication No. 2015 / 152153, compounds described in International Publication No. 2017 / 051680, compounds described in Japanese Patent Publication No. 2017-198865, compounds described in paragraphs 0025 to 0038 of International Publication No. 2017 / 164127, compounds described in International Publication No. 2013 / 167515, etc., and these contents are incorporated by reference into this specification.

[0781] Preferred oxime compounds include, for example, compounds having the following structures, 3-benzoyliminobutan-2-one, 3-acetoxyliminobutan-2-one, 3-propionyloxyliminobutan-2-one, 2-acetoxyliminopentan-3-one, 2-acetoxylimino-1-phenylpropan-1-one, 2-benzoylimino-1-phenylpropan-1-one, 3-(4-toluenesulfonyloxy)iminobutan-2-one, and 2-ethoxycarbonyloxylimino-1-phenylpropan-1-one. In the resin composition of the present invention, it is particularly preferable to use an oxime compound (an oxime-based photoradical polymerization initiator) as a photoradical polymerization initiator. Oxime-based photoradical polymerization initiators have a >C=NOC(=O)- linker within the molecule.

[0782] [Chemical Formula 39]

[0783]

[0784] Commercially available products such as IRGACURE OXE 01, IRGACURE OXE 02, IRGACURE OXE 03, and IRGACURE OXE 04 (all manufactured by BASF), and Adeka Optomer N-1919 (manufactured by ADEKA Inc., photoradical polymerization initiator 2 described in Japanese Patent Publication No. 2012-014052) are also suitably used. In addition, TR-PBG-304, TR-PBG-305 (manufactured by Changzhou Tronly New Electronic Materials Co., Ltd.), Adeka Arcles NCI-730, NCI-831, and Adeka Arcles NCI-930 (manufactured by ADEKA Inc.) can also be used. Furthermore, DFI-091 (manufactured by Daito Chemics Inc.) and SpeedCure PDO (manufactured by SARTOMER ARKEMA) can be used. In addition, oxime compounds of the following structure may also be used.

[0785] [Chemical Formula 40]

[0786]

[0787] As a photoradical polymerization initiator, an oxime compound having a fluorene ring may be used. Specific examples of oxime compounds having a fluorene ring include the compound described in Japanese Patent Publication No. 2014-137466 and the compound described in Japanese Patent Publication No. 06636081, and these contents are incorporated herein by reference.

[0788] As a photoradical polymerization initiator, an oxime compound having a backbone in which at least one benzene ring of a carbazole ring is a naphthalene ring may be used. Specific examples of such an oxime compound include the compound described in International Publication No. 2013 / 083505, the contents of which are incorporated herein by reference.

[0789] In addition, it is also possible to use oxime compounds having fluorine atoms. Specific examples of such oxime compounds include compounds described in Japanese Patent Publication No. 2010-262028, compounds 24, 36-40 described in paragraph 0345 of Japanese Patent Publication No. 2014-500852, and compounds (C-3) described in paragraph 0101 of Japanese Patent Publication No. 2013-164471, and these contents are incorporated by reference into this specification.

[0790] As a photopolymerization initiator, an oxime compound having a nitro group may be used. It is also preferable to form the oxime compound having a nitro group as a dimer. Specific examples of oxime compounds having a nitro group include compounds described in paragraphs 0031 to 0047 of Japanese Patent Publication No. 2013-114249, paragraphs 0008 to 0012 and 0070 to 0079 of Japanese Patent Publication No. 2014-137466, and compounds described in paragraphs 0007 to 0025 of Japanese Patent Publication No. 4223071, the contents of which are incorporated herein by reference. Additionally, ADEKA Arcles NCI-831 (manufactured by ADEKA Inc.) may be cited as an oxime compound having a nitro group.

[0791] As a photoradical polymerization initiator, an oxime compound having a benzofuran backbone may be used. Specific examples include OE-01 to OE-75 described in International Publication No. 2015 / 036910.

[0792] As a photoradical polymerization initiator, an oxime compound having a hydroxyl group attached to a carbazole backbone may be used. Examples of such photopolymerization initiators include compounds described in International Publication No. 2019 / 088055, the contents of which are incorporated herein by reference.

[0793] As a photopolymerization initiator, an aromatic ring Ar in which an electron-requiring group is introduced to the aromatic ring is used. OX1 An oxime compound having (hereinafter also referred to as oxime compound OX) may be used. The above aromatic group Ar OX1 Examples of the electron-attracting groups include acyl groups, nitro groups, trifluoromethyl groups, alkylsulfeneyl groups, arylsulfeneyl groups, alkylsulfonyl groups, arylsulfonyl groups, and cyano groups; acyl groups and nitro groups are preferred, and acyl groups are more preferred because they facilitate the formation of a film with excellent light resistance, and benzoyl groups are even more preferred. The benzoyl group may have a substituent. As a substituent, it is preferable that it be a halogen atom, a cyano group, a nitro group, a hydroxyl group, an alkyl group, an alkoxy group, an aryloxy group, a heterocyclic group, a heterocyclic oxy group, an alkeneyl group, an alkylsulfaneyl group, an arylsulfaneyl group, an acyl group, or an amino group, more preferable that it be an alkyl group, an alkoxy group, an aryloxy group, a heterocyclic oxy group, an alkylsulfaneyl group, an arylsulfaneyl group, or an amino group, and even more preferable that it be an alkoxy group, an alkylsulfaneyl group, or an amino group.

[0794] The oxime compound OX is preferably at least one selected from the compound represented by formula (OX1) and the compound represented by formula (OX2), and more preferably is the compound represented by formula (OX2).

[0795] [Chemical Formula 41]

[0796]

[0797] During the meal, R X1 Representing silver, alkyl group, alkenyl group, alkoxy group, aryl group, aryloxy group, heterocyclic group, heterocyclic oxy group, alkylsulfaneyl group, arylsulfaneyl group, alkylsulfeneyl group, arylsulfeneyl group, alkylsulfonyl group, arylsulfonyl group, acyl group, acyloxy group, amino group, phosphinoyl group, carbamoyl group, or sulfamoyl group,

[0798] R X2 ...represents an alkyl group, an alkenyl group, an alkoxy group, an aryl group, an aryloxy group, a heterocyclic group, a heterocyclic oxy group, an alkylsulfaneyl group, an arylsulfaneyl group, an alkylsulfeneyl group, an arylsulfeneyl group, an alkylsulfonyl group, an arylsulfonyl group, an acyloxy group, or an amino group,

[0799] R X3 ~R X14 Each represents a hydrogen atom or a substituent independently;

[0800] However, R X10 ~R X14 At least one of them is an electronic spheroid.

[0801] In the above formula, R X12 ga is an electronic incubator, and R X10 , R X11 , R X13 , R X14 It is preferable that it be a hydrogen atom.

[0802] Specific examples of oxime compounds OX include compounds described in paragraphs 0083 to 0105 of Japanese Patent Publication No. 4600600, and the contents thereof are incorporated herein by reference.

[0803] Examples of the most desirable oxime compounds include oxime compounds having specific substituents as described in Japanese Patent Publication No. 2007-269779, or oxime compounds having thioryl groups as described in Japanese Patent Publication No. 2009-191061, and these contents are incorporated herein by reference.

[0804] In terms of exposure sensitivity, the photoradical polymerization initiator is preferably a compound selected from the group consisting of trihalomethyltriazine compounds, benzyldimethylketal compounds, α-hydroxyketone compounds, α-aminoketone compounds, acylphosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazole dimers, onium salt compounds, benzothiasol compounds, benzophenone compounds, acetophenone compounds and their derivatives, cyclopentadiene-benzene-iron complexes and their salts, halomethyloxadiazole compounds, and 3-aryl substituted coumarin compounds.

[0805] A more preferred photoradical polymerization initiator is a trihalomethyltriazine compound, an α-aminoketone compound, an acylphosphine compound, a phosphine oxide compound, a metallocene compound, an oxime compound, a triarylimidazole dimer, an onium salt compound, a benzophenone compound, or an acetophenone compound; at least one compound selected from the group consisting of a trihalomethyltriazine compound, an α-aminoketone compound, a metallocene compound, an oxime compound, a triarylimidazole dimer, or a benzophenone compound is even more preferred, and using a metallocene compound or an oxime compound is even more preferred.

[0806] In addition, the photoradical polymerization initiator may use N,N'-tetraalkyl-4,4'-diaminobenzophenone such as benzophenone, N,N'-tetramethyl-4,4'-diaminobenzophenone (Mihler ketone), aromatic ketones such as 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1,2-methyl-1-[4-(methylthio)phenyl]-2-morpholino-propanone-1, quinones condensed with aromatic rings such as alkylanthraquinone, benzoin ether compounds such as benzoin alkyl ether, benzoin compounds such as benzoin and alkylbenzoin, benzyl derivatives such as benzyldimethylketal, etc. In addition, a compound represented by the following formula (I) may be used.

[0807] [Chemical Formula 42]

[0808]

[0809] In Equation (I), R I00 Silver, an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms interrupted by one or more oxygen atoms, an alkoxy group having 1 to 12 carbon atoms, a phenyl group, or, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, a halogen atom, a cyclopentyl group, a cyclohexyl group, an alkeneyl group having 2 to 12 carbon atoms, a phenyl group substituted with at least one of an alkyl group having 2 to 18 carbon atoms interrupted by one or more oxygen atoms and an alkyl group having 1 to 4 carbon atoms, or a biphenyl group, and R I01 is either a unit represented by Equation (II) or R I00 It is the same as and, R I02 ~R I04 Each is independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, or a halogen atom.

[0810] [Chemical Formula 43]

[0811]

[0812] During the meal, R I05 ~R I07 is R of the above equation (I). I02 ~R I04 It is the same as.

[0813] In addition, the photoradical polymerization initiator may use compounds described in paragraphs 0048 to 0055 of International Publication No. 2015 / 125469, and this is incorporated herein by reference.

[0814] As a photoradical polymerization initiator, a photoradical polymerization initiator with two or more functional groups may be used. By using such a photoradical polymerization initiator, two or more radicals are generated from one molecule of the photoradical polymerization initiator, so good sensitivity is obtained. In addition, when a compound with an asymmetric structure is used, crystallinity is reduced, solubility in solvents, etc. is improved, and it becomes difficult to precipitate over time, thereby improving the stability of the resin composition over time. Specific examples of photoradical polymerization initiators having two or more functions are: dimers of oxime compounds described in Japanese Patent Publication No. 2010-527339, Japanese Patent Publication No. 2011-524436, International Publication No. 2015 / 004565, paragraphs 0407–0412 of Japanese Patent Publication No. 2016-532675, and paragraphs 0039–0055 of International Publication No. 2017 / 033680; compounds (E) and (G) described in Japanese Patent Publication No. 2013-522445; Cmpd 1–7 described in International Publication No. 2016 / 034963; and paragraph No. Examples include the oxime ester photoinitiator described in 0007, the photoinitiator described in paragraphs 0020 to 0033 of Japanese Patent Publication No. 2017-167399, the photopolymerization initiator described in paragraphs 0017 to 0026 of Japanese Patent Publication No. 2017-151342 (A), and the oxime ester photoinitiator described in Japanese Patent Publication No. 6469669, and the contents thereof are incorporated by reference into this specification.

[0815] When a photopolymerization initiator is included, the content thereof is preferably 0.1 to 30 mass% with respect to the total solid content of the resin composition in the present invention, more preferably 0.1 to 20 mass%, even more preferably 0.5 to 15 mass%, and even more preferably 1.0 to 10 mass%. The photopolymerization initiator may be included as a single type or as two or more types. When two or more types of photopolymerization initiators are included, the total amount is preferably within the above range.

[0816] In addition, since photopolymerization initiators can also function as thermal polymerization initiators, crosslinking by the photopolymerization initiator can be further advanced by heating with an oven or hot plate.

[0817] [Increase / Decrease System]

[0818] The resin composition may include a sensitizer. The sensitizer absorbs specific active radiation and becomes electron-excited. The electron-excited sensitizer comes into contact with a thermal radical polymerization initiator, a photoradical polymerization initiator, etc., and actions such as electron transfer, energy transfer, and exothermic reaction occur. As a result, the thermal radical polymerization initiator and the photoradical polymerization initiator undergo chemical changes and decompose to generate radicals, acids, or bases.

[0819] As usable sensitizers, compounds such as benzophenone-based, mihiller ketone-based, coumarin-based, pyrazolazo-based, anilinoazo-based, triphenylmethane-based, anthraquinone-based, anthracene-based, anthrapyridone-based, benzylidene-based, oxonol-based, pyrazolotriazoleazo-based, pyridonazo-based, cyanine-based, phenothiazine-based, pyrrolopyrazolazomethine-based, xanthen-based, phthalocyanine-based, benzopyran-based, and indigo-based compounds may be used.

[0820] As sensitizers, for example, mihiller ketone, 4,4'-bis(diethylamino)benzophenone, 2,5-bis(4'-diethylaminobenzal)cyclopentane, 2,6-bis(4'-diethylaminobenzal)cyclohexanone, 2,6-bis(4'-diethylaminobenzal)-4-methylcyclohexanone, 4,4'-bis(dimethylamino)chalcone, 4,4'-bis(diethylamino)chalcone, p-dimethylaminocinnamylidene indanone, p-dimethylaminobenzylidene indanone, 2-(p-dimethylaminophenylbiphenylene)-benzothiazol, 2-(p-dimethylaminophenylvinylene)benzothiazol, 2-(p-dimethylaminophenylvinylene)isonaphthothiazol, 1,3-Bis(4'-Dimethylaminobenzal)acetone, 1,3-Bis(4'-Diethylaminobenzal)acetone, 3,3'-Carbonyl-Bis(7-Diethylaminocoumarin), 3-Acetyl-7-Dimethylaminocoumarin, 3-Ethoxycarbonyl-7-Dimethylaminocoumarin, 3-Benzyloxycarbonyl-7-Dimethylaminocoumarin, 3-Methoxycarbonyl-7-Diethylaminocoumarin, 3-Ethoxycarbonyl-7-Diethylaminocoumarin(7-(Diethylamino)Coumarin-3-EthylCarboxylate), N-Phenyl-N'-Ethylethanolamine, N-Phenyldiethanolamine, Np-Tolyldiethanolamine, N-Phenylethanolamine, 4-Mopolinobenzophenone, Dimethylaminobenzoic acid Examples include isoamyl, isoamyl diethylaminobenzoate, 2-mercaptobenzimidazole, 1-phenyl-5-mercaptotetrazol, 2-mercaptobenzthiazole, 2-(p-dimethylaminostyryl)benzoxazole, 2-(p-dimethylaminostyryl)benzothiazole, 2-(p-dimethylaminostyryl)naphtho(1,2-d)thiazole, 2-(p-dimethylaminobenzoyl)styrene, diphenylacetamide, benzanilide, N-methylacetanilide, 3',4'-dimethylacetanilide, etc.

[0821] In addition, other sensitizing dyes may be used.

[0822] For details regarding the sensitizing pigment, reference may be made to paragraphs 0161 to 0163 of Japanese Patent Publication No. 2016-027357, and this content is incorporated herein by reference.

[0823] When the resin composition includes a sensitizer, the content of the sensitizer is preferably 0.01 to 20 mass% with respect to the total solid content of the resin composition, more preferably 0.1 to 15 mass%, and even more preferably 0.5 to 10 mass%. The sensitizer may be used alone or in combination of two or more types.

[0824] [Chain Movement System]

[0825] The resin composition of the present invention may contain a chain transfer agent. Chain transfer agents are defined, for example, in pages 683-684 of the Polymer Dictionary, 3rd Edition (edited by the Polymer Society, 2005). As chain transfer agents, for example, a group of compounds having -SS-, -SO2-S-, -NO-, SH, PH, SiH, and GeH within the molecule, and dithiobenzoates, trithiocarbonates, dithiocarbamates, and xanthate compounds having thiocarbonylthio groups used in RAFT (Reversible Addition Fragmentation Chain Transfer) polymerization are used. These can generate radicals by donating hydrogen to low-activity radicals, or by deprotonating after oxidation. In particular, thiol compounds may be preferably used.

[0826] Additionally, the chain transfer agent may use compounds described in paragraphs 0152 to 0153 of International Publication No. 2015 / 199219, and this is incorporated herein by reference.

[0827] In the case where the resin composition of the present invention has a chain transfer agent, the content of the chain transfer agent is preferably 0.01 to 20 parts by mass, more preferably 0.1 to 10 parts by mass, and more preferably 0.5 to 5 parts by mass, based on 100 parts by mass of the total solid content of the resin composition of the present invention. The chain transfer agent may be of only one type or may be of two or more types. If there are two or more types of chain transfer agents, it is preferable that their total amount falls within the above range.

[0828] Base generator

[0829] The resin composition of the present invention may include a base generating agent. Here, a base generating agent is a compound capable of generating a base through physical or chemical action. The specific resins described above are not included in the base generating agent referred to herein. Preferred base generating agents in the resin composition of the present invention include thermobase generating agents and photobase generating agents.

[0830] In particular, when the resin composition includes a precursor of a cyclization resin, it is preferable that the resin composition include a base generating agent. By including a thermobase generating agent in the resin composition, the cyclization reaction of the precursor can be promoted, for example, by heating, thereby improving the mechanical properties and chemical resistance of the cured product, and, for example, improving performance as an interlayer insulating film for a redistribution layer included in a semiconductor package.

[0831] As for the base generator, it may be an ionic base generator or a non-ionic base generator.

[0832] Examples of bases generated from base generating agents include secondary amines and tertiary amines.

[0833] There are no particular limitations on the base generating agent according to the present invention, and known base generating agents may be used. Examples of known base generating agents may be used, such as carbamoyloxime compounds, carbamoylhydroxylamine compounds, carbamic acid compounds, formamide compounds, acetamide compounds, carbamate compounds, benzylcarbamate compounds, nitrobenzylcarbamate compounds, sulfonamide compounds, imidazole derivative compounds, amineimide compounds, pyridine derivative compounds, α-aminoacetophenone derivative compounds, quaternary ammonium salt derivative compounds, pyridinium salts, α-lactone ring derivative compounds, amineimide compounds, phthalimide derivative compounds, acyloxyimino compounds, etc.

[0834] Specific compounds of nonionic base generators include compounds represented by formula (B1), formula (B2), or formula (B3).

[0835] [Chemical Formula 44]

[0836]

[0837] Among Equations (B1) and (B2), Rb 1 , Rb 2 and Rb 3 Each is independently an organic group, a halogen atom, or a hydrogen atom that does not have a tertiary amine structure. However, Rb 1 and Rb 2 There is no case where it simultaneously becomes a hydrogen atom. Also, Rb 1 , Rb 2 and Rb 3 There are no cases where all of them have carboxyl groups. In addition, in this specification, a tertiary amine structure refers to a structure in which all three bonding hands of a trivalent nitrogen atom are covalently bonded to carbon atoms of the hydrocarbon system. Therefore, cases in which the bonded carbon atom is a carbon atom forming a carbonyl group, that is, cases in which an amide group is formed together with a nitrogen atom, are not limited thereto.

[0838] In equations (B1) and (B2), Rb1 , Rb 2 and Rb 3 It is preferable that at least one of these includes a cyclic structure, and more preferable that at least two include a cyclic structure. As for the cyclic structure, it may be either a single ring or a condensed ring, and a single ring or a condensed ring formed by the condensation of two single rings is preferred. The single ring is preferably a five-membered ring or a six-membered ring, and a six-membered ring is preferred. The single ring is preferably a cyclohexane ring and a benzene ring, and a cyclohexane ring is more preferred.

[0839] More specifically, Rb 1 and Rb 2 It is preferable that the atom is a hydrogen atom, an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 2 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably 2 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 10 carbon atoms), or an arylalkyl group (preferably having 7 to 25 carbon atoms, more preferably 7 to 19 carbon atoms, and more preferably 7 to 12 carbon atoms). These groups may have substituents within the range that exhibits the effects of the present invention. Rb 1 and Rb 2 They may be combined to form a ring. As the ring formed, a nitrogen-containing heterocyclic ring of 4 to 7 groups is preferred. Rb 1 and Rb 2 In particular, it is preferably a straight-chain, branched, or cyclic alkyl group that may have substituents (preferably 1 to 24 carbon atoms, more preferably 2 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms), more preferably a cycloalkyl group that may have substituents (preferably 3 to 24 carbon atoms, more preferably 3 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms), and more preferably a cyclohexyl group that may have substituents.

[0840] Rb 3As, alkyl group (preferably 1 to 24 carbon atoms, more preferably 2 to 18, and more preferably 3 to 12), aryl group (preferably 6 to 22 carbon atoms, more preferably 6 to 18, and more preferably 6 to 10), alkenyl group (preferably 2 to 24 carbon atoms, more preferably 2 to 12, and more preferably 2 to 6), arylalkyl group (preferably 7 to 23 carbon atoms, more preferably 7 to 19, and more preferably 7 to 12), arylalkenyl group (preferably 8 to 24 carbon atoms, more preferably 8 to 20, and more preferably 8 to 16), alkoxyl group (preferably 1 to 24 carbon atoms, more preferably 2 to 18, and more preferably 3 to 12), aryloxy group (preferably 6 to 22 carbon atoms, and more preferably 6 to 18, Examples include 6 to 12 carbon atoms, or arylalkyloxy groups (7 to 23 carbon atoms are preferred, 7 to 19 are more preferred, and 7 to 12 are more preferred). Among these, cycloalkyl groups (3 to 24 carbon atoms are preferred, 3 to 18 are more preferred, and 3 to 12 are more preferred), arylalkenyl groups, and arylalkyloxy groups are preferred. Rb 3 It may have additional substituents within the range exhibiting the effects of the present invention.

[0841] The compound represented by formula (B1) is preferably a compound represented by the following formula (B1-1) or the following formula (B1-2).

[0842] [Chemical Formula 45]

[0843]

[0844] In the food, Rb 11 and Rb 12 , and, Rb 31 and Rb 32 are, respectively, Rb in Equation (B1). 1 and Rb 2 It is the same as.

[0845] Rb 13The group is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and more preferably 3 to 12), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably 2 to 18, and more preferably 3 to 12), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and more preferably 6 to 12), and an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and more preferably 7 to 12), and may have substituents within the range exhibiting the effects of the present invention. Among these, Rb 13 An arylalkyl group is preferred.

[0846] Rb 33 and Rb 34 Each is independently a hydrogen atom, an alkyl group (preferably 1 to 12 carbon atoms, more preferably 1 to 8 carbon atoms, and more preferably 1 to 3 carbon atoms), an alkenyl group (preferably 2 to 12 carbon atoms, more preferably 2 to 8 carbon atoms, and more preferably 2 to 3 carbon atoms), an aryl group (preferably 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 10 carbon atoms), and an arylalkyl group (preferably 7 to 23 carbon atoms, more preferably 7 to 19 carbon atoms, and more preferably 7 to 11 carbon atoms), and a hydrogen atom is preferred.

[0847] Rb 35 The group is an alkyl group (preferably 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and more preferably 3 to 8 carbon atoms), an alkenyl group (preferably 2 to 12 carbon atoms, more preferably 2 to 10 carbon atoms, and more preferably 3 to 8 carbon atoms), an aryl group (preferably 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 12 carbon atoms), and an aryl alkyl group (preferably 7 to 23 carbon atoms, more preferably 7 to 19 carbon atoms, and more preferably 7 to 12 carbon atoms), and the aryl group is preferred.

[0848] The compound represented by formula (B1-1) is also preferred as the compound represented by formula (B1-1a).

[0849] [Chemical Formula 46]

[0850]

[0851] Rb 11 and Rb 12 is Rb in Equation (B1-1) 11 and Rb 12 It has the same meaning as

[0852] Rb 15 and Rb 16 The hydrogen atom, an alkyl group (preferably 1 to 12 carbon atoms, more preferably 1 to 6 carbon atoms, and more preferably 1 to 3 carbon atoms), an alkenyl group (preferably 2 to 12 carbon atoms, more preferably 2 to 6 carbon atoms, and more preferably 2 to 3 carbon atoms), an aryl group (preferably 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 10 carbon atoms), an arylalkyl group (preferably 7 to 23 carbon atoms, more preferably 7 to 19 carbon atoms, and more preferably 7 to 11 carbon atoms), and a hydrogen atom or a methyl group is preferred.

[0853] Rb 17 The group is an alkyl group (preferably 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and more preferably 3 to 8 carbon atoms), an alkenyl group (preferably 2 to 12 carbon atoms, more preferably 2 to 10 carbon atoms, and more preferably 3 to 8 carbon atoms), an aryl group (preferably 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 12 carbon atoms), and an arylalkyl group (preferably 7 to 23 carbon atoms, more preferably 7 to 19 carbon atoms, and more preferably 7 to 12 carbon atoms), and among these, an aryl group is preferred.

[0854] [Chemical Formula 47]

[0855]

[0856] In formula (B3), L represents a divalent hydrocarbon group having a saturated hydrocarbon group along the path of a linking chain connecting adjacent oxygen and carbon atoms, wherein the number of atoms along the linking chain path is 3 or more. Also, R N1 and R N2 Each represents a monovalent organic group independently.

[0857] In this specification, "linking chain" refers to the shortest (minimum number of atoms) connection of two atoms or groups of atoms in a path connecting the two atoms or groups of atoms to be connected. For example, in a compound represented by the following formula, L is composed of a phenylethylene group and has an ethylene group as a saturated hydrocarbon group, the linking chain is composed of four carbon atoms, and the number of atoms in the path of the linking chain (i.e., the number of atoms constituting the linking chain, hereinafter also referred to as "linking chain length" or "linking chain length") is 4.

[0858] [Chemical Formula 48]

[0859]

[0860] In formula (B3), the number of carbon atoms in L (including carbon atoms other than those in the linking chain) is preferably 3 to 24. The upper limit is more preferably 12 or less, more preferably 10 or less, and particularly preferably 8 or less. The lower limit is more preferably 4 or more. From the perspective of rapidly proceeding the intramolecular cyclization reaction, the upper limit of the linking chain length of L is preferably 12 or less, more preferably 8 or less, more preferably 6 or less, and particularly preferably 5 or less. In particular, the linking chain length of L is preferably 4 or 5, and most preferably 4. Specific preferred compounds for base generating agents include, for example, compounds described in paragraphs 0102 to 0168 of International Publication No. 2020 / 066416 and compounds described in paragraphs 0143 to 0177 of International Publication No. 2018 / 038002.

[0861] In addition, it is also desirable for the base generator to include a compound represented by the following formula (N1).

[0862] [Chemical Formula 49]

[0863]

[0864] In equation (N1), R N1 and R N2 Each represents a monovalent organic group independently, RC1 represents a hydrogen atom or a protecting group, and L represents a divalent linker.

[0865] L is a divalent linker, and it is preferable that it be a divalent organic group. The linker chain length is preferably 1 or more, and more preferably 2 or more. As an upper limit, it is preferably 12 or less, more preferably 8 or less, and more preferably 5 or less. The linker chain length is the number of atoms in the atomic arrangement that is the shortest path between the two carbonyl groups in the formula.

[0866] In equation (N1), R N1 and R N2 Each independently represents a monovalent organic group (preferably 1 to 24 carbon atoms, more preferably 2 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms), and is preferably a hydrocarbon group (preferably 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and more preferably 1 to 10 carbon atoms). Specifically, examples include an aliphatic hydrocarbon group (preferably 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and more preferably 1 to 10 carbon atoms) or an aromatic hydrocarbon group (preferably 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and more preferably 6 to 10 carbon atoms), and an aliphatic hydrocarbon group is preferred. R N1 and R N2 As such, using an aliphatic hydrocarbon group is desirable because the basicity of the resulting base is high. In addition, the aliphatic hydrocarbon group and the aromatic hydrocarbon group may have substituents, and the aliphatic hydrocarbon group and the aromatic hydrocarbon group may have oxygen atoms in the aliphatic hydrocarbon chain, the aromatic ring, or the substituents. In particular, an embodiment in which the aliphatic hydrocarbon group has oxygen atoms in the hydrocarbon chain is exemplified.

[0867] R N1 and R N2 Examples of aliphatic hydrocarbon groups constituting the group include straight-chain or branched chain alkyl groups, cyclic alkyl groups, groups related to combinations of chain alkyl groups and cyclic alkyl groups, and alkyl groups having oxygen atoms in the chain. The straight-chain or branched chain alkyl groups preferably have 1 to 24 carbon atoms, more preferably 2 to 18 carbon atoms, and more preferably 3 to 12 carbon atoms. Examples of straight-chain or branched chain alkyl groups include methyl groups, ethyl groups, propyl groups, butyl groups, pentyl groups, hexyl groups, heptyl groups, octyl groups, nonyl groups, decyl groups, undecyl groups, dodecyl groups, isopropyl groups, isobutyl groups, secondary butyl groups, tertiary butyl groups, isopentyl groups, neopentyl groups, tertiary pentyl groups, isohexyl groups, etc.

[0868] The cyclic alkyl group preferably has 3 to 12 carbon atoms, and more preferably 3 to 6 carbon atoms. Examples of cyclic alkyl groups include cyclopropyl groups, cyclobutyl groups, cyclopentyl groups, cyclohexyl groups, cyclooctyl groups, etc.

[0869] The group in the combination of chain alkyl groups and cyclic alkyl groups preferably has 4 to 24 carbon atoms, more preferably 4 to 18 carbon atoms, and more preferably 4 to 12 carbon atoms. Examples of the group in the combination of chain alkyl groups and cyclic alkyl groups include cyclohexylmethyl groups, cyclohexylethyl groups, cyclohexylpropyl groups, methylcyclohexylmethyl groups, ethylcyclohexylethyl groups, etc.

[0870] The alkyl group having oxygen atoms in the chain is preferably 2 to 12 carbon atoms, more preferably 2 to 6 carbon atoms, and even more preferably 2 to 4 carbon atoms. The alkyl group having oxygen atoms in the chain may be chain-shaped or cyclic, and may be straight-chain or branched.

[0871] In particular, from the perspective of raising the boiling point of the decomposition-product bases described later, R N1 and R N2An alkyl group having 5 to 12 carbon atoms is preferred. However, in formulations where adhesion is important when laminated with a layer of metal (e.g., copper), it is preferred to be a group having a cyclic alkyl group or an alkyl group having 1 to 8 carbon atoms.

[0872] R N1 and R N2 They may be connected to each other to form a ring structure. In forming a ring structure, they may contain oxygen atoms, etc., within the chain. Also, R N1 and R N2 The cyclic structure formed by the ring may be a single ring or a condensed ring, but a single ring is preferred. As for the cyclic structure formed, a five-membered or six-membered ring containing a nitrogen atom in formula (N1) is preferred, and examples include a pyrrole ring, an imidazole ring, a pyrazol ring, a pyrroline ring, a pyrrolidine ring, an imidazolidin ring, a pyrazolidin ring, a piperidine ring, a piperazine ring, a morpholine ring, etc., and pyrroline ring, a pyrrolidine ring, a piperidine ring, a piperazine ring, and a morpholine ring are preferred.

[0873] R C1 Silver represents a hydrogen atom or a protecting group, and a hydrogen atom is preferred.

[0874] As for the protecting group, a protecting group that decomposes by the action of an acid or a base is preferred, and a protecting group that decomposes by an acid is preferred.

[0875] Specific examples of protecting groups include chain- or cyclic alkyl groups or chain- or cyclic alkyl groups having an oxygen atom in the chain. Examples of chain- or cyclic alkyl groups include methyl groups, ethyl groups, isopropyl groups, tert-butyl groups, cyclohexyl groups, etc. Examples of chain-type alkyl groups having an oxygen atom in the chain include, specifically, alkyloxyalkyl groups, and more specifically, methyloxymethyl (MOM) groups, ethyloxyethyl (EE) groups, etc. Examples of cyclic alkyl groups having an oxygen atom in the chain include epoxy groups, glycidyl groups, oxetanyl groups, tetrahydrofuranyl groups, tetrahydropyranyl (THP) groups, etc.

[0876] As for the divalent linker constituting L, although not specifically determined, a hydrocarbon group is preferred, and an aliphatic hydrocarbon group is more preferred. The hydrocarbon group may have substituents, and may also have atoms of a type other than carbon atoms in the hydrocarbon chain. More specifically, it is preferred to be a divalent hydrocarbon linker that may have an oxygen atom in the chain, and a group relating to a combination of a divalent aliphatic hydrocarbon group that may have an oxygen atom in the chain, a divalent aromatic hydrocarbon group, or a divalent aliphatic hydrocarbon group that may have an oxygen atom in the chain is more preferred, and a divalent aliphatic hydrocarbon group that may have an oxygen atom in the chain is more preferred. It is preferable that these groups do not have an oxygen atom.

[0877] The divalent hydrocarbon linker preferably has 1 to 24 carbon atoms, more preferably 2 to 12, and more preferably 2 to 6. The divalent aliphatic hydrocarbon group preferably has 1 to 12 carbon atoms, more preferably 2 to 6, and more preferably 2 to 4. The divalent aromatic hydrocarbon group preferably has 6 to 22 carbon atoms, more preferably 6 to 18, and more preferably 6 to 10. The group (e.g., arylenealkyl group) in combination with the divalent aliphatic hydrocarbon group and the divalent aromatic hydrocarbon group preferably has 7 to 22 carbon atoms, more preferably 7 to 18, and more preferably 7 to 10.

[0878] Specifically, as the linker L, a straight or branched chain alkylene group, a cyclic alkylene group, a group relating to a combination of a chain alkylene group and a cyclic alkylene group, an alkylene group having an oxygen atom in the chain, a straight or branched chain alkenylene group, a cyclic alkenylene group, an arylene group, or an arylenealkylene group is preferred.

[0879] The straight or branched chain-shaped alkylene group preferably has 1 to 12 carbon atoms, more preferably 2 to 6 carbon atoms, and even more preferably 2 to 4 carbon atoms.

[0880] The cyclic alkylene group preferably has 3 to 12 carbon atoms, and more preferably 3 to 6 carbon atoms.

[0881] The group having a combination of chain alkylene groups and cyclic alkylene groups preferably has 4 to 24 carbon atoms, more preferably 4 to 12 carbon atoms, and even more preferably 4 to 6 carbon atoms.

[0882] The alkylene group having an oxygen atom in the chain may be chain-shaped or cyclic, and may be straight-chain or branched. The alkylene group having an oxygen atom in the chain preferably has 1 to 12 carbon atoms, more preferably 1 to 6 carbon atoms, and even more preferably 1 to 3 carbon atoms.

[0883] The straight or branched alkene group preferably has 2 to 12 carbon atoms, more preferably 2 to 6, and more preferably 2 to 3. The straight or branched alkene group preferably has 1 to 10 C=C bonds, more preferably 1 to 6, and more preferably 1 to 3.

[0884] The cyclic alkenylene group preferably has 3 to 12 carbon atoms, and more preferably 3 to 6. The number of C=C bonds in the cyclic alkenylene group is preferably 1 to 6, more preferably 1 to 4, and more preferably 1 to 2.

[0885] The arylene group preferably has 6 to 22 carbon atoms, more preferably 6 to 18, and more preferably 6 to 10.

[0886] The arylenealkylene group preferably has 7 to 23 carbon atoms, more preferably 7 to 19 carbon atoms, and even more preferably 7 to 11 carbon atoms.

[0887] Among these, chain alkylene groups, cyclic alkylene groups, alkylene groups having an oxygen atom in the chain, chain alkenylene groups, arylene groups, and arylenealkylene groups are preferred, and 1,2-ethylene groups, propanediyl groups (particularly 1,3-propanediyl groups), cyclohexanediyl groups (particularly 1,2-cyclohexanediyl groups), vinylene groups (particularly cis-vinylene groups), phenylene groups (1,2-phenylene groups), phenylenemethylene groups (particularly 1,2-phenylenemethylene groups), and ethyleneoxyethylene groups (particularly 1,2-ethyleneoxy-1,2-ethylene groups) are more preferred.

[0888] Examples of base-generating agents may be given below, but the present invention is not to be interpreted as being limited thereto.

[0889] [Chemical Formula 50]

[0890]

[0891] The molecular weight of the nonionic base generator is preferably 800 or less, more preferably 600 or less, and even more preferably 500 or less. As for the lower limit, it is preferably 100 or more, more preferably 200 or more, and even more preferably 300 or more.

[0892] Specific preferred compounds of ionic base generating agents include, for example, compounds described in paragraphs 0148 to 0163 of International Publication No. 2018 / 038002.

[0893] Specific examples of ammonium salts include the following compounds, but the present invention is not limited to these.

[0894] [Chemical Formula 51]

[0895]

[0896] Specific examples of aluminum salts include the following compounds, but the present invention is not limited to these.

[0897] [Chemical Formula 52]

[0898]

[0899] When the resin composition of the present invention includes a base generating agent, the content of the base generating agent is preferably 0.1 to 50 parts by mass per 100 parts by mass of the resin in the resin composition of the present invention. The lower limit is more preferably 0.3 parts by mass or more, and more preferably 0.5 parts by mass or more. The upper limit is more preferably 30 parts by mass or less, more preferably 20 parts by mass or less, and even more preferably 10 parts by mass or less, and may be 5 parts by mass or less, or 4 parts by mass or less.

[0900] One or more base generating agents may be used. When two or more are used, it is preferable that the total amount be within the above range.

[0901] In addition, as described above, in the present invention, a base may be generated from a specific resin, or a base or a base generating agent may be included in the developer or treatment solution to penetrate the film.

[0902] Therefore, compared to a resin composition containing a conventional base generator and a cyclizing resin or its precursor, the composition can be designed to reduce the content of the base generator. As a result, residues after base generation and undissolved base generators themselves are less likely to remain in the composition, which reduces the amount of outgassing from the cured product and is believed to improve the adhesion of the cured product.

[0903] In such an embodiment, it is also preferable to have the content of the base generating agent 2 mass% or less per 100 mass parts of resin. Furthermore, it is preferable to have the content of the base generating agent 1 mass% or less per 100 mass parts of resin, and more preferable to have it 0.5 mass% or less. In addition, it is also preferable to have the content of the base generating agent 0.1 mass% or less per 100 mass parts of resin. In these embodiments, the lower limit of the content of the base generating agent may be 0 mass%.

[0904] The content of the base generating agent can be determined by considering the type and amount of base generated from a specific resin, the type and amount of base included in the developer or treatment solution, heating conditions, etc.

[0905] Solvent

[0906] In the present invention, the resin composition preferably includes a solvent.

[0907] A known solvent may be used at any time. An organic solvent is preferred. Examples of organic solvents include compounds such as esters, ethers, ketones, cyclic hydrocarbons, sulfoxides, amides, ureas, and alcohols.

[0908] As esters, for example, ethyl acetate, n-butyl acetate, isobutyl acetate, hexyl acetate, amyl formate, isoamyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkyloxyacetates (for example, methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (for example, methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkyloxypropionate esters (for example, methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate). et al. (e.g., methyl methoxypropionate, ethyl methoxypropionate, methyl ethoxypropionate, ethyl ethoxypropionate, etc.), alkyl esters of 2-alkyloxypropionates (e.g., methyl 2-alkyloxypropionate, ethyl 2-alkyloxypropionate, propyl 2-alkyloxypropionate, etc. (e.g., methyl methoxypropionate, ethyl methoxypropionate, propyl methoxypropionate, methyl ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkyloxy-2-methylpropionate and ethyl 2-alkyloxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, Suitable examples include 2-ethoxy-2-methylpropionate ethyl, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, 2-methyl oxobutanate, 2-ethyl oxobutanate, ethyl hexanoate, ethyl heptanoate, dimethyl malonicate, diethyl malonicate, etc.

[0909] As ethers, for example, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol butyl methyl ether, triethylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol dimethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, Suitable examples include diethylene glycol ethyl methyl ether, propylene glycol monopropyl ether acetate, dipropylene glycol dimethyl ether, etc.

[0910] Suitable ketones include, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 3-methylcyclohexanone, levoglucosenone, dihydrolevoglucosenone.

[0911] Suitable examples of cyclic hydrocarbons include aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene.

[0912] As for sulfoxides, for example, dimethyl sulfoxide can be cited as a suitable example.

[0913] Suitable amides include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, N,N-dimethylisobutylamide, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide, N-formylmorpholine, N-acetylmorpholine, etc.

[0914] Suitable examples of ureas include N,N,N',N'-tetramethylurea, 1,3-dimethyl-2-imidazolidinone, etc.

[0915] Examples of alcohols include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 1-hexanol, benzyl alcohol, ethylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-ethoxyethanol, diethylene glycol monoethyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monomethyl ether, polyethylene glycol monomethyl ether, polypropylene glycol, tetraethylene glycol, ethylene glycol monobutyl ether, ethylene glycol monobenzyl ether, ethylene glycol monophenyl ether, methylphenylcarbinol, n-amyl alcohol, methylamyl alcohol, and diacetone alcohol.

[0916] For the solvent, it is also desirable to use a mixture of two or more types from the perspective of improving the properties of the coated surface.

[0917] In the present invention, one solvent selected from methyl 3-ethoxypropionate, ethyl ethoxypropionate, ethyl cellosolve acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, cyclohexanone, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, ethyl carbitol acetate, butyl carbitol acetate, N-methyl-2-pyrrolidone, propylene glycol methyl ether, and propylene glycol methyl ether acetate, levoglucosenone, and dihydrolevoglucosenone, or a mixed solvent composed of two or more types is preferred. The combined use of dimethyl sulfoxide and γ-butyrolactone, or the combined use of N-methyl-2-pyrrolidone and ethyl lactate is particularly preferred.

[0918] From the perspective of coating properties, the solvent content is preferably such that the total solid content of the resin composition in the present invention is 5 to 80 mass%, more preferably such that it is 5 to 75 mass%, even more preferably such that it is 10 to 70 mass%, and even more preferably such that it is 20 to 70 mass%. The solvent content can be adjusted according to the desired thickness of the coating film and the coating method.

[0919] The resin composition of the present invention may contain only one type of solvent or may contain two or more types. When two or more types of solvents are contained, it is preferable that the total amount is within the above range.

[0920] Metal Adhesion Improver

[0921] In the present invention, the resin composition preferably includes a metal adhesion modifier to improve adhesion to metal materials used for electrodes or wiring. Examples of metal adhesion modifiers include silane coupling agents having an alkoxysilyl group, aluminum-based adhesion aids, titanium-based adhesion aids, compounds having a sulfonamide structure and compounds having a thiourea structure, phosphate derivative compounds, β-keto ester compounds, amino compounds, etc.

[0922] [Silain Coupling Agent]

[0923] Examples of silane coupling agents include the compound described in paragraph 0167 of International Patent Publication No. 2015 / 199219, the compound described in paragraphs 0062 to 0073 of Japanese Patent Publication No. 2014-191002, the compound described in paragraphs 0063 to 0071 of International Patent Publication No. 2011 / 080992, the compound described in paragraphs 0060 to 0061 of Japanese Patent Publication No. 2014-191252, the compound described in paragraphs 0045 to 0052 of Japanese Patent Publication No. 2014-041264, the compound described in paragraph 0055 of International Patent Publication No. 2014 / 097594, and the compound described in paragraphs 0067 to 0078 of Japanese Patent Publication No. 2018-173573, the contents of which are provided herein By reference in the specification. In addition, it is also preferable to use two or more different silane coupling agents as described in paragraphs 0050 to 0058 of Japanese Patent Publication No. 2011-128358. In addition, it is also preferable to use the following compounds as silane coupling agents. In the following formulas, Me represents a methyl group and Et represents an ethyl group.

[0924] [Chemical Formula 53]

[0925]

[0926] Other silane coupling agents include, for example, vinyl trimethoxysilane, vinyl trimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyl trimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, p-styryl trimethoxysilane, 3-methacryloxypropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, Examples include N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, tris-(trimethoxysilylpropyl)isocyanurate, 3-ureidopropyltrialkoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane, and 3-trimethoxysilylpropylsuccinic anhydride. These may be used individually or in combination of two or more.

[0927] [Aluminum-based adhesive preparations]

[0928] Examples of aluminum-based adhesive aids include aluminum tris(ethyl acetoacetate), aluminum tris(acetylacetonate), ethyl acetoacetate aluminum diisopropylate, etc.

[0929] In addition, as other metal adhesion modifiers, compounds described in paragraphs 0046 to 0049 of Japanese Patent Publication No. 2014-186186 and sulfide-based compounds described in paragraphs 0032 to 0043 of Japanese Patent Publication No. 2013-072935 may be used, and the contents thereof are incorporated herein by reference.

[0930] The content of the metal adhesion modifier is preferably in the range of 0.01 to 30 parts by mass, more preferably in the range of 0.1 to 10 parts by mass, and even more preferably in the range of 0.5 to 5 parts by mass, per 100 parts by mass of a specific resin. By making the content above the lower limit value, the adhesion between the pattern and the metal layer is improved, and by making the content below the upper limit value, the heat resistance and mechanical properties of the pattern are improved. The metal adhesion modifier may be of only one type or two or more types. When two or more types are used, it is preferable that their total amount falls within the above range.

[0931] Migration Inhibitor

[0932] In the present invention, the resin composition preferably further comprises a migration inhibitor. By including a migration inhibitor, it is possible to effectively inhibit the movement of metal ions originating from the metal layer (metal wiring) into the membrane.

[0933] Examples of migration inhibitors include, although not specifically limited, compounds having a heterocyclic ring (pyrrole ring, furan ring, thiophene ring, imidazole ring, oxazole ring, thiazole ring, pyrazol ring, iso-oxazole ring, isothiazol ring, tetrazole ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, piperidine ring, piperazine ring, morpholine ring, 2H-pyran ring and 6H-pyran ring, triazine ring), thiourea groups and compounds having a sulfanyl group, hindered phenolic compounds, salicylic acid derivative compounds, and hydrazide derivative compounds. In particular, triazole compounds such as 1,2,4-triazole, benzotriazole, 3-amino-1,2,4-triazole, and 3,5-diamino-1,2,4-triazole, and tetrazole compounds such as 1H-tetrazole, 5-phenyltetrazole, and 5-amino-1H-tetrazole can be preferably used.

[0934] Alternatively, an ion trapping agent that captures anions such as halogen ions may be used.

[0935] Other migration inhibitors may be used, such as the rust inhibitor described in paragraph 0094 of Japanese Patent Publication No. 2013-015701, the compounds described in paragraphs 0073 to 0076 of Japanese Patent Publication No. 2009-283711, the compounds described in paragraph 0052 of Japanese Patent Publication No. 2011-059656, the compounds described in paragraphs 0114, 0116, and 0118 of Japanese Patent Publication No. 2012-194520, and the compounds described in paragraph 0166 of International Patent Publication No. 2015 / 199219, the contents of which are incorporated herein by reference.

[0936] Specific examples of migration inhibitors include the following compounds.

[0937] [Chemical Formula 54]

[0938]

[0939] In the case where the resin composition of the present invention has a migration inhibitor, the content of the migration inhibitor is preferably 0.01 to 5.0 mass% with respect to the total solid content of the resin composition of the present invention, more preferably 0.05 to 2.0 mass%, and even more preferably 0.1 to 1.0 mass%.

[0940] There may be only one type of migration inhibitor, or two or more types. If there are two or more types of migration inhibitors, it is preferable that the total is within the above range.

[0941] Polymerization Inhibitor

[0942] In the present invention, the resin composition preferably includes a polymerization inhibitor. Examples of polymerization inhibitors include phenolic compounds, quinone compounds, amino compounds, N-oxyl free radical compounds, nitro compounds, nitroso compounds, heteroaromatic compounds, metal compounds, etc.

[0943] Specific compounds of polymerization inhibitors include p-hydroquinone, o-hydroquinone, o-methoxyphenol, p-methoxyphenol, di-tert-butyl-p-cresol, pyrrogallol, p-tert-butylcatechol, 1,4-benzoquinone, diphenyl-p-benzoquinone, 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-tert-butylphenol), N-nitrosophenylhydroxyamine cerium salt, N-nitroso-N-phenylhydroxyamine aluminum salt, N-nitrosodiphenylamine, N-phenylnaphthylamine, ethylenediamine tetraacetic acid, 1,2-cyclohexanediamine tetraacetic acid, glycol etherdiamine tetraacetic acid, 2,6-di-tert-butyl-4-methylphenol, 5-nitroso-8-hydroxyquinoline, 1-nitroso-2-naphthol, 2-nitroso-1-naphthol, 2-nitroso-5-(N-ethyl-N-sulfopropylamino)phenol, N-nitroso-N-(1-naphthyl)hydroxyamine ammonium salt, bis(4-hydroxy-3,5-tert-butyl)phenylmethane, 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical, 2,2,6,6-tetramethylpiperidine 1-oxyl free radical, phenothiazine, phenoxazine, 1,1-diphenyl-2-picrylhydrazine, dibutyldithiocarbanate copper(II), nitrobenzene, N-nitroso-N-phenylhydroxylamine aluminum salt, N-nitroso-N-phenylhydroxylamine ammonium salt, etc. are suitably used. In addition, polymerization inhibitors described in paragraph 0060 of Japanese Patent Publication No. 2015-127817 and compounds described in paragraphs 0031 to 0046 of International Patent Publication No. 2015 / 125469 may be used, and the contents thereof are incorporated herein by reference.

[0944] When the resin composition of the present invention has a polymerization inhibitor, the content of the polymerization inhibitor is preferably 0.01 to 20 mass% with respect to the total solid content of the resin composition of the present invention, more preferably 0.02 to 15 mass% or less, and even more preferably 0.05 to 10 mass% or less.

[0945] There may be only one type of polymerization inhibitor or two or more types. If there are two or more types of polymerization inhibitors, it is preferable that the total amount is within the above range.

[0946] Other Additives

[0947] In the resin composition of the present invention, within the range where the effects of the present invention are obtained, various additives, such as surfactants, higher fatty acid derivatives, thermal polymerization initiators, inorganic particles, ultraviolet absorbers, organic titanium compounds, antioxidants, anti-aggregation agents, phenolic compounds, other polymer compounds, plasticizers, and other additives (such as defoaming agents, flame retardants, etc.) may be incorporated as needed. By appropriately including these components, properties such as film properties can be adjusted. These components may be described by referring, for example, to paragraph no. 0183 onwards of Japanese Patent Publication No. 2012-003225 (paragraph no. 0237 of the corresponding U.S. Patent Application Publication No. 2013 / 0034812), and paragraphs no. 0101 to 0104, 0107 to 0109 of Japanese Patent Publication No. 2008-250074, the contents of which are incorporated herein by reference. When these additives are incorporated, it is preferable that the total amount incorporated be 3 mass% or less of the solid content of the resin composition in the present invention.

[0948] [Surfactant]

[0949] Various surfactants, such as fluorine-based surfactants, silicone-based surfactants, and hydrocarbon-based surfactants, can be used as surfactants. The surfactant may be a nonionic surfactant, a cationic surfactant, or an anionic surfactant.

[0950] By incorporating a surfactant into the resin composition of the present invention, the liquid characteristics (particularly fluidity) when prepared as a coating solution are further improved, thereby further enhancing the uniformity of the coating thickness and liquid reduction. That is, when forming a film using a coating solution to which a composition containing a surfactant has been applied, the interfacial tension between the surface to be coated and the coating solution is reduced, thereby improving wettability to the surface to be coated and enhancing coating performance. Consequently, it is possible to more suitably form a film of uniform thickness with minimal thickness non-uniformity.

[0951] As fluorinated surfactants, for example, Megapac F171, F172, F173, F176, F177, F141, F142, F143, F144, R30, F437, F475, F479, F482, F554, F780, RS-72-K (all manufactured by DIC Inc.), Fluorad FC430, FC431, FC171, Novec FC4430, FC4432 (all manufactured by 3M Japan Inc.), Surfron S-382, SC-101, SC-103, SC-104, SC-105, SC-1068, SC-381, SC-383, S-393, etc. Examples include KH-40 (manufactured by Asahi Glass Co., Ltd.), PF636, PF656, PF6320, PF6520, and PF7002 (manufactured by OMNOVA). As for the fluorine-based surfactant, compounds described in paragraphs 0015 to 0158 of Japanese Patent Publication No. 2015-117327 and compounds described in paragraphs 0117 to 0132 of Japanese Patent Publication No. 2011-132503 may be used, the contents thereof being incorporated herein by reference. Block polymers may be used as fluorine-based surfactants, and specific examples include, for instance, compounds described in Japanese Patent Publication No. 2011-89090, the contents thereof being incorporated herein by reference.

[0952] Fluorine-based surfactants may preferably include fluorine-containing polymer compounds comprising repeating units derived from (meth)acrylate compounds having fluorine atoms and repeating units derived from (meth)acrylate compounds having 2 or more (preferably 5 or more) alkyleneoxy groups (preferably ethyleneoxy groups, propyleneoxy groups), and the following compounds are also exemplified as fluorine-based surfactants used in the present invention.

[0953] [Chemical Formula 55]

[0954]

[0955] The weight average molecular weight of the above compound is preferably 3,000 to 50,000, and more preferably 5,000 to 30,000.

[0956] As for the fluorine-based surfactant, a fluorine-containing polymer having an ethylenically unsaturated group in its side chain may be used as the fluorine-based surfactant. Specific examples include compounds described in paragraphs 0050 to 0090 and 0289 to 0295 of Japanese Patent Publication No. 2010-164965, which are incorporated herein by reference. In addition, commercially available products include, for example, MegaPac RS-101, RS-102, RS-718K, etc., manufactured by DIC Inc.

[0957] The fluorine content in the fluorine-based surfactant is preferably 3 to 40 mass%, more preferably 5 to 30 mass%, and particularly preferably 7 to 25 mass%. Fluorine-based surfactants with a fluorine content within this range are effective in terms of uniformity of coating film thickness and liquid reduction, and also have good solubility in the composition.

[0958] Examples of silicone-based surfactants include Toray Silicon DC3PA, Toray Silicon SH7PA, Toray Silicon DC11PA, Toray Silicon SH21PA, Toray Silicon SH28PA, Toray Silicon SH29PA, Toray Silicon SH30PA, and Toray Silicon SH8400 (all manufactured by Toray Dow Corning Inc.), TSF-4440, TSF-4300, TSF-4445, TSF-4460, and TSF-4452 (all manufactured by Momentive Performance Materials Inc.), KP-341, KF6001, and KF6002 (all manufactured by Shin-Etsu Silicon Inc.), and BYK307, BYK323, and BYK330 (all manufactured by Big Chemie Inc.).

[0959] Examples of hydrocarbon surfactants include Pionin A-76, Newcargen FS-3PG, Pionin B-709, Pionin B-811-N, Pionin D-1004, Pionin D-3104, Pionin D-3605, Pionin D-6112, Pionin D-2104-D, Pionin D-212, Pionin D-931, Pionin D-941, Pionin D-951, Pionin E-5310, Pionin P-1050-B, Pionin P-1028-P, Pionin P-4050-T, etc. (all manufactured by Takemoto Y.C.).

[0960] Examples of nonionic surfactants include glycerol, trimethylolpropane, trimethylolethane and their ethoxylates and propoxylates (e.g., glycerol propoxylate, glycerol ethoxylate, etc.), polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether, polyethylene glycol dilaurate, polyethylene glycol distearate, sorbitan fatty acid ester, etc. Examples of commercially available products include Pluronic (registered trademark) L10, L31, L61, L62, 10R5, 17R2, 25R2 (manufactured by BASF), Tetronic 304, 701, 704, 901, 904, 150R1 (manufactured by BASF), Solspers 20000 (manufactured by Nihon Lubrizol Co., Ltd.), NCW-101, NCW-1001, NCW-1002 (manufactured by Wako Junyaku Kogyo Co., Ltd.), Pioneerin D-6112, D-6112-W, D-6315 (manufactured by Takemoto Yushi Co., Ltd.), Olfin E1010, Surfinol 104, 400, 440 (manufactured by Nissin Kagaku Kogyo Co., Ltd.), etc.

[0961] Specifically, cationic surfactants include organosiloxane polymer KP-341 (manufactured by Shin-Etsu Chemical Co., Ltd.), (meth)acrylic acid-based (co)polymer Polyflow No. 75, No. 77, No. 90, No. 95 (manufactured by Kyoei Chemical Co., Ltd.), W001 (manufactured by Yusho Co., Ltd.), etc.

[0962] Specifically, examples of anionic surfactants include W004, W005, W017 (manufactured by Yusho Co., Ltd.), Sandet BL (manufactured by Sanyo Kasei Co., Ltd.), etc.

[0963] Surfactants may be used in the form of only one type, or two or more types may be combined.

[0964] The content of the surfactant is preferably 0.001 to 2.0 mass% with respect to the total solid content of the composition, and more preferably 0.005 to 1.0 mass%.

[0965] [Higher Fatty Acid Derivatives]

[0966] In order to prevent polymerization inhibition caused by oxygen, the resin composition of the present invention may include a higher fatty acid derivative, such as behenic acid or behenic acid amide, and may be distributed on the surface of the resin composition of the present invention during the drying process after coating.

[0967] In addition, higher fatty acid derivatives may use compounds described in paragraph 0155 of International Publication No. 2015 / 199219, and this is incorporated herein by reference.

[0968] In the case where the resin composition of the present invention has a higher fatty acid derivative, the content of the higher fatty acid derivative is preferably 0.1 to 10 mass% with respect to the total solid content of the resin composition of the present invention. The higher fatty acid derivative may be one type or two or more types. If there are two or more types of higher fatty acid derivatives, the total thereof is preferably within the above range.

[0969] [Thermal Polymerization Initiator]

[0970] The resin composition of the present invention may include a thermal polymerization initiator, and in particular, may include a thermal radical polymerization initiator. A thermal radical polymerization initiator is a compound that generates radicals by thermal energy to initiate or promote the polymerization reaction of a polymerizable compound. Since the polymerization reaction of the resin and the polymerizable compound can be carried out by adding a thermal radical polymerization initiator, solvent resistance can be further improved. In addition, the aforementioned photopolymerization initiator may also have the function of initiating polymerization by heat and may be added as a thermal polymerization initiator.

[0971] As a thermal radical polymerization initiator, specifically, compounds described in paragraphs 0074 to 0118 of Japanese Patent Publication No. 2008-063554 may be cited, and the contents thereof are incorporated herein by reference.

[0972] When a thermal polymerization initiator is included, the content thereof is preferably 0.1 to 30 mass% with respect to the total solid content of the resin composition in the present invention, more preferably 0.1 to 20 mass%, and even more preferably 0.5 to 15 mass%. The thermal polymerization initiator may be included as a single type or as two or more types. When two or more types of thermal polymerization initiators are included, the total amount is preferably within the above range.

[0973] [Inorganic Particles]

[0974] The resin composition of the present invention may include inorganic particles. Specifically, as inorganic particles, calcium carbonate, calcium phosphate, silica, kaolin, talc, titanium dioxide, alumina, barium sulfate, calcium fluoride, lithium fluoride, zeolite, molybdenum sulfide, glass, etc.

[0975] As for the average particle size of the above inorganic particles, 0.01 to 2.0 μm is preferred, 0.02 to 1.5 μm is more preferred, 0.03 to 1.0 μm is more preferred, and 0.04 to 0.5 μm is particularly preferred.

[0976] The above average particle size of the inorganic particle is the primary particle size and also the volume average particle size. The volume average particle size can be measured by dynamic light scattering using Nanotrac WAVE II EX-150 (manufactured by Nikkiso Co., Ltd.).

[0977] If the above measurement is difficult, it may also be measured by centrifugal sedimentation light transmission, X-ray transmission, or laser diffraction and scattering.

[0978] [UV absorber]

[0979] The resin composition of the present invention may include an ultraviolet absorber. As the ultraviolet absorber, ultraviolet absorbers such as salicylate-based, benzophenone-based, benzotriazole-based, substituted acrylonitrile-based, and triazine-based absorbers may be used.

[0980] Examples of salicylate-based ultraviolet absorbers include phenyl salicylate, p-octylphenyl salicylate, pt-butylphenyl salicylate, etc. Examples of benzophenone-based ultraviolet absorbers include 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2,4-dihydroxybenzophenone, 2-hydroxy-4-octoxybenzophenone, etc. In addition, examples of benzotriazole-based ultraviolet absorbers include 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-amyl-5'-isobutylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-propylphenyl)-5-chlorobenzotriazole, and 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole. Examples include 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[2'-hydroxy-5'-(1,1,3,3-tetramethyl)phenyl]benzotriazole, etc.

[0981] Examples of substituted acrylonitrile-based ultraviolet absorbers include 2-cyano-3,3-diphenylacrylate ethyl, 2-cyano-3,3-diphenylacrylate 2-ethylhexyl. In addition, examples of triazine-based ultraviolet absorbers include mono(hydroxyphenyl)triazine compounds such as 2-[4-[(2-hydroxy-3-dodecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine, 2-[4-[(2-hydroxy-3-tridecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine, and 2-(2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine; Bis(hydroxyphenyl)triazine compounds such as 2,4-bis(2-hydroxy-4-propyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-triazine, 2,4-bis(2-hydroxy-3-methyl-4-propyloxyphenyl)-6-(4-methylphenyl)-1,3,5-triazine, 2,4-bis(2-hydroxy-3-methyl-4-hexyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-triazine; Examples include tris(hydroxyphenyl)triazine compounds such as 2,4-bis(2-hydroxy-4-butoxyphenyl)-6-(2,4-dibutoxyphenyl)-1,3,5-triazine, 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazine, and 2,4,6-tris[2-hydroxy-4-(3-butoxy-2-hydroxypropyloxy)phenyl]-1,3,5-triazine.

[0982] In the present invention, the various ultraviolet absorbers may be used as a single type or in combination of two or more types.

[0983] The resin composition of the present invention may or may not include an ultraviolet absorber, but if included, the content of the ultraviolet absorber is preferably 0.001 mass% or more and 1 mass% or less with respect to the total solid mass of the resin composition of the present invention, and more preferably 0.01 mass% or more and 0.1 mass% or less.

[0984] [Organic Titanium Compounds]

[0985] The resin composition of the present embodiment may contain an organic titanium compound. By containing an organic titanium compound, the resin composition can form a resin layer with excellent chemical resistance even when cured at a low temperature.

[0986] Examples of usable organic titanium compounds include those in which an organic group is bonded to a titanium atom through covalent or ionic bonds.

[0987] Specific examples of organic titanium compounds are shown in I) to VII) below:

[0988] I) Titanium chelate compounds: Among these, titanium chelate compounds having two or more alkoxy groups are more preferred in that they provide good storage stability of the resin composition and a good curing pattern. Specific examples include titanium bis(triethanolamine)diisopropoxide, titanium di(n-butoxide)bis(2,4-pentanethionate), titanium diisopropoxide bis(2,4-pentanethionate), titanium diisopropoxide bis(tetramethylheptanethionate), titanium diisopropoxide bis(ethylacetoacetate), etc.

[0989] II) Tetraalkoxytitanium compounds: e.g., titanium tetra(n-butoxide), titanium tetraethoxide, titanium tetra(2-ethylhexooxide), titanium tetraisobutoxide, titanium tetraisopropoxide, titanium tetramethoxide, titanium tetramethoxypropoxide, titanium tetramethylphenoxide, titanium tetra(n-nonyloxide), titanium tetra(n-propoxide), titanium tetrastearyloxide, titanium tetrakis[bis{2,2-(allyloxymethyl)butoxide}], etc.

[0990] III) Titanocene compounds: for example, pentamethylcyclopentadieneyl titanium trimethoxide, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluorophenyl)titanium, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluoro-3-(1H-pyrrole-1-yl)phenyl)titanium, etc.

[0991] IV) Monoalkoxytitanium compounds: Examples include titanium tris(dioctyl phosphate)isopropoxide, titanium tris(dodecylbenzenesulfonate)isopropoxide, etc.

[0992] V) Titanium oxide compounds: Examples include titanium oxide bis(pentanethionate), titanium oxide bis(tetramethylheptanethionate), phthalocyanine titanium oxide, etc.

[0993] VI) Titanium tetraacetylacetonate compounds: e.g., titanium tetraacetylacetonate, etc.

[0994] VII) Titanate coupling agents: e.g., isopropyltridodecylbenzenesulfonyl titanate, etc.

[0995] Among these, as an organic titanium compound, it is preferable that at least one compound selected from the group consisting of I) titanium chelate compounds, II) tetraalkoxytitanium compounds, and III) titanocene compounds exhibits better chemical resistance. In particular, titanium diisopropoxide bis(ethylacetoacetate), titanium tetra(n-butoxide), and bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluoro-3-(1H-pyrrole-1-yl)phenyl)titanium are preferred.

[0996] When incorporating an organic titanium compound, the amount of incorporation is preferably 0.05 to 10 parts by mass per 100 parts by mass of a specific resin, and more preferably 0.1 to 2 parts by mass. When the incorporation amount is 0.05 parts by mass or more, good heat resistance and chemical resistance are more effectively expressed in the resulting cured pattern, whereas when it is 10 parts by mass or less, the storage stability of the composition is superior.

[0997] [Antioxidant]

[0998] The resin composition of the present invention may include an antioxidant. By including an antioxidant as an additive, the elongation characteristics of the film after curing and the adhesion to the metal material can be improved. Examples of antioxidants include phenol compounds, phosphite ester compounds, and thioether compounds. As for the phenol compound, any phenol compound known as a phenolic antioxidant may be used. Preferred phenol compounds include hindered phenol compounds. A compound having a substituent at a site adjacent to the phenolic hydroxyl group (orthosite) is preferred. As for the aforementioned substituent, a substituted or unsubstituted alkyl group having 1 to 22 carbon atoms is preferred. In addition, a compound having a phenol group and a phosphite ester group within the same molecule is also preferred as the antioxidant. Furthermore, phosphorus-based antioxidants may also be suitably used as the antioxidant. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetrakis(1,1-dimethylethyl)dibenzo[d,f][1,3,2]dioxaphosperfin-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tert-butyldibenzo[d,f][1,3,2]dioxaphosperfin-2-yl)oxy]ethyl]amine, and ethylbis(2,4-di-tert-butyl-6-methylphenyl) phosphite. Examples of commercially available antioxidants include Adekastav AO-20, Adekastav AO-30, Adekastav AO-40, Adekastav AO-50, Adekastav AO-50F, Adekastav AO-60, Adekastav AO-60G, Adekastav AO-80, Adekastav AO-330 (all manufactured by ADEKA Inc.). Additionally, compounds described in paragraphs 0023 to 0048 of Japanese Patent Publication No. 6268967 may be used as antioxidants, and this content is incorporated herein by reference. Furthermore, the resin composition of the present invention may contain a latent antioxidant if necessary.Examples of potential antioxidants include compounds in which the portion functioning as an antioxidant is protected by a protecting group, and compounds that function as antioxidants by heating at 100 to 250°C or by heating at 80 to 200°C in the presence of an acid / base catalyst, thereby removing the protecting group. Examples of potential antioxidants include compounds described in International Publication No. 2014 / 021023, International Publication No. 2017 / 030005, and Japanese Patent Publication No. 2017-008219, the contents of which are incorporated herein by reference. Examples of commercially available potential antioxidants include ADEKA Arcles GPA-5001 (manufactured by ADEKA Inc.).

[0999] Examples of desirable antioxidants include 2,2-thiobis(4-methyl-6-t-butylphenol), 2,6-di-t-butylphenol, and compounds represented by formula (3).

[1000] [Chemical Formula 56]

[1001]

[1002] In general formula (3), R 5 represents a hydrogen atom or an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), and R 6 represents an alkylene group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms). R 7 It represents an organic group having 1 to 4 valence comprising at least one of an alkylene group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), an oxygen atom, and a nitrogen atom. k represents an integer from 1 to 4.

[1003] The compound represented by formula (3) inhibits the oxidative deterioration of aliphatic groups or phenolic hydroxyl groups in the resin. In addition, it can inhibit metal oxidation through its anti-corrosion action on metal materials.

[1004] Since it can act on resin and metal materials simultaneously, an integer k of 2 to 4 is more preferable. R 7Examples include alkyl groups, cycloalkyl groups, alkoxy groups, alkyl ether groups, alkylsilyl groups, alkoxysilyl groups, aryl groups, aryl ether groups, carboxyl groups, carbonyl groups, allyl groups, vinyl groups, heterocyclic groups, -O-, -NH-, -NHNH-, and combinations thereof, and may have additional substituents. Among these, having an alkyl ether group or -NH- is preferable in terms of solubility in the developer and metal adhesion, and -NH- is more preferable in terms of metal adhesion due to interaction with the resin and metal complex formation.

[1005] Compounds represented by general formula (3) include the following examples, but are not limited to the following structures.

[1006] [Chemical Formula 57]

[1007]

[1008] [Chemical Formula 58]

[1009]

[1010] [Chemical Formula 59]

[1011]

[1012] [Chemical Formula 60]

[1013]

[1014] The amount of antioxidant added relative to the resin is preferably 0.1 to 10 parts by mass, and more preferably 0.5 to 5 parts by mass. By adding an amount of 0.1 parts by mass or more, it is easy to obtain effects such as improved elongation characteristics or adhesion to metal materials even under high temperature and high humidity environments, and by adding an amount of 10 parts by mass or less, the sensitivity of the resin composition is improved, for example, through interaction with a photosensitive agent. Only one type of antioxidant may be used, or two or more types may be used. If two or more types are used, it is preferable that their total amount be within the above range.

[1015] [Inhibitor]

[1016] The resin composition of the present embodiment may contain an anti-aggregation agent as needed. Examples of anti-aggregation agents include sodium polyacrylate.

[1017] In the present invention, one type of anti-coagulant may be used alone, or two or more types may be used in combination.

[1018] The resin composition of the present invention may or may not include an anti-aggregation agent, but if included, the content of the anti-aggregation agent is preferably 0.01 mass% or more and 10 mass% or less with respect to the total solid mass of the resin composition of the present invention, and more preferably 0.02 mass% or more and 5 mass% or less.

[1019] [Phenol compounds]

[1020] The resin composition of the present embodiment may contain a phenolic compound as needed. Examples of phenolic compounds include Bis-Z, BisP-EZ, TekP-4HBPA, TrisP-HAP, TrisP-PA, BisOCHP-Z, BisP-MZ, BisP-PZ, BisP-IPZ, BisOCP-IPZ, BisP-CP, BisRS-2P, BisRS-3P, BisP-OCHP, Methylenethris-FR-CR, BisRS-26X (all trade names, manufactured by Honshu Kagaku Kogyo Co., Ltd.), BIP-PC, BIR-PC, BIR-PTBP, BIR-BIPC-F (all trade names, manufactured by Asahi Yukizai Kogyo Co., Ltd.).

[1021] In the present invention, one type of phenolic compound may be used alone, or two or more types may be used in combination.

[1022] The resin composition of the present invention may or may not include a phenolic compound, but if included, the content of the phenolic compound is preferably 0.01 mass% or more and 30 mass% or less with respect to the total solid content mass of the resin composition of the present invention, and more preferably 0.02 mass% or more and 20 mass% or less.

[1023] [Other polymer compounds]

[1024] Other polymer compounds include siloxane resin, (meth)acrylic polymer copolymerized with (meth)acrylic acid, novolak resin, resol resin, polyhydroxystyrene resin and copolymers thereof. Other polymer compounds may be modified materials in which crosslinking groups such as methylol groups, alkoxymethyl groups, and epoxy groups have been introduced.

[1025] In the present invention, other polymer compounds may be used alone or in combination of two or more types.

[1026] The resin composition of the present invention may or may not include other polymer compounds, but if included, the content of the other polymer compounds is preferably 0.01 mass% or more and 30 mass% or less with respect to the total solid mass of the resin composition of the present invention, and more preferably 0.02 mass% or more and 20 mass% or less.

[1027] Characteristics of the Resin Composition

[1028] The viscosity of the resin composition in the present invention can be adjusted by the solid content concentration of the resin composition. In terms of coating film thickness, 1,000 mm 2 / s~12,000mm 2 / s is preferable, and 2,000mm 2 / s~10,000mm 2 / s is more preferable, and 2,500mm 2 / s~8,000mm 2 / s is more preferable. Within the above range, it becomes easier to obtain a coating film with high uniformity. 1,000mm 2 If it is greater than / s, for example, it is easy to apply to a film thickness required as an insulating film for redistribution, and 12,000mm 2 If / s or less, a coating film with excellent surface finish is obtained.

[1029] <Limitations on materials contai...

Claims

Claim 1 A method for manufacturing a cured product comprising a film forming process in which a resin composition including a precursor of a cyclized resin is applied to a substrate to form a film, and a heating process in which the film is heated at a heating temperature of 180°C or lower, wherein the glass transition temperature of the obtained cured product is 200°C or higher, the resin composition comprises a polymerizable compound having an aliphatic ring structure, and the precursor of the cyclized resin is a resin having at least one of a repeating unit represented by the following formula (2) and a repeating unit represented by formula (PAI-2). [Chemical Formula 1] Among equation (2), A 1 and A 2 are, respectively, oxygen atoms or -NR z - indicates, R 111 Silver represents a divalent organic group, and R 115 represents a tetravalent organic group, and R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group. In formula (PAI-2), R 117 represents a trivalent organic group, and R 111 represents a divalent organic group, and A 2 is an oxygen atom or -NR z - indicates, R 113 represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group. Claim 2 A method for manufacturing a cured product according to claim 1, wherein the heating temperature is 170℃ or lower. Claim 3 A method for manufacturing a cured product according to claim 1 or claim 2, wherein the film after the heating process is a polyimide film comprising polyimide, and the imidization rate of the polyimide is 90% or more. Claim 4 A method for manufacturing a cured article according to claim 1 or claim 2, further comprising an exposure process for selectively exposing the film between the film forming process and the heating process. Claim 5 A method for manufacturing a cured product according to claim 4, further comprising a developing process between the exposure process and the heating process, wherein the film after exposure is developed by a developing solution to form a pattern. Claim 6 A method for manufacturing a cured product according to claim 5, wherein the developer comprises an organic solvent. Claim 7 A method for manufacturing a cured product according to claim 5, wherein the developing process is a process for forming a negative type pattern. Claim 8 A method for manufacturing a cured product according to claim 5, wherein the developer comprises a base. Claim 9 A method for manufacturing a cured product according to claim 5, comprising a treatment process of contacting a treatment solution containing a base with the pattern between the development process and the heating process. Claim 10 A method for manufacturing a cured product according to claim 1 or claim 2, wherein the resin composition comprises a photosensitive agent. Claim 11 A method for producing a cured product according to claim 1 or claim 2, wherein the resin composition comprises a solvent, and the content of the precursor of the cyclized resin is 70 mass% or more with respect to the total solid content of the resin composition. Claim 12 A method for manufacturing a cured product according to claim 1 or claim 2, wherein the resin composition comprises a polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere. Claim 13 A method for manufacturing a cured product according to claim 12, wherein the polymerizable compound having a boiling point of 200°C or higher at 1 atmosphere is a compound having three or more (meth)acrylate groups. Claim 14 A method for preparing a cured product according to claim 1 or claim 2, wherein the polymerizable compound having an aliphatic ring structure is tricyclodecanedimethylethanoldi(meth)acrylate. Claim 15 In claim 1 or claim 2, R in formula (2) 115 a is a group represented by any one of the following formulas (X1-1) to (X1-3), or a group comprising one or more aliphatic ring structures, wherein R in the above formula (PAI-2) 117 A method for preparing a hardened product comprising a group represented by any one of the following formulas (X2-1) to (X2-3), or a group comprising one or more aliphatic ring structures. [Chemical Formula 2] In Formula (X1-1), R represents a substituent, n1 represents an integer from 0 to 2, and * represents a binding site with another structure. In Formula (X1-2), R independently represents a substituent, m1 independently represents an integer from 0 to 3, and * represents a binding site with another structure. In Formula (X1-3), R independently represents a substituent, m1 independently represents an integer from 0 to 2, and L 1 -CR C Represents 2- or -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure. In Formula (X2-1), R represents a substituent, n2 represents an integer from 0 to 2, and * represents a binding site with another structure. In Formula (X2-2), R independently represents a substituent, m2 represents an integer from 0 to 3, m3 represents an integer from 0 to 4, and * represents a binding site with another structure. In Formula (X2-3), R independently represents a substituent, m2 represents an integer from 0 to 2, m3 represents an integer from 0 to 3, and L 2 is -CR C Represents 2-, -S(=O)2- or -O-, and R C represents a monovalent organic group, and * represents a binding site with another structure, respectively. Claim 16 In claim 1 or claim 2, R in formula (2) 111 A group represented by any one of the following formulas (W1-1) to (W1-5), or a group comprising one or more aliphatic ring structures, wherein R in the above formula (PAI-2) 111 A method for preparing a hardened product comprising a group represented by any one of the following formulas (W1-1) to (W1-3), or a group comprising one or more aliphatic ring structures. [Chemical Formula 3] In Formula (W1-1), R represents a substituent, n1 represents an integer from 0 to 4, and * represents a binding site with another structure. In Formula (W1-2), R represents a substituent independently, m4 represents an integer from 0 to 4 independently, and * represents a binding site with another structure independently. In Formula (W1-3), R represents a substituent independently, m4 represents an integer from 0 to 3 independently, and L 3 -CR C Represents 2- or -S(=O)2-, and R C represents a monovalent organic group, and * represents a binding site with another structure. In Formula (W1-4), R independently represents a substituent, n3 represents an integer from 0 to 6, and * represents a binding site with another structure. In Formula (W1-5), R independently represents a substituent, n4 independently represents an integer from 0 to 3, and X 1 and X 2 Each independently is an oxygen atom, -S(=O)2 or -CR C Representing 2-, and R C Each represents independently a hydrogen atom or a monovalent organic group, and * represents a bonding site with another structure. Claim 17 A method for manufacturing a cured product according to claim 14, wherein if the precursor of the cyclizing resin does not include a repeating unit represented by formula (PAI-2), the following condition 1 is satisfied; if the precursor of the cyclizing resin does not include a repeating unit represented by formula (2), the following condition 2 is satisfied; and if the precursor of the cyclizing resin includes a repeating unit represented by formula (2) and a repeating unit represented by formula (PAI-2), at least one of the following conditions 1 and 2 is satisfied. Condition 1: The precursor of the cyclizing resin is -A in formula (2). 2 -R 113 and -A 1 -R 114 At least one of them includes a repeating unit represented by the following formula (3-1). Condition 2: The precursor of the cyclizing resin is -A in the formula (PAI-2). 2 -R 113 This includes the repeating unit represented by the following formula (3-1). [Chemical Formula 4] In Equation (3-1), Z 1 and Z 2 , each independently represents an organic group, and Z 1 and Z 2 It may combine to form a ring structure, and * indicates a site of connection with another structure. Claim 18 A method for manufacturing a laminate comprising repeating the method for manufacturing a cured product described in claim 1 a plurality of times. Claim 19 A method for manufacturing a semiconductor device comprising the method for manufacturing a cured article as described in claim 1 or claim 2, or the method for manufacturing a laminate as described in claim 18. Claim 20 A resin composition comprising a precursor of a cyclized resin, wherein, when the glass transition temperature is measured under measurement condition 1 below, at least one of three films of different thicknesses has a glass transition temperature of 200°C or higher, the resin composition comprises a polymerizable compound having an aliphatic ring structure, and the precursor of the cyclized resin is a resin having at least one of a repeating unit represented by formula (2) and a repeating unit represented by formula (PAI-2); Measurement condition 1: The resin composition is applied to a silicon substrate to a thickness of 5 μm, 10 μm, or 20 μm, respectively, dried at 100°C for 5 minutes, and then a cured product is obtained by heating at 180°C for 2 hours, and the glass transition temperature of the cured product returned to 25°C is measured using a differential scanning calorimeter. [Chemical Formula 5] Among equation (2), A 1 and A 2 are, respectively, oxygen atoms or -NR z - indicates, R 111 Silver represents a divalent organic group, and R 115 represents a tetravalent organic group, and R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group. In formula (PAI-2), R 117 represents a trivalent organic group, and R 111 represents a divalent organic group, and A 2 is an oxygen atom or -NR z - indicates, R 113 represents a hydrogen atom or a monovalent organic group, and R z represents a hydrogen atom or a monovalent organic group. Claim 21 A resin composition according to claim 20, wherein the polymerizable compound having an aliphatic ring structure is tricyclodecane dimethanol di(meth)acrylate. Claim 22 A cured product formed by curing the resin composition described in claim 20. Claim 23 A laminate comprising two or more layers of a cured product formed by curing a resin composition including a precursor of a cyclized resin, wherein at least one of the layers of the cured product is a layer of the cured product described in claim 22. Claim 24 A semiconductor device comprising the cured material described in claim 22 or the laminate described in claim 23.